Form: 424B3

Prospectus [Rule 424(b)(3)]

November 18, 2025

 

Filed pursuant to Rule 424(b)(3)

File No. 333-283111

 

ANTARES PRIVATE CREDIT FUND

SUPPLEMENT NO. 6 DATED NOVEMBER 18, 2025

TO THE PROSPECTUS DATED FEBRUARY 12, 2025

 

This prospectus supplement (“Supplement”) is part of and should be read in conjunction with the prospectus of Antares Private Credit Fund (the “Company”), dated February 12, 2025, (as supplemented to date, the “Prospectus”). Unless otherwise defined herein, capitalized terms used in this Supplement shall have the same meanings as set forth in the Prospectus.

 

The purpose of this Supplement is to include our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025.

 

Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2025

 

On November 14, 2025, we filed our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 with the Securities and Exchange Commission. The report (without exhibits) is attached to this Supplement.

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________________________________________________

 

FORM 10-Q

_______________________________________________________________________

 

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2025

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 814-01700

_______________________________________________________________________

 

ANTARES PRIVATE CREDIT FUND

(Exact name of Registrant as specified in its Charter)

_______________________________________________________________________

 

Delaware 93-3416650
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
   

320 South Canal Street, Suite 4200

Chicago, IL

 

60606

(Address of principal executive offices) (Zip Code)

 

312-638-4117

Registrant’s telephone number, including area code

_______________________________________________________________________

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange
on which registered
None   None   None

 

Securities registered pursuant to Section 12(g) of the Act:

Class I Shares, par value $0.01 per share

Class S Shares, par value $0.01 per share

Class D Shares, par value $0.01 per share

(Title of class)

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  x  NO  ¨

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).    Yes  x   NO  ¨

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company" and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer ¨   Accelerated filer ¨
Non-accelerated filer x   Smaller reporting company ¨
Emerging growth company x      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).  YES  ¨   NO  x

 

The Registrant’s common shares of beneficial interest (“Common Shares”), $0.01 par value per share, outstanding as of November 13, 2025 was 28,405,834 of Class I Shares. No Class S or Class D Shares have been issued as of November 13, 2025. Common Shares outstanding exclude November 1, 2025 subscriptions, as the issuance price is not yet finalized at this time.

 

 

 

 

  

Table of Contents

 

    Page
PART I FINANCIAL INFORMATION  
Item 1. Consolidated Financial Statements  
  Consolidated Statements of Assets and Liabilities as of September 30, 2025 (Unaudited) and December 31, 2024 4
  Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024 (Unaudited) 5
  Consolidated Statements of Changes in Net Assets for the three and nine months ended September 30, 2025 and 2024 (Unaudited) 6
  Consolidated Statement of Cash Flows for the nine months ended September 30, 2025 (Unaudited) 8
  Consolidated Schedules of Investments as of September 30, 2025 (Unaudited) and December 31, 2024 9
  Notes to Consolidated Financial Statements (Unaudited) 74
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 98
Item 3. Quantitative and Qualitative Disclosures About Market Risk 110
Item 4. Controls and Procedures 111
     
PART II OTHER INFORMATION  
Item 1. Legal Proceedings 112
Item 1A. Risk Factors 112
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 112
Item 3. Defaults Upon Senior Securities 112
Item 4. Mine Safety Disclosures 112
Item 5. Other Information 112
Item 6. Exhibits 113
  Signatures 114

 

2

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report. In addition, some of the statements in this Quarterly Report (including in the following discussion) constitute forward-looking statements, which relate to future events or the future performance or financial condition of Antares Private Credit Fund (the “Company,” “we,” “us,” or “our”). The Company is externally managed by Antares Capital Credit Advisers LLC (the “Adviser”). The forward-looking statements contained in this report involve a number of risks and uncertainties, including statements concerning:

 

we have a limited operating history;

 

our, or our portfolio companies’, future business, operations, operating results or prospects;

 

the return or impact of current and future investments;

 

changes in the general economy, including those caused by tariffs and trade disputes with other countries, changes in inflation, risk of recession and a prolonged United States government shutdown;

 

the impact of changes in laws or regulations (including the interpretation thereof), including tax laws, governing our operations or the operations of our portfolio companies or the operations of our competitors;

 

the valuation of our investments in portfolio companies, particularly those having no liquid trading market;

 

market conditions and our ability to access different debt markets and additional debt and equity capital and our ability to manage our capital resources effectively;

 

our contractual arrangements and relationships with third parties;

 

the state of the general economy;

 

the impact of supply chain constraints on our portfolio companies and the global economy;

 

uncertainty surrounding global financial stability, including the liquidity of certain banks;

 

the financial condition of our current and prospective portfolio companies and their ability to achieve their objectives;

 

the impact of information technology system failures, data security breaches, data privacy compliance, network disruptions, and cybersecurity attacks;

 

our ability to raise capital in the private and public debt and equity markets;

 

our ability to anticipate and identify evolving market expectations with respect to environmental, social and governance matters, including the environmental impacts of our portfolio companies’ supply chain and operations;

 

the outcome and impact of any litigation or regulatory proceeding;

 

the adequacy of our cash resources and working capital;

 

the timing, form and amount of any dividend distributions;

 

the timing of cash flows, if any, from the operations of our portfolio companies; and

 

the ability of our adviser to locate suitable investments for us and to monitor and administer our investments.

 

We use words such as “anticipates,” “believes,” “expects,” “intends,” “project,” “estimates,” “will,” “should,” “could,” “would,” “may” and similar expressions to identify forward-looking statements, although not all forward-looking statements include these words. Our actual results and condition could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Risk Factors” on the Company’s registration statement on Form N-2, Annual Report on Form 10-K and this Quarterly Report.

 

We have based the forward-looking statements included in this Quarterly Report on information available to us on the filing date of this Quarterly Report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we have filed or in the future may file with the Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, registration statement on Form N-2, quarterly reports on Form 10-Q and current reports on Form 8-K.

 

3

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Consolidated Financial Statements

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES

(in thousands, except share and per share amounts)

 

   September 30,
2025
   December 31,
2024
 
   (Unaudited)     
ASSETS          
Investments at fair value:          
Non-controlled/non-affiliated investments, at fair value (amortized cost — $1,395,830 and $849,742 as of September 30, 2025 and December 31, 2024, respectively)  $1,393,758   $848,360 
Short-term investments (amortized cost — $29,010 and $0 as of September 30, 2025 and December 31, 2024, respectively) (1)   29,010     
Total investments at fair value   1,422,768    848,360 
Cash and cash equivalents (1)   11,701    42,146 
Foreign currencies (cost — $8,905 and $20,235 as of September 30, 2025 and December 31, 2024, respectively)   9,091    20,194 
Interest receivable from non-controlled/non-affiliated investments   6,322    3,824 
Dividend receivable from non-controlled/non-affiliated investments   176     
Deferred offering costs   428    943 
Receivable from adviser (Note 3)   1,361    2,839 
Receivable for investments sold / repaid   30    82 
Prepaid expenses and other assets   59    446 
Total assets  $1,451,936   $918,834 
           
LIABILITIES          
Debt outstanding  $720,127   $110,194 
Less: Deferred financing costs   (5,081)   (3,087)
Total debt, net of deferred financing costs   715,046    107,107 
Payable for investments purchased   20,816    160,489 
Interest payable   2,145    361 
Distributions payable   5,782    8,290 
Administrative service fee payable   283    93 
Accrued expenses and other liabilities   2,027    986 
Management fees payable   1,174     
Income based incentive fee payable   1,223     
Due to affiliates   221    4,049 
Total liabilities   748,717    281,375 
Commitments and contingencies (Note 7)          
NET ASSETS          
Common Shares, par value $0.01 (27,894,139 and 25,405,674 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively)   279    254 
Paid-in capital in excess of par value   698,118    635,495 
Accumulated net distributable earnings   4,822    1,710 
Total net assets   703,219    637,459 
Total liabilities and net assets  $1,451,936   $918,834 
Net asset value per share  $25.21   $25.09 

 

(1)The Company has made a prospective presentation change to reclassify money market fund investments as short-term investments, resulting in their exclusion from cash and cash equivalents beginning in the reporting period ended June 30, 2025. See Note 2 for additional detail.

 

See accompanying notes to the consolidated financial statements.

 

4

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except share and per share amounts)

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2025   2024   2025   2024 
Investment income:                    
From total investments:                    
Interest income  $31,035   $   $80,732   $ 
Payment-in-kind interest income   170        423     
Dividend income   220        539     
Other income   791        3,361     
Total investment income   32,216        85,055     
Expenses:                    
Interest and debt expenses   10,779        23,741     
Management fees (Note 3)   2,180        6,184     
Income based incentive fee (Note 3)   2,366        7,034     
Administrative service fee   190        522     
Board of Trustees’ fee   45        115     
Other general and administrative expenses   743        2,366     
Organization and offering costs   512    113    1,575    161 
Total expenses   16,815    113    41,537    161 
Management fees waiver (Note 3)   (1,005)       (5,009)    
Incentive fees waiver (Note 3)   (1,143)       (5,811)    
Reimbursable expenses paid by adviser (Note 3)   (35)   (113)   (683)   (161)
Net expenses, net of fee waivers   14,632        30,034     
Net investment income (loss)   17,584        55,021     
                     
Net realized and change in unrealized gain (loss):                    
Net realized gain (loss):                    
Non-controlled/non-affiliated investments   1        (13)    
Foreign currency transactions   153        960     
Total net realized gain (loss)   154        947     
Net change in unrealized appreciation (depreciation):                    
Non-controlled/non-affiliated investments   (249)       (689)    
Translation of assets and liabilities in foreign currencies   350        (2,133)    
Total net change in unrealized appreciation (depreciation)   101        (2,822)    
Total net realized and change in unrealized gain (loss)   255        (1,875)    
Net increase (decrease) in net assets resulting from operations  $17,839   $   $53,146   $ 
                     
Per share information                    
Net investment income (loss) per share (basic and diluted)  $0.64   $   $2.09   $ 
Earnings per share (basic and diluted)  $0.65   $   $2.02   $ 
Distributions declared per share  $0.65   $   $1.90   $ 
Weighted average shares outstanding (basic and diluted)   27,415,336    1,000    26,305,369    1,000 

 

See accompanying notes to the consolidated financial statements.

 

5

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (Unaudited)

(in thousands, except shares)

 

Three Months Ended September 30, 2025

 

               Accumulated Net     
   Common Shares   Paid-in-Capital in   Distributable
Earnings
   Total 
   Shares   Par Value   Excess of Par Value   (Losses)   Net Assets 
Net assets at beginning of period   26,615,155   $266   $665,867   $4,710   $670,843 
Operations:                         
Net investment income (loss)               17,584    17,584 
Net realized gain (loss)               154    154 
Net change in unrealized appreciation (depreciation)               101    101 
Net increase (decrease) in net assets resulting from operations               17,839    17,839 
Capital Transactions:                         
Issuance of shares   1,263,848    13    31,869        31,882 
Common Shares issued from reinvestment of distributions   15,136        382        382 
Distributions to shareholders               (17,727)   (17,727)
Net increase (decrease) in net assets resulting from capital transactions   1,278,984    13    32,251    (17,727)   14,537 
Total net increase (decrease)   1,278,984    13    32,251    112    32,376 
Net assets at end of period   27,894,139   $279   $698,118   $4,822   $703,219 

 

Nine Months Ended September 30, 2025

 

               Accumulated Net     
   Common Shares   Paid-in-Capital in   Distributable
Earnings
   Total 
   Shares   Par Value   Excess of Par Value   (Losses)   Net Assets 
Net assets at beginning of period   25,405,674   $254   $635,495   $1,710   $637,459 
Operations:                         
Net investment income (loss)               55,021    55,021 
Net realized gain (loss)               947    947 
Net change in unrealized appreciation (depreciation)               (2,822)   (2,822)
Net increase (decrease) in net assets resulting from operations               53,146    53,146 
Capital Transactions:                         
Issuance of shares   2,470,603    25    62,173        62,198 
Common Shares issued from reinvestment of distributions   17,862        450        450 
Distributions to shareholders               (50,034)   (50,034)
Net increase (decrease) in net assets resulting from capital transactions   2,488,465    25    62,623    (50,034)   12,614 
Total net increase (decrease)   2,488,465    25    62,623    3,112    65,760 
Net assets at end of period   27,894,139   $279   $698,118   $4,822   $703,219 

 

See accompanying notes to the consolidated financial statements.

 

6

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (Unaudited)(Continued)

(in thousands, except shares)

 

Three Months Ended September 30, 2024

 

               Accumulated Net     
   Common Shares   Paid-in-Capital in   Distributable
Earnings
   Total 
   Shares   Par Value   Excess of Par Value   (Losses)   Net Assets 
Net assets at beginning of period   1,000   $   $25   $   $25 
Operations:                         
Net investment income (loss)                    
Net realized gain (loss)                    
Net change in unrealized appreciation (depreciation)                    
Net increase (decrease) in net assets resulting from operations                    
Shareholder distributions:                         
Net increase (decrease) in net assets resulting from shareholder distributions                    
Capital Transactions:                         
Issuance of shares                    
Distributions to shareholders                    
Net increase (decrease) in net assets resulting from capital transactions                    
Total net increase (decrease)                    
Net assets at end of period   1,000   $   $25   $   $25 

 

Nine Months Ended September 30, 2024

 

               Accumulated Net     
   Common Shares   Paid-in-Capital in   Distributable
Earnings
   Total 
   Shares   Par Value   Excess of Par Value   (Losses)   Net Assets 
Net assets at beginning of period   1,000   $   $25   $   $25 
Operations:                         
Net investment income (loss)                    
Net realized gain (loss)                    
Net change in unrealized appreciation (depreciation)                    
Net increase (decrease) in net assets resulting from operations                    
Shareholder distributions:                         
Net increase (decrease) in net assets resulting from shareholder distributions                    
Capital Transactions:                         
Issuance of shares                    
Distributions to shareholders                    
Net increase (decrease) in net assets resulting from capital transactions                    
Total net increase (decrease)                    
Net assets at end of period   1,000   $   $25   $   $25 

 

See accompanying notes to the consolidated financial statements.

 

7

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

(in thousands)

 

   Nine Months
Ended
September 30,
2025
 
Cash flow from operating activities     
Net increase (decrease) in net assets resulting from operations  $53,146 
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:     
Accrued interest and dividends received in-kind   (770)
Net accretion of discount and amortization of premium   (1,372)
Proceeds from sale of investments and principal repayments   158,206 
Purchases of investments   (702,165)
Purchase/sale of short-term investments, net (1)   10,516 
Net realized (gains) losses on investments   13 
Net change in unrealized (appreciation) depreciation on investments   689 
Amortization of deferred financing costs   821 
Amortization of deferred offering costs   1,457 
(Increase) decrease in operating assets:     
Interest receivable from non-controlled/non-affiliated investments   (2,498)
Dividend receivable from non-controlled/non-affiliated investments   (176)
Receivable from adviser   1,478 
Receivable for investments sold / repaid   52 
Prepaid expenses and other assets   387 
Increase (decrease) in operating liabilities:     
Due to affiliates   (3,828)
Payable for investments purchased   (139,673)
Management fees payable   1,174 
Income based incentive fee payable   1,223 
Interest payable   1,784 
Administrative service fee payable   190 
Accrued expenses and other liabilities   1,041 
Net cash provided by (used in) operating activities   (618,305)
Cash flow from financing activities     
Proceeds from issuance of shares   62,198 
Debt borrowings   646,928 
Debt repayments   (36,995)
Distributions paid   (52,092)
Deferred offering costs paid   (941)
Deferred financing costs paid   (2,815)
Net cash provided by (used in) financing activities   616,283 
Net increase (decrease) in cash and cash equivalents   (2,022)
Cash, cash equivalents and foreign currencies at the beginning of period (1)   22,814 
Cash, cash equivalents and foreign currencies at the end of period (1)  $20,792 
Supplemental disclosure of cash flow information     
Cash paid for interest  $21,136 
Cash paid for taxes  $74 
Distributions payable   5,782 

 

(1)The Company has made a prospective presentation change to reclassify money market fund investments as short-term investments, resulting in their exclusion from cash and cash equivalents beginning in the reporting period June 30, 2025. As a result, cash and cash equivalents at the beginning of this period exclude $39,527 of money market fund investments. See Note 2 for additional detail.

 

See accompanying notes to the consolidated financial statements.

 

8

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)

September 30, 2025

(in thousands)

 

Investments (1)   Footnotes     Asset Type   Reference
Rate and
Spread (2)
  Interest Rate   Maturity
Date
  Par
Amount /
Shares
    Amortized
Cost (4)
    Fair
Value
    Percentage
of Net
Assets
 
Investments - non-controlled/non-affiliated                                                      
Secured Debt                                                      
Aerospace and Defense                                                      
Bleriot US Bidco Inc.   (5)(8)(15)   First Lien Term Loan   S + 2.50%   6.48%   10/31/2030   $ 4,640     $ 4,650     $ 4,648       0.66 %
GSP Holdings, LLC   (6)(8)(12)   First Lien Term Loan   S + 5.75%   10.63% (Incl. 0.75% PIK)   11/6/2026     102       102       95       0.01  
GSP Holdings, LLC   (3 )(6)(8)(12)   First Lien Term Loan   S + 5.75%   10.63% (Incl. 0.75% PIK)   11/6/2026           1              
TransDigm Inc.   (5)(6)(8)(15)   First Lien Term Loan   S + 2.25%   6.23%   3/22/2030     3,687       3,703       3,688       0.52  
                                    8,456       8,431       1.19  
Air Freight and Logistics                                                      
Kenco PPC Buyer LLC   (8)(12)   First Lien Term Loan   S + 4.75%   8.60%   11/15/2029     5,356       5,330       5,356       0.76  
Kenco PPC Buyer LLC   (7)(12)   First Lien Revolver   S + 4.75%   8.73%   11/15/2029     359       70       72       0.01  
Lightbeam Bidco Inc.   (8)(13)   First Lien Term Loan   S + 5.00%   8.98%   5/6/2030     4,913       4,913       4,912       0.70  
Lightbeam Bidco Inc.   (13 )   First Lien Delayed Draw Term Loan   S + 5.00%   8.98%   5/6/2030     647       647       647       0.09  
Lightbeam Bidco Inc.   (7)(13)   First Lien Revolver   S + 5.00%   8.98%   5/4/2029     491                    
                                    10,960       10,987       1.56  
Automobile Components                                                      
Enthusiast Auto Holdings, LLC   (8)(12)   First Lien Term Loan   S + 4.50%   8.63%   12/19/2026     5,876       5,876       5,876       0.84  
Enthusiast Auto Holdings, LLC   (7)(12)   First Lien Revolver   S + 4.50%   8.63%   12/19/2026     64                    
JHCC Holdings LLC   (8)(12)   First Lien Term Loan   S + 5.25%   9.23%   9/9/2027     1,457       1,451       1,449       0.21  
JHCC Holdings LLC   (8)(12)   First Lien Delayed Draw Term Loan   S + 5.25%   9.23%   9/9/2027     422       421       420       0.06  
JHCC Holdings LLC   (7)(12)   First Lien Revolver   S + 5.25%   9.23%   9/9/2027     168       67       66       0.01  
OAC Holdings I Corp   (8)(12)   First Lien Term Loan   S + 5.00%   9.13%   3/30/2029     186       186       186       0.03  
Power Stop, LLC   (5)(8)(14)   First Lien Term Loan   S + 4.75%   8.83%   1/26/2029     198       198       179       0.02  
Quality Automotive Services, LLC   (8)(12)   First Lien Term Loan   S + 5.00%   8.98%   7/16/2027     4,657       4,642       4,634       0.66  
Quality Automotive Services, LLC   (12)   First Lien Delayed Draw Term Loan   S + 5.00%   9.13%   7/16/2027     1,117       1,113       1,111       0.16  
Quality Automotive Services, LLC   (8)(12)   First Lien Delayed Draw Term Loan   S + 5.00%   9.13%   7/16/2027     918       915       913       0.13  
Quality Automotive Services, LLC   (7)(12)   First Lien Delayed Draw Term Loan   S + 5.00%   9.13%   7/16/2027     1,333       1,048       1,044       0.15  
Quality Automotive Services, LLC   (7)(12)   First Lien Delayed Draw Term Loan   S + 5.00%   8.98%   7/16/2027     2,000       (10 )     (10 )      
Quality Automotive Services, LLC   (7)(12)   First Lien Revolver   S + 5.00%   8.98%   7/16/2027     257       (1 )     (1 )      
Truck-Lite Co., LLC   (8)(13)   First Lien Term Loan   S + 5.00%   9.13%   2/13/2032     1,905       1,904       1,899       0.27  
Truck-Lite Co., LLC   (7)(13)   First Lien Delayed Draw Term Loan   S + 5.00%   9.13%   2/13/2032      993       (3)       (3)      
Truck-Lite Co., LLC   (7)(13)   First Lien Delayed Draw Term Loan   S + 5.75%   9.88%   2/13/2032     1,873       730       736       0.10  
Truck-Lite Co., LLC   (7)(13)   First Lien Revolver   S + 5.00%   9.13%   2/13/2031     176             (1 )      
                                    18,537       18,498       2.64  
Beverages                                                      
Pegasus BidCo B.V.   (5)(6)(8)(15)   First Lien Term Loan   S + 2.75%   6.73%   7/12/2029     998       1,002       1,002       0.14  
                                    1,002       1,002       0.14  

 

9

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par 
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Building Products                                   
80/20, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  3/1/2027  $198   $198   $197    0.03%
MDC Interior Acquisition Inc  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  4/26/2030   291    290    290    0.04 
MDC Interior Acquisition Inc  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  4/26/2030   756    752    752    0.11 
MDC Interior Acquisition Inc  (7)(12)  First Lien Revolver  S + 5.00%  8.98%  4/26/2030   42             
Surewerx Purchaser III Inc.  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  12/28/2029   198    198    198    0.03 
WST USA Holdco, Inc.  (6)(8)(12)  First Lien Term Loan  S + 4.75%  8.83%  3/31/2027   1,712    1,712    1,708    0.24 
WST USA Holdco, Inc.  (6)(7)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.83%  3/31/2027   586    213    211    0.03 
                        3,363    3,356    0.48 
Capital Markets                                   
Allworth Financial Group, L.P.  (8)(12)  First Lien Term Loan  S + 4.75%  8.88%  12/23/2027   198    198    198    0.03 
Arax MidCo, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  4/11/2029   4,298    4,270    4,298    0.61 
Arax MidCo, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  4/11/2029   1,807    1,798    1,807    0.26 
Arax MidCo, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  4/11/2029   3,096    138    146    0.02 
Arax MidCo, LLC  (12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  4/11/2029   196    190    196    0.03 
Arax MidCo, LLC  (7)(12)  First Lien Revolver  S + 5.00%  8.98%  4/11/2029   431    48    52    0.01 
Cub Financing Intermediate, LLC  (8)(14)  First Lien Term Loan  S + 4.75%  8.73%  6/28/2030   3,752    3,736    3,752    0.53 
Cub Financing Intermediate, LLC  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  6/28/2030   1,741    706    717    0.10 
Edgeco Buyer, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  6/1/2028   7,411    7,410    7,411    1.05 
Edgeco Buyer, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  6/1/2028   2,769    331    336    0.05 
Edgeco Buyer, Inc.  (8)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  6/1/2028   878    878    878    0.12 
Edgeco Buyer, Inc.  (12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  6/1/2028   481    481    481    0.07 
Edgeco Buyer, Inc.  (7)(12)  First Lien Revolver  S + 4.50%  8.48%  6/1/2028   304    14    15     
HighTower Holding, LLC  (5)(7)(15)  First Lien Revolver  S + 3.00%  6.98%  2/1/2030   110             
Lido Advisors, LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  5/10/2032   199    198    198    0.03 
Lido Advisors, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  5/10/2032   3,513    1,238    1,235    0.18 
Lido Advisors, LLC  (12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  5/10/2032   527    523    524    0.07 
Lido Advisors, LLC  (7)(12)  First Lien Revolver  S + 4.75%  8.73%  5/10/2032   615    356    356    0.05 
The Ultimus Group Midco, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  7/1/2032   4,068    4,048    4,068    0.58 
The Ultimus Group Midco, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  7/1/2032   1,356    (3)        
The Ultimus Group Midco, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  7/1/2032   509    (3)        
                        26,555    26,668    3.79 

 

10

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Chemicals                                   
Americhem, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  3/1/2032  $10,474   $10,425   $10,422    1.48%
Americhem, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  3/1/2032   2,691    (6)   (13)    
Americhem, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  3/1/2032   1,906    (10)   (10)    
Aurora Plastics, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.98%  8/12/2030   12,462    12,435    12,403    1.76 
Aurora Plastics, LLC  (8)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.98%  8/12/2030   1,409    1,409    1,402    0.20 
Aurora Plastics, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.98%  8/12/2030   1,140    (3)   (5)    
Aurorium Global Holdings LLC  (8)(13)  First Lien Term Loan  S + 5.75%  9.88%  12/22/2027   99    98    94    0.01 
Boulder Scientific Company, LLC  (8)(12)  First Lien Term Loan  S + 4.50%  8.48%  12/31/2027   97    97    97    0.01 
Bulab Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  7/1/2032   8,346    8,305    8,304    1.18 
Bulab Holdings, Inc.  (8)(13)  First Lien Term Loan  E + 4.75%  6.68%  7/1/2032  EUR 1,352    1,588    1,578    0.22 
Bulab Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  7/1/2032   1,931    (5)   (10)    
Bulab Holdings, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  7/1/2032   1,862    (9)   (9)    
Charkit Chemical Company, LLC  (8)(12)  First Lien Term Loan  S + 4.88%  9.11%  12/29/2026   100    99    99    0.01 
DCG Acquisition Corp.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  6/13/2031   6,991    6,991    6,938    0.99 
DCG Acquisition Corp.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  6/13/2031   1,169    701    693    0.10 
Hasa Acquisition, LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.73%  1/10/2029   198    199    198    0.03 
LTI Holdings, Inc.  (5)(8)(15)  First Lien Term Loan  S + 3.75%  7.88%  7/29/2029   1,980    1,988    2,000    0.28 
Lubricant Engineers  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  9/1/2029   7,906    7,885    7,906    1.12 
Lubricant Engineers  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  9/1/2029   1,372             
Lubricant Engineers  (7)(12)  First Lien Revolver  S + 5.25%  9.23%  9/1/2029   885    (4)        
Lummus Technology Holdings V LLC  (5)(8)(15)  First Lien Term Loan  S + 2.50%  6.63%  12/31/2029   249    249    250    0.04 
Plaskolite PPC Intermediate II LLC  (8)(12)  First Lien Term Loan  S + 4.00%  12.13% (Incl. 4.00% PIK)  5/9/2030   1,400    1,387    1,346    0.19 
Plaskolite PPC Intermediate II LLC  (7)(12)  First Lien Revolver  S + 7.00%  11.13%  2/7/2030   101    10    4     
Potters Industries LLC  (5)(7)(15)  First Lien Revolver  S + 2.75%  6.83%  9/14/2027   100             
Rocket Bidco, Inc.  (6)(8)(15)  First Lien Term Loan  C + 4.75%  7.63%  11/1/2030   CAD 198    143    141    0.02 
                        53,972    53,828    7.64 
Commercial Services and Supplies                                   
Acuren Delaware Holdco, Inc.  (5)(6)(8)(15) First Lien Term Loan  S + 2.75%  6.88%  7/30/2031   352    352    353    0.05 
Anticimex Global AB  (5)(6)(8)(14)  First Lien Term Loan  S + 3.40%  7.38%  11/16/2028   1,604    1,604    1,611    0.23 
Ares Holdings, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  11/18/2027   2,952    2,941    2,941    0.42 
Ares Holdings, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  11/18/2027   198    197    197    0.03 
AWP Group Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  12/23/2030   14,251    14,191    14,108    2.01 
AWP Group Holdings, Inc.  (7)(12)  First Lien Revolver  S + 4.50%  8.63%  12/23/2030   320    134    133    0.02 
BCPE Empire Holdings, Inc.  (5)(8)(14)  First Lien Term Loan  S + 3.25%  7.38%  12/11/2030   924    923    923    0.13 
BIFM CA Buyer Inc.  (5)(6)(8)(14)  First Lien Term Loan  S + 3.75%  7.88%  5/31/2028   651    651    653    0.09 
CoolSys, Inc.  (5)(8)(13)  First Lien Term Loan  S + 4.75%  8.99%  8/11/2028   198    195    178    0.03 
Denali Buyerco LLC  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  9/15/2028   4,788    4,788    4,788    0.68 
Denali Buyerco LLC  (13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  9/15/2028   7,515    7,509    7,515    1.07 

 

11

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Commercial Services and Supplies (continued)                                   
Discovery Purchaser Corporation  (5)(6)(8)(14)  First Lien Term Loan  S + 3.75%  7.73%  10/4/2029  $3,475   $3,480   $3,463    0.49%
Ext Acquisitions, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  6/26/2026   198    198    198    0.03 
FL Hawk Intermediate Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  2/22/2030   960    957    960    0.14 
Fresh Holdco, Inc.  (8)(12)  First Lien Term Loan  S + 5.25%  9.38%  1/24/2026   388    387    388    0.06 
HeartLand PPC Buyer, LLC  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  12/12/2029   5,778    5,720    5,778    0.82 
HeartLand PPC Buyer, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  12/12/2029   861    739    748    0.11 
HeartLand PPC Buyer, LLC  (7)(13)  First Lien Revolver  S + 5.25%  9.38%  12/12/2029   297    111    114    0.02 
Hercules Borrower LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  12/15/2028   5,274    5,268    5,249    0.75 
Hercules Borrower LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  12/15/2028   2,094    (4)   (10)    
Hercules Borrower LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  12/15/2028   589    (5)   (3)    
High Bar Brands Operating, LLC  (6)(8)(12)  First Lien Term Loan  S + 5.25%  9.23%  12/19/2029   198    196    198    0.03 
HP RSS Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  12/11/2029   1,312    1,301    1,312    0.19 
HP RSS Buyer, Inc.  (13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  12/11/2029   844    837    844    0.12 
HP RSS Buyer, Inc.  (13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  12/11/2029   3,482    3,417    3,466    0.49 
HP RSS Buyer, Inc.  (8)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  12/11/2029   280    278    280    0.04 
HP RSS Buyer, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  12/11/2029   4,416    15    4     
Low Voltage Holdings Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  4/28/2032   11,073    11,033    11,046    1.57 
Low Voltage Holdings Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  4/28/2032   3,223    (6)   (8)    
Low Voltage Holdings Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  4/28/2032   1,421    (5)   (4)    
Low Voltage Holdings Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  4/28/2032  CAD 178             
Monarch Landscape Holdings, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  10/2/2028   198    197    198    0.03 
Onyx-Fire Protection Services Inc.  (6)(8)(13)  First Lien Term Loan  C + 4.50%  7.06%  7/31/2031  CAD 9,080    6,532    6,523    0.93 
Onyx-Fire Protection Services Inc.  (6)(7)(13)  First Lien Delayed Draw Term Loan  C + 4.50%  7.06%  7/31/2031  CAD 860    (6)        
Onyx-Fire Protection Services Inc.  (6)(7)(13)  First Lien Revolver  C + 4.50%  7.06%  7/31/2031  CAD 2,149    98    103    0.01 
Palmetto Acquisitionco Inc.  (8)(12)  First Lien Term Loan  S + 5.75%  9.73%  9/18/2029   198    198    198    0.03 
Pavion Corp.  (8)(13)  First Lien Term Loan  S + 3.75%  10.13% (Incl. 2.25% PIK)  10/30/2030   195    195    193    0.03 
Service Logic Acquisition, Inc.  (5)(7)(15)  First Lien Revolver  S + 3.75%  7.84%  10/30/2025   100             
The Hiller Companies, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  6/20/2030   7,394    7,363    7,394    1.05 
The Hiller Companies, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  6/20/2030   2,045    1,889    1,904    0.27 
The Hiller Companies, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  6/20/2030   1,079    366    365    0.05 
The Hiller Companies, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  6/20/2030   1,299    (6)        
Thermostat Purchaser III, Inc.  (5)(8)(13)  First Lien Term Loan  S + 4.25%  8.23%  8/31/2028   198    198    199    0.03 
Valet Waste Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 6.00%  10.13%  5/1/2029   5,184    5,142    5,184    0.74 
Valet Waste Holdings, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 6.00%  10.13%  5/1/2029   7,213    (58)        

 

12

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par 
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Commercial Services and Supplies (continued)                                   
WRE Holding Corp.  (13)  First Lien Term Loan  S + 5.00%  8.85%  7/2/2031  $252   $251   $250    0.04%
WRE Holding Corp.  (8)(13)  First Lien Term Loan  S + 5.00%  8.85%  7/2/2031   2,293    2,283    2,275    0.32 
WRE Holding Corp.  (13)  First Lien Term Loan  S + 5.00%  8.98%  7/2/2031   63    63    63    0.01 
WRE Holding Corp.  (13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  7/2/2031   39    39    38    0.01 
WRE Holding Corp.  (13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.85%  7/2/2031   235    235    234    0.03 
WRE Holding Corp.  (7)(13)  First Lien Revolver  S + 5.00%  8.85%  7/2/2030   316    (1)   (2)    
YLG Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  12/23/2030   9,360    9,335    9,290    1.32 
YLG Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  12/23/2030   1,375    812    805    0.11 
YLG Holdings, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  12/23/2030   1,214    66    64    0.01 
Zinc Buyer Corporation  (13)  First Lien Term Loan  S + 4.75%  8.73%  7/24/2031   7,128    7,092    7,128    1.01 
Zinc Buyer Corporation  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  7/24/2031   830    (5)        
Zinc Buyer Corporation  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  7/24/2031   790    (5)        
Zone Climate Services, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 6.00%  10.13%  3/9/2028   3,180    371    393    0.05 
Zone Climate Services, Inc.  (7)(12)  First Lien Revolver  S + 5.75%  9.88%  3/9/2028   636    293    298    0.04 
                        110,339    110,520    15.74 
Construction & Engineering                                   
Ampirical Solutions, LLC  (8)(13)  First Lien Term Loan  S + 4.25%  8.23%  9/30/2032   1,770    1,761    1,761    0.25 
Ampirical Solutions, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.25%  8.23%  9/30/2032   2,655    (13)   (13)    
Ampirical Solutions, LLC  (7)(13)  First Lien Revolver  S + 4.25%  8.23%  9/30/2032   708    (7)   (4)    
CLS Management Services, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  3/27/2030   198    196    197    0.03 
FR Vision Holdings Inc  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  1/20/2031   3,967    3,963    3,967    0.56 
FR Vision Holdings Inc  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  1/20/2031   3,119    974    985    0.14 
FR Vision Holdings Inc  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  1/22/2030   248             
Hydraulic Technologies USA LLC  (8)(12)  First Lien Term Loan  S + 5.50%  9.48%  6/3/2031   830    817    816    0.12 
Hydraulic Technologies USA LLC  (7)(12)  First Lien Revolver  S + 5.50%  9.48%  6/3/2030   114    51    51    0.01 
Kleinfelder Intermediate LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  9/18/2030   198    198    198    0.03 
Mei Buyer LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  6/29/2029   198    198    198    0.03 
Trilon Group, LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.73%  5/29/2029   3,884    3,863    3,854    0.55 
Trilon Group, LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  5/29/2029   4,177    4,125    4,143    0.59 
Trilon Group, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  5/29/2029   1,995    552    543    0.08 
Trilon Group, LLC  (7)(12)  First Lien Revolver  S + 4.75%  8.73%  5/29/2029   1,212    (7)   (10)    
                        16,671    16,686    2.39 
Construction Materials                                   
Pearlman Enterprises Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.73%  5/5/2027   198    196    194    0.03 
Red Fox CD Acquisition Corporation  (7)(12)  First Lien Delayed Draw Term Loan  S + 6.00%  9.98%  3/4/2030   13,614    11,325    11,403    1.62 
                        11,521    11,597    1.65 

 

13

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
 Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Containers and Packaging                                   
Anchor Packaging, LLC  (5)(7)(15)  First Lien Revolver  S + 3.25%  7.23%  4/17/2029  $100   $   $    %
Berlin Packaging LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 3.25%  7.38%  6/9/2031   2,990    2,996    3,002    0.43 
CFs Brands, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  10/2/2030   3,472    3,472    3,472    0.49 
CFs Brands, LLC  (7)(12)  First Lien Revolver  S + 5.00%  9.13%  10/2/2029   493             
Clydesdale Acquisition Holdings, Inc.  (5)(8)(14)  First Lien Term Loan  S + 3.25%  7.38%  4/1/2032   1,961    1,947    1,960    0.28 
Clydesdale Acquisition Holdings, Inc.  (5)(7)(8)(14)  First Lien Delayed Draw Term Loan  S + 3.25%  7.38%  4/1/2032   34    1    1     
Cold Chain Technologies, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.73%  7/2/2026   10,716    10,710    10,690    1.52 
Cold Chain Technologies, LLC  (7)(12)  First Lien Revolver  S + 5.75%  9.73%  7/2/2026   522    274    273    0.04 
Nelipak Holding Company  (8)(12)  First Lien Term Loan  S + 5.50%  9.63%  3/26/2031   6,359    6,359    6,264    0.89 
Nelipak Holding Company  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.50%  9.63%  3/26/2031   2,486        (37)   (0.01)
Nelipak Holding Company  (7)(12)  First Lien Revolver  S + 5.50%  9.63%  3/26/2031   1,855    1,150    1,122    0.16 
Packaging Coordinators Midco, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  1/22/2032   9,169    9,161    9,123    1.30 
Packaging Coordinators Midco, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  1/22/2032   4,882        (24)    
Packaging Coordinators Midco, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  1/22/2032   926    (1)   (5)    
Plastipak Holdings, Inc.  (5)(8)(15)  First Lien Term Loan  S + 2.50%  6.48%  9/10/2032   1,152    1,146    1,153    0.16 
PLZ Corp.  (5)(8)(13)  First Lien Term Loan  S + 3.75%  7.99%  8/3/2026   99    96    89    0.01 
Pro Mach Group, Inc.  (5)(8)(12)  First Lien Term Loan  S + 2.75%  6.88%  8/31/2028   1,163    1,168    1,167    0.17 
Proampac PG Borrower LLC  (5)(7)(15)  First Lien Revolver  S + 3.75%  7.99%  6/16/2028   100    48    47    0.01 
Ring Container Technologies Group, LLC  (5)(8)(14)  First Lien Term Loan  S + 2.50%  6.48%  9/15/2032   1,500    1,506    1,499    0.21 
Rohrer Corp.  (8)(12)  First Lien Term Loan  S + 5.00%  9.10%  3/15/2027   198    198    198    0.03 
St Athena Global LLC  (6)(8)(13)  First Lien Term Loan  S + 5.25%  9.23%  6/26/2030   3,861    3,826    3,822    0.54 
St Athena Global LLC  (6)(8)(13)  First Lien Term Loan  SON + 5.25%  9.22%  6/26/2030  GBP 2,274    2,940    3,027    0.43 
St Athena Global LLC  (6)(7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  6/26/2030   213    (2)   (2)    
St Athena Global LLC  (6)(7)(13)  First Lien Revolver  S + 5.25%  9.23%  6/26/2029   590    138    137    0.02 
Tank Holding Corp.  (8)(13)  First Lien Term Loan  S + 5.75%  9.98%  3/31/2028   198    196    188    0.03 
TricorBraun Holdings, Inc.  (5)(8)(14)  First Lien Term Loan  S + 3.25%  7.38%  3/3/2031   5,060    5,048    5,042    0.72 
Trident TPI Holdings, Inc.  (5)(8)(14)  First Lien Term Loan  S + 3.75%  7.73%  9/15/2028   2,481    2,486    2,441    0.35 
Verde Purchaser, LLC  (5)(8)(15)  First Lien Term Loan  S + 4.00%  7.98%  11/30/2030   3,980    3,990    3,945    0.56 
                        58,853    58,594    8.34 
Distributors                                   
Aurora Parts & Accessories LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.88%  1/13/2029   99    98    99    0.01 
BC Group Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  12/21/2027   4,107    4,082    4,087    0.58 
BC Group Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  12/21/2027   7,099    4,892    4,908    0.70 

 

14

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par 
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Distributors (continued)                                   
Blackbird Purchaser, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.50%  9.48%  12/19/2030  $184   $109   $109    0.02%
Blackbird Purchaser, Inc.  (7)(13)  First Lien Revolver  S + 5.50%  9.48%  12/19/2029   124    87    87    0.01 
Blackhawk Industrial Distribution, Inc.  (8)(12)  First Lien Term Loan  S + 5.25%  9.38%  9/17/2026   5,311    5,299    5,250    0.75 
Blackhawk Industrial Distribution, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  9/17/2026   114    113    112    0.02 
Blackhawk Industrial Distribution, Inc.  (7)(12)  First Lien Revolver  S + 5.25%  9.38%  9/17/2026   1,028    458    451    0.06 
BradyPlus Holdings, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  10/31/2029   6,235    6,235    6,235    0.89 
BradyPlus Holdings, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  10/31/2029   700    228    230    0.03 
Component Hardware Group, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  7/1/2026   91    91    91    0.01 
DFS Holding Company, Inc.  (8)(12)  First Lien Term Loan  S + 7.00%  11.13%  1/31/2029   198    196    187    0.03 
Vessco Midco Holdings, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  7/24/2031   4,970    4,949    4,970    0.71 
Vessco Midco Holdings, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  7/24/2031   1,657    892    900    0.13 
Vessco Midco Holdings, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  7/24/2031   552    (2)        
                        27,727    27,716    3.95 
Diversified Consumer Services                                   
AAH Topco., LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.23%  12/22/2027   2,970    258    266    0.04 
American Residential Services LLC  (5)(7)(15)  First Lien Revolver  S + 2.50%  6.48%  1/31/2030   870        (2)    
Apex Service Partners, LLC  (12)  First Lien Term Loan  S + 5.00%  8.98%  10/24/2030   4,813    4,793    4,792    0.68 
Apex Service Partners, LLC  (12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  10/24/2030   774    771    771    0.11 
Apex Service Partners, LLC  (7)(12)  First Lien Revolver  S + 5.00%  8.98%  10/24/2029   660    (3)        
Ascend Learning, LLC  (5)(8)(14)  First Lien Term Loan  S + 3.00%  7.13%  12/11/2028   997    999    998    0.14 
Ave Holdings III, Corp.  (13)  First Lien Term Loan  S + 5.50%  9.60%  2/25/2028   6,253    6,158    6,066    0.86 
Ave Holdings III, Corp.  (13)  First Lien Delayed Draw Term Loan  S + 5.50%  9.60%  2/25/2028   167    164    162    0.02 
Ave Holdings III, Corp.  (7)(13)  First Lien Revolver  S + 5.50%  9.60%  2/25/2028   514    (8)   (15)    
AVG Intermediate Holdings LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 6.00%  10.08%  3/16/2027   198    195    195    0.03 
Cop Hometown Acquisitions, Inc. (fka Cop Airco Acquisitions, Inc.)  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  7/16/2027   913    909    905    0.13 
Cop Hometown Acquisitions, Inc. (fka Cop Airco Acquisitions, Inc.)  (8)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  7/16/2027   3,970    3,951    3,939    0.56 
CVP Holdco, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  6/30/2031   6,459    6,449    6,445    0.92 
CVP Holdco, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  6/30/2031   1,715    365    367    0.05 
CVP Holdco, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  6/28/2030   686    (1)   (1)    
Essential Services Holding Corporation  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  6/17/2031   2,014    2,010    2,010    0.29 
Essential Services Holding Corporation  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  6/17/2031   395    (1)   (1)    
Essential Services Holding Corporation  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  6/17/2030   247    49    49    0.01 
Fitness International LLC  (5)(8)(15)  First Lien Term Loan  S + 4.50%  8.63%  2/12/2029   10,798    10,797    10,882    1.55 
Flint Opco, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  8/15/2030   3,219    (8)        
Flint Opco, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  8/15/2030   3,040    1,910    1,923    0.27 

 

15

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
 

Par

 Amount /
Shares

   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Diversified Consumer Services (continued)                                   
FSHS I, LLC  (8)(13)  First Lien Term Loan  S + 5.50%  9.63%  11/18/2028  $198   $196   $196    0.03%
GS Seer Group Borrower, LLC  (8)(12)  First Lien Term Loan  S + 6.75%  10.73%  4/29/2030   99    98    96    0.01 
GSV Holding, LLC  (8)(12)  First Lien Term Loan  S + 2.63%  9.73% (Incl. 3.13% PIK)  10/18/2030   4,967    4,946    4,942    0.70 
GSV Holding, LLC  (7)(12)  First Lien Revolver  S + 4.25%  8.23%  10/18/2030   217    (1)        
Health Buyer LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.50%  9.48%  4/27/2029   3,299    643    655    0.09 
Home Service Topco IV, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.58%  12/31/2027   198    198    197    0.03 
Innovetive Petcare, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.23%  6/30/2028   5,419    5,419    5,365    0.76 
Innovetive Petcare, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  6/30/2028   1,998    651    636    0.09 
Innovetive Petcare, Inc.  (12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  6/30/2028   1,509    1,509    1,494    0.21 
Innovetive Petcare, Inc.  (12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.23%  6/30/2028   6,241    6,230    6,179    0.88 
Intel 471 INC.  (12)  First Lien Term Loan  S + 5.25%  9.23%  9/27/2028   200    200    198    0.03 
Learning Care Group (US) No. 2 Inc.  (5)(8)(14)  First Lien Term Loan  S + 4.00%  7.98%  8/11/2028   992    991    978    0.14 
Quick Quack Car Wash Holdings, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  6/10/2031   198    198    197    0.03 
Quick Quack Car Wash Holdings, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  6/10/2031   4,941    798    789    0.11 
Quick Quack Car Wash Holdings, LLC  (13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  6/10/2031   101    101    100    0.01 
Seahawk Bidco, LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.73%  12/19/2031   5,789    5,770    5,789    0.82 
Seahawk Bidco, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  12/19/2031   1,813    1,136    1,143    0.16 
Seahawk Bidco, LLC  (7)(12)  First Lien Revolver  S + 4.75%  8.73%  12/19/2030   545    (2)        
Southern Veterinary Partners, LLC  (5)(8)(15)  First Lien Term Loan  S + 2.50%  6.48%  12/4/2031   937    939    936    0.13 
Taymax Group Acquisition, LLC  (8)(12)  First Lien Term Loan  S + 6.00%  10.23%  7/31/2026   198    198    198    0.03 
Trackforce Acquireco, Inc.  (13)  First Lien Term Loan  S + 5.25%  9.23%  6/23/2028   200    200    200    0.03 
University Support Services LLC  (5)(8)(14)  First Lien Term Loan  S + 2.75%  6.88%  2/10/2029   2,374    2,343    2,342    0.33 
US Fitness Holdings, LLC  (8)(13)  First Lien Term Loan  S + 5.50%  9.48%  9/4/2031   9,196    9,157    9,196    1.31 
US Fitness Holdings, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.50%  9.48%  9/4/2031   1,764    (9)        
US Fitness Holdings, LLC  (7)(13)  First Lien Revolver  S + 5.50%  9.48%  9/4/2030   172    (1)        
Vertex Service Partners, LLC  (8)(13)  First Lien Term Loan  S + 6.00%  9.98%  11/8/2030   198    198    197    0.03 
Vertex Service Partners, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  11/8/2030   250    48    40    0.01 
VPP Intermediate Holdings, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.98%  12/1/2027   1,851    1,845    1,847    0.26 
VPP Intermediate Holdings, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  12/1/2027   3,210    617    602    0.09 
VPP Intermediate Holdings, LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 5.75%  9.98%  12/1/2027   2,231    2,223    2,226    0.32 
VPP Intermediate Holdings, LLC  (12)  First Lien Delayed Draw Term Loan  S + 5.75%  9.88%  12/1/2027   2,624    2,614    2,611    0.37 
VPP Intermediate Holdings, LLC  (7)(12)  First Lien Revolver  S + 5.75%  9.98%  12/1/2027   229    (1)   (1)    
                        89,209    89,099    12.67 
Diversified Telecommunication Services                                   
Coral-US Co-Borrower LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 3.25%  7.23%  1/31/2032   800    799    793    0.11 
Guardian US Holdco LLC  (5)(8)(14)  First Lien Term Loan  S + 3.50%  7.48%  1/31/2030   2,227    2,235    2,231    0.32 
Virgin Media Bristol LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 3.18%  7.12%  3/31/2031   2,000    1,989    1,975    0.28 
Zacapa S.a r.l.  (5)(6)(8)(14)  First Lien Term Loan  S + 3.75%  7.73%  3/22/2029   2,992    2,997    3,000    0.43 
                        8,020    7,999    1.14 

 

16

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Electrical Equipment                                   
Infinite Bidco LLC  (5)(8)(14)  First Lien Term Loan  S + 6.25%  10.23%  3/2/2028  $99   $99   $97    0.01%
Power Grid Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  12/2/2030   8,912    8,912    8,812    1.25 
Power Grid Holdings, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  12/2/2030   890    107    97    0.01 
TPC Engineering Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 5.50%  9.73%  2/16/2027   7,050    7,007    7,050    1.00 
TPC Engineering Holdings, Inc.  (7)(12)  First Lien Revolver  S + 5.50%  9.73%  2/16/2027   441    173    176    0.03 
                        16,298    16,232    2.30 
Electronic Equipment, Instruments and Components                                   
Dwyer Instruments, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  7/20/2029   3,860    3,828    3,821    0.54 
Dwyer Instruments, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  7/20/2029   505    (2)   (5)    
Dwyer Instruments, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  7/20/2029   706    50    50    0.01 
Excelitas Technologies Corp.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  8/13/2029   2,522    (10)   (3)    
Phoenix 1 Buyer Corp.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  11/20/2030   5,799    5,799    5,799    0.82 
Phoenix 1 Buyer Corp.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  11/20/2029   1,142             
Wildcat Topco, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  11/17/2031   1,502    1,496    1,498    0.21 
Wildcat Topco, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  11/17/2031   270    (1)   (1)    
Wildcat Topco, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  11/17/2031   270    6    7     
                        11,166    11,166    1.58 
Energy Equipment and Services                                   
CRCI Longhorn Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  8/27/2031   6,072    6,047    6,072    0.86 
CRCI Longhorn Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  8/27/2031   1,530    (7)        
CRCI Longhorn Holdings, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  8/27/2031   1,020    (4)        
DMC Holdco, LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.88%  7/13/2029   198    196    198    0.03 
Integrated Power Services Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.99%  11/22/2028   7,345    7,341    7,333    1.04 
Integrated Power Services Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.99%  11/22/2028   5,106    (11)   (10)    
Phillips & Temro Industries Inc.  (8)(12)  First Lien Term Loan  S + 5.25%  9.38%  3/12/2027   192    192    191    0.03 
                        13,754    13,784    1.96 
Financial Services                                   
1364720 B.C. LTD.  (6)(8)(13)  First Lien Term Loan  C + 4.50%  7.38%  9/9/2028  CAD 8,954    6,327    6,432    0.91 
1364720 B.C. LTD.  (6)(7)(13)  First Lien Delayed Draw Term Loan  C + 4.50%  7.38%  9/9/2028  CAD  5,598    3,590    3,545    0.50 
Aprio Advisory Group, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  8/1/2031   8,313    8,294    8,273    1.18 
Aprio Advisory Group, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  8/1/2031   4,167    931    922    0.13 
Aprio Advisory Group, LLC  (13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  8/1/2031   3,257    3,252    3,242    0.46 
Aprio Advisory Group, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  8/1/2031   1,638    (3)   (8)    
Ascensus Group Holdings, Inc.  (5)(6)(8)(14)  First Lien Term Loan  S + 3.00%  7.13%  8/2/2028   2,740    2,747    2,741    0.39 

 

17

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Financial Services (continued)                                   
Cerity Partners Equity Holding LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  7/30/2029  $5,000   $333   $354    0.05%
Cerity Partners Equity Holding LLC  (13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  7/28/2029   11,399    11,376    11,399    1.62 
Cerity Partners Equity Holding LLC  (7)(13)  First Lien Revolver  S + 5.25%  9.38%  7/28/2028   543    67    68    0.01 
CFGI Holdings, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  11/2/2027   6,247    6,211    6,212    0.88 
CFGI Holdings, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  11/2/2027   270    (2)   (2)    
Cherry Bekaert Advisory LLC  (8)(13)  First Lien Term Loan  S + 5.25%  9.38%  6/30/2028   198    198    198    0.03 
ClearCapital Holdings, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  6/30/2032   2,151    2,137    2,138    0.30 
ClearCapital Holdings, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  6/30/2032   1,024    (3)   (6)    
ClearCapital Holdings, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  6/30/2032   410    (3)   (2)    
Contractual Buyer, LLC  (8)(13)  First Lien Term Loan  S + 5.75%  9.73%  10/10/2030   198    198    197    0.03 
Focus Financial Partners, LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 2.75%  6.88%  9/15/2031   5,055    5,043    5,062    0.72 
Foreside Financial Group, LLC  (12)  First Lien Term Loan  S + 5.25%  9.38%  9/30/2027   564    564    564    0.08 
Foreside Financial Group, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  9/30/2027   11,643    1,358    1,358    0.19 
Frazier & Deeter Advisory, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  5/3/2032   2,203    2,194    2,203    0.31 
Frazier & Deeter Advisory, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  5/3/2032   937    (3)        
Frazier & Deeter Advisory, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.48%  5/2/2031   325    (2)        
GTCR Everest Borrower, LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 2.75%  6.73%  9/5/2031   384    383    384    0.05 
Heights Buyer, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.83%  8/25/2028   5,307    5,307    5,307    0.75 
Heights Buyer, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.08%  8/25/2028   923    919    919    0.13 
Heights Buyer, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.08%  8/25/2028   1,254    (3)   (6)    
Heights Buyer, LLC  (12)  First Lien Delayed Draw Term Loan  S + 5.75%  9.83%  8/25/2028   869    861    869    0.12 
Heights Buyer, LLC  (7)(12)  First Lien Revolver  S + 5.75%  9.83%  8/25/2028   764    87    87    0.01 
Kestra Advisor Services Holdings A, Inc.  (5)(6)(8)(15)  First Lien Term Loan  S + 3.00%  7.13%  3/22/2031   2,209    2,211    2,213    0.31 
Kriv Acquisition Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  7/31/2031   452    451    449    0.06 
Kriv Acquisition Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  7/31/2031   2,042    (7)   (10)    
Kriv Acquisition Inc.  (7)(12)  First Lien Revolver  S + 5.00%  8.98%  7/31/2031   186    17    17     
Minotaur Acquisition, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  6/3/2030   8,616    8,542    8,542    1.21 
Minotaur Acquisition, Inc.  (8)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  6/3/2030   1,407    1,395    1,395    0.20 
Minotaur Acquisition, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  6/3/2030   1,455    (12)   (12)    
Minotaur Acquisition, Inc.  (7)(12)  First Lien Revolver  S + 5.00%  9.13%  6/3/2030   873    (7)   (7)    
NAB Holdings, LLC  (5)(8)(14)  First Lien Term Loan  S + 2.50%  6.48%  11/23/2028   2,494    2,469    2,416    0.34 
Neon Maple Purchaser Inc.  (5)(6)(8)(15)  First Lien Term Loan  S + 2.75%  6.88%  11/17/2031   4,975    4,995    4,981    0.71 
Osaic Holdings, Inc.  (5)(6)(8)(15)  First Lien Term Loan  S + 3.00%  7.13%  7/30/2032   2,370    2,372    2,372    0.34 
Osttra Group Ltd.  (5)(6)(8)(15)  First Lien Term Loan  S + 3.50%  7.48%  5/20/2032   721    717    725    0.10 
Pathstone Family Office LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.23%  5/15/2029   3,771    3,756    3,762    0.53 
Pathstone Family Office LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.23%  5/15/2029   1,454    (9)   (4)    
Pathstone Family Office LLC  (7)(12)  First Lien Revolver  S + 5.00%  9.23%  5/15/2028   374    (1)   (1)    
Petrus Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  10/17/2029   198    198    198    0.03 

 

18

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Financial Services (continued)                                   
Project Accelerate Parent LLC  (7)(13)  First Lien Revolver  S + 5.25%  9.23%  2/24/2031  $100   $   $    %
Ryan, LLC  (5)(7)(15)  First Lien Revolver  S + 3.00%  7.13%  11/14/2028   100    49    49    0.01 
The Chartis Group, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  9/17/2031   1,256    1,251    1,250    0.18 
The Chartis Group, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  9/17/2031   388    (2)   (2)    
The Chartis Group, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.48%  9/17/2031   194    (1)   (1)    
Wealth Enhancement Group, LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  10/2/2028   198    197    198    0.03 
Wealth Enhancement Group, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  10/2/2028   12,105    1,504    1,491    0.21 
Wealth Enhancement Group, LLC  (7)(12)  First Lien Revolver  S + 4.50%  8.48%  10/2/2028   323        (1)    
                        92,443    92,470    13.11 
Food Products                                   
BCPE North Star US Holdco 2, Inc.  (5)(7)(15)  First Lien Revolver  S + 3.75%  7.88%  3/10/2028   100    34    39    0.01 
Fiesta Purchaser, Inc.  (5)(8)(15)  First Lien Term Loan  S + 2.75%  6.88%  2/12/2031   4,153    4,164    4,150    0.59 
Primary Products Finance LLC  (5)(8)(14)  First Lien Term Loan  S + 3.25%  7.23%  4/1/2029   4,011    4,027    3,924    0.56 
RB Holdings Interco, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  5/4/2028   198    195    198    0.03 
Sigma Holdco B.V.  (5)(6)(8)(15)  First Lien Term Loan  S + 3.75%  7.76%  1/3/2028   4,077    4,086    3,942    0.56 
Sugar Ppc Buyer LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  10/2/2031   6,795    2,007    2,002    0.28 
WPP Bullet Buyer, LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  12/7/2030   5,130    5,098    5,079    0.72 
WPP Bullet Buyer, LLC  (7)(12)  First Lien Revolver  S + 5.25%  9.23%  12/7/2029   83    (1)   (1)    
                        19,610    19,333    2.75 
Gas Utilities                                   
Edpo, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  12/10/2029   11,569    11,562    11,513    1.64 
Edpo, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  12/10/2029   1,657    (4)   (8)    
Edpo, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  12/8/2028   744    65    65    0.01 
                        11,623    11,570    1.65 
Ground Transportation                                   
AMS Parent, LLC  (5)(8)(13)  First Lien Term Loan  S + 4.75%  8.99%  10/25/2028   198    196    187    0.03 
                        196    187    0.03 
Health Care Technology                                   
Acentra Holdings, LLC  (8)(14)  First Lien Term Loan  S + 5.50%  9.48%  12/17/2029   76    75    76    0.01 
Acentra Holdings, LLC  (7)(14)  First Lien Delayed Draw Term Loan  S + 5.50%  9.48%  12/17/2029   220             
Athenahealth Group Inc.  (5)(7)(15)  First Lien Revolver  S + 2.75%  6.88%  2/15/2027   100             
Bracket Intermediate Holding Corp.  (7)(14)  First Lien Revolver  S + 4.50%  8.48%  2/7/2028   100             
Caerus US 1 Inc.  (6)(8)(13)  First Lien Term Loan  S + 5.00%  8.98%  5/25/2029   198    195    198    0.03 
Continental Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  4/2/2031   6,720    6,720    6,704    0.95 
Continental Buyer, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  4/2/2031   1,818    134    131    0.02 
Continental Buyer, Inc.  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  4/2/2031   1,398    (2)   (3)    
Cotiviti, Inc.  (5)(8)(15)  First Lien Term Loan  S + 2.75%  6.88%  3/26/2032   4,924    4,876    4,844    0.69 
DeLorean Purchaser, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  12/16/2031   4,334    4,305    4,302    0.61 
DeLorean Purchaser, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  12/16/2031   653    (5)   (5)    
Empower Payments Investor, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  3/12/2031   5,248    5,240    5,210    0.74 

 

19

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Health Care Technology (continued)                                   
Empower Payments Investor, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  3/12/2031  $1,805   $(4)  $(14)   %
Empower Payments Investor, LLC  (13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  3/12/2031   304    304    302    0.04 
Empower Payments Investor, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  3/12/2030   163        (1)    
Ensemble RCM, LLC  (5)(7)(15)  First Lien Revolver  S + 3.00%  6.98%  6/27/2028   100             
F&M Buyer LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  3/18/2032   3,582    3,565    3,582    0.51 
F&M Buyer LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  3/18/2032   1,194    (3)        
F&M Buyer LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.48%  3/18/2032   522    (3)        
Goldeneye Parent, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  3/31/2032   12,018    11,990    12,018    1.71 
Goldeneye Parent, LLC  (7)(13)  First Lien Revolver  S + 5.00%  9.13%  3/31/2032   1,744    (4)        
HT Intermediary III, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  11/12/2030   6,253    6,228    6,221    0.88 
HT Intermediary III, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  11/12/2030   1,527    (3)   (8)    
HT Intermediary III, Inc.  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  11/12/2030   573    17    16     
IMO Investor Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.85%  5/11/2029   3,210    3,210    3,210    0.46 
IMO Investor Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  5/11/2029   337    337    337    0.05 
IMO Investor Holdings, Inc.  (13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.85%  5/11/2029   385    385    385    0.05 
IMO Investor Holdings, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  8.85%  5/11/2028   370             
Invictus Buyer, LLC  (13)  First Lien Term Loan  S + 4.50%  8.48%  6/3/2031   7,760    7,760    7,760    1.10 
Invictus Buyer, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  6/3/2031   3,266             
Invictus Buyer, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  6/3/2031   1,210             
Net Health Acquisition Corp.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  7/7/2031   7,531    7,487    7,493    1.07 
Net Health Acquisition Corp.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  7/3/2031   1,497    1,489    1,489    0.21 
Net Health Acquisition Corp.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  7/7/2031   973    (4)   (5)    
SDS Buyer, Inc.  (8)(12)  First Lien Term Loan  S + 4.75%  8.83%  9/30/2027   198    198    198    0.03 
Swoop Intermediate III, Inc.  (8)(14)  First Lien Term Loan  S + 4.50%  8.63%  4/12/2032   5,161    5,149    5,149    0.73 
Swoop Intermediate III, Inc.  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  4/12/2032   3,643    (4)   (9)    
Swoop Intermediate III, Inc.  (7)(14)  First Lien Revolver  S + 4.50%  8.63%  4/12/2032   1,214    (3)   (3)    
Unlimited Technology Holdings, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  3/12/2032   5,586    5,572    5,572    0.79 
Unlimited Technology Holdings, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.48%  3/12/2032   747    (2)   (2)    
Wisdom Purchaser, LLC  (8)(14)  First Lien Term Loan  S + 4.50%  8.48%  7/24/2032   6,152    6,136    6,137    0.87 
Wisdom Purchaser, LLC  (7)(14)  First Lien Revolver  S + 4.50%  8.48%  7/24/2032   636    (2)   (2)    
Zelis Cost Management Buyer, Inc.  (5)(7)(15)  First Lien Revolver  S + 2.75%  6.73%  1/17/2029   100             
                        81,333    81,282    11.55 
Healthcare Equipment and Supplies                                   
Alcor Scientific LLC  (8)(12)  First Lien Term Loan  S + 4.50%  8.73%  1/31/2028   200    200    200    0.03 
Aspen Medical Products, LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.88%  6/10/2028   1,833    1,833    1,833    0.26 
Belmont Instrument, LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  8/19/2028   198    198    198    0.03 
Blades Buyer, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.23%  3/28/2028   200    200    200    0.03 
Blades Buyer, Inc.  (12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.23%  3/28/2028   7    7    7     
Cadence, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  5/21/2026   198    198    197    0.03 
CDL Parent, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  12/7/2027   198    198    197    0.03 
CDL Parent, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  12/7/2027   2,802    2,790    2,788    0.40 

 

20

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Healthcare Equipment and Supplies (continued)                                   
CDL Parent, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  12/7/2027  $702   $(2)  $(4)   %
CPC/Cirtec Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  1/30/2029   1,652    1,646    1,644    0.23 
CPC/Cirtec Holdings, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  9.13%  10/31/2028   558    87    86    0.01 
Resonetics, LLC  (5)(7)(15)  First Lien Revolver  S + 3.75%  7.73%  6/18/2029   100    (1)        
TIDI Legacy Products, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  12/19/2029   198    198    198    0.03 
                        7,552    7,544    1.08 
Healthcare Providers and Services                                   
123Dentist Inc.  (6)(7)(13)  First Lien Delayed Draw Term Loan  C + 5.00%  7.56%  8/10/2029  CAD 10,084    5,881    5,924    0.84 
AB Centers Acquisition Corporation  (8)(13)  First Lien Term Loan  S + 5.25%  9.38%  7/2/2031   6,094    6,067    6,072    0.86 
AB Centers Acquisition Corporation  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  7/2/2031   452    159    160    0.02 
AB Centers Acquisition Corporation  (7)(13)  First Lien Revolver  S + 5.25%  9.38%  7/2/2031   428    (2)   (2)    
ACI Group Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 2.75%  10.23% (Incl. 3.25% PIK)  8/2/2028   205    205    198    0.03 
Arrow Management Acquisition, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  7/26/2032   2,197    2,186    2,187    0.31 
Arrow Management Acquisition, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  7/26/2032   785    (2)   (4)    
Arrow Management Acquisition, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  7/26/2032   262    (1)   (1)    
Azalea TopCo, Inc.  (5)(8)(15)  First Lien Term Loan  S + 3.00%  7.13%  4/30/2031   1,496    1,498    1,494    0.21 
Cardiology Management Holdings, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.73%  1/31/2029   198    198    196    0.03 
Community Medical Acquisition Corp.  (8)(12)  First Lien Term Loan  S + 4.50%  8.60%  12/15/2028   99    97    99    0.01 
Crown Laundry, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  5/28/2031   2,674    2,661    2,664    0.38 
Crown Laundry, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  5/28/2031   435    (1)   (2)    
Crown Laundry, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  5/28/2031   507    (3)   (2)    
CVR Management, LLC  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  1/4/2027   9    9    9     
CVR Management, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  1/4/2027   111             
CVR Management, LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  1/4/2027   198    198    197    0.03 
DCA Investment Holding LLC  (8)(13)  First Lien Term Loan  S + 6.41%  10.38%  4/3/2028   198    195    181    0.03 
Docs, MSO, LLC  (8)(13)  First Lien Term Loan  S + 5.75%  9.98%  6/1/2028   99    98    99    0.01 
ENT MSO, LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  12/31/2028   159    159    158    0.02 
EPFS Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  7/31/2031   6,040    6,009    6,011    0.85 
EPFS Buyer, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  7/31/2031   1,029    (3)   (5)    
EPFS Buyer, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  7/31/2031   686    (3)   (3)    
Eyesouth Eye Care Holdco, LLC  (8)(12)  First Lien Term Loan  S + 5.50%  9.73%  10/5/2029   2,118    2,118    2,118    0.30 
Eyesouth Eye Care Holdco, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.50%  9.73%  10/5/2029   4,293    2,430    2,454    0.35 
Golden State Buyer, Inc.  (5)(8)(13)  First Lien Term Loan  S + 4.75%  8.98%  3/21/2027   198    198    198    0.03 
ImageFirst Holdings, LLC  (5)(7)(15)  First Lien Revolver  S + 3.25%  7.23%  3/12/2030   2,800             
IvyRehab Intermediate II, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  9.08%  4/23/2029   198    198    198    0.03 
JKC Parent, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  2/13/2032   377    376    375    0.05 
JKC Parent, Inc.  (13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  2/13/2032   131    126    130    0.02 
JKC Parent, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  2/13/2032   702    (3)   (4)    
JKC Parent, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  2/13/2032   87             
MRO Corporation  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  6/9/2032   9,138    9,070    9,070    1.29 
MRO Corporation  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  6/9/2032   795    (3)   (6)    
MRO Corporation  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  6/9/2032   795    (6)   (6)    

 

21

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Healthcare Providers and Services (continued)                                   
OB Hospitalist Group, Inc.  (8)(13)  First Lien Term Loan  S + 5.25%  9.48%  9/27/2027  $198   $198   $198    0.03%
OIS Management Services, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  11/16/2028   3,802    3,742    3,755    0.53 
OIS Management Services, LLC  (13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  11/16/2028   3,127    3,077    3,088    0.44 
ONS MSO, LLC  (12)  First Lien Delayed Draw Term Loan  S + 5.75%  9.73%  7/7/2028   212    210    206    0.03 
ONS MSO, LLC  (7)(12)  First Lien Revolver  S + 6.25%  10.23%  7/7/2028   24    7    6     
Onsite Holdings, LLC  (8)(12)  First Lien Term Loan  S + 6.75%  11.04% PIK  12/28/2027   346    346    345    0.05 
Onsite Holdings, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 6.75%  11.04% PIK  12/28/2027   938    (5)   (5)    
Onsite Holdings, LLC  (12)  First Lien Revolver  S + 6.75%  11.04% PIK  12/28/2025   94    94    94    0.01 
Orsini Pharmaceutical Services, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  5/22/2031   3,343    3,328    3,311    0.47 
Orsini Pharmaceutical Services, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  5/22/2030   226    (1)   (2)    
Phantom Purchaser, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  9/19/2031   2,966    2,961    2,960    0.42 
Phantom Purchaser, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  9/19/2031   1,465    (6)   (7)    
Phynet Dermatology LLC  (8)(12)  First Lien Term Loan  S + 6.50%  10.48%  10/20/2029   198    198    191    0.03 
Premise Health Holding Corp.  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  3/3/2031   6,042    6,042    6,042    0.86 
Premise Health Holding Corp.  (7)(13)  First Lien Revolver  S + 5.25%  9.23%  3/1/2030   712             
Raven Acquisition Holdings, LLC  (5)(8)(15)  First Lien Term Loan  S + 3.00%  7.13%  11/19/2031   4,643    4,644    4,647    0.66 
Raven Acquisition Holdings, LLC  (5)(7)(15)  First Lien Delayed Draw Term Loan  S + 3.00%  7.13%  11/19/2031   333    (3)        
RxSense Holdings LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  3/12/2027   4,088    4,088    4,068    0.58 
RxSense Holdings LLC  (7)(12)  First Lien Revolver  S + 5.25%  9.23%  3/12/2027   619        (3)    
Smile Doctors LLC  (8)(13)  First Lien Term Loan  S + 5.90%  9.85%  12/23/2028   99    99    99    0.01 
Soleo Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  1/30/2032   4,807    4,799    4,807    0.68 
Soleo Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  1/30/2032   704    (1)        
Soleo Holdings, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  1/30/2032   704    (2)        
Specialized Dental Holdings II, LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.88%  11/1/2027   198    198    198    0.03 
Specialtycare, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  12/18/2029   6,170    6,135    6,139    0.87 
Specialtycare, Inc.  (7)(15)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  12/18/2029   1,353    (3)   (7)    
Specialtycare, Inc.  (7)(15)  First Lien Revolver  S + 3.75%  7.84%  12/18/2029   204    15    15     
STCH Acquisition Inc.  (8)(12)  First Lien Term Loan  S + 5.25%  9.48%  10/30/2026   2,281    2,275    2,281    0.32 
STCH Acquisition Inc.  (7)(12)  First Lien Revolver  S + 5.25%  9.48%  10/30/2026   196    (1)        
TurningPoint Healthcare Solutions, LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.98%  7/14/2027   198    197    198    0.03 
United Digestive MSO Parent, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.73%  3/30/2029   198    198    198    0.03 
Urology Management Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 5.50%  9.63%  6/15/2027   198    196    198    0.03 
USHV Management, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  9/8/2032   3,295    3,279    3,279    0.47 
USHV Management, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  9/8/2032   1,016    (3)   (5)    
USHV Management, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  9/8/2031   549    (3)   (3)    
Valeris, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  9/19/2031   8,873    8,829    8,829    1.26 
Vital Care Buyer, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  7/30/2031   5,289    5,268    5,266    0.75 
Vital Care Buyer, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.48%  7/30/2031   696    (3)   (3)    
WCG Intermediate Corp.  (5)(8)(12)  First Lien Term Loan  S + 3.00%  7.13%  2/25/2032   2,039    2,029    2,027    0.29 
                        102,530    102,567    14.58 

 

22

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Hotels, Restaurants and Leisure                                   
BJH Holdings III Corp.  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  8/19/2027  $198   $197   $197    0.03%
Movati Athletic (Group) Inc.  (6)(8)(12)  First Lien Term Loan  C + 4.75%  7.63%  5/29/2030  CAD 7,476    5,354    5,357    0.76 
Movati Athletic (Group) Inc.  (6)(7)(12)  First Lien Delayed Draw Term Loan  C + 4.75%  7.61%  5/29/2030  CAD 918    (7)   (2)    
Southpaw Ap Buyer, LLC  (8)(12)  First Lien Term Loan  S + 5.50%  9.63%  3/2/2028   2,776    2,769    2,769    0.39 
Southpaw Ap Buyer, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.50%  9.63%  3/2/2028   626    567    569    0.08 
Southpaw Ap Buyer, LLC  (7)(12)  First Lien Revolver  S + 5.50%  9.63%  3/2/2028   252    57    57    0.01 
                        8,937    8,947    1.27 
Household Durables                                   
Stanton Carpet Intermediate Holdings II, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  10/1/2027   200    200    200    0.03 
                        200    200    0.03 
Household Products                                   
TPC US Parent, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.88%  2/23/2026   198    198    198    0.03 
Wu Holdco, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  4/19/2032   10,264    10,239    10,239    1.46 
Wu Holdco, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  4/19/2032   2,497    (3)   (6)    
Wu Holdco, Inc.  (7)(15)  First Lien Revolver  S + 4.75%  8.73%  4/19/2032   777    (2)   (2)    
                        10,432    10,429    1.49 
Industrial Conglomerates                                   
FCG Acquisitions, Inc.  (5)(8)(14)  First Lien Term Loan  S + 3.25%  7.38%  3/31/2028   2,977    2,983    2,987    0.42 
Harvey Tool Company, LLC  (8)(13)  First Lien Term Loan  E + 5.00%  6.93%  8/6/2032  EUR 617    715    722    0.10 
Harvey Tool Company, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  8/6/2032   9,199    9,199    9,132    1.30 
Harvey Tool Company, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  8/6/2032   3,424    (7)   (25)    
Harvey Tool Company, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  8/6/2032   1,179        (8)    
Indicor, LLC  (5)(6)(8)(14)  First Lien Term Loan  S + 2.75%  6.73%  11/22/2029   2,492    2,500    2,498    0.36 
                        15,390    15,306    2.18 
Insurance                                   
Allied Benefit Systems Intermediate LLC  (8)(13)  First Lien Term Loan  S + 5.25%  9.38%  10/31/2030   3,346    3,346    3,346    0.48 
Allied Benefit Systems Intermediate LLC  (13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  10/31/2030   629    629    629    0.09 
AMBA Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 5.25%  9.33%  7/30/2027   3,578    3,560    3,560    0.51 
AMBA Buyer, Inc.  (8)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.33%  7/30/2027   858    854    854    0.12 
AMBA Buyer, Inc.  (7)(13)  First Lien Revolver  S + 5.25%  9.33%  7/30/2027   223    (1)   (1)    
Amerilife Holdings LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  8/31/2029   3,308    3,300    3,301    0.47 
Amerilife Holdings LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  8/31/2029   13,318    11,139    11,145    1.58 
Amerilife Holdings LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  8/31/2028   556    91    91    0.01 

 

23

 

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Insurance (continued)                                   
AQ Sunshine, Inc.  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  7/24/2031  $198   $197   $198    0.03%
Ardonagh Midco 3 Limited  (5)(6)(8)(15)  First Lien Term Loan  S + 2.75%  6.60%  2/15/2031   4,975    4,975    4,961    0.71 
Asurion, LLC  (5)(8)(15)  First Lien Term Loan  S + 3.25%  7.49%  7/31/2027   3,990    3,995    3,991    0.57 
Bellwether Buyer, L.L.C.  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  4/15/2032   4,182    4,173    4,172    0.59 
Bellwether Buyer, L.L.C.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  4/15/2032   2,178    (3)   (5)    
Bellwether Buyer, L.L.C.  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  4/15/2032   871    216    216    0.03 
Beyond Risk Parent Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.73%  10/8/2027   6,369    515    526    0.07 
Broadstreet Partners, Inc.  (5)(6)(8)(15)  First Lien Term Loan  S + 2.75%  6.88%  6/13/2031   2,494    2,499    2,500    0.35 
Foundation Risk Partners, Corp.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  10/29/2030   4,294    205    215    0.03 
Galway Borrower LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  9/29/2028   198    196    196    0.03 
Imagine 360 LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  9/30/2028   1,389    1,384    1,389    0.20 
Imagine 360 LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  9/30/2028   767    (3)        
Imagine 360 LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  9/30/2028   327    (3)        
Integrity Marketing Acquisition, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  8/25/2028   7,603    7,580    7,565    1.08 
Mclarens Midco Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  12/19/2027   2,570    2,570    2,557    0.36 
Mclarens Midco Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  12/19/2027   663    462    459    0.06 
Mclarens Midco Inc.  (8)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  12/19/2027   898    898    894    0.13 
Mclarens Midco Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.83%  12/19/2027   287        (1)    
Oakbridge Insurance Agency, LLC  (8)(13)  First Lien Term Loan  S + 5.75%  9.88%  11/1/2029   198    198    198    0.03 
Oakbridge Insurance Agency, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  11/1/2029   2,583    703    712    0.10 
OneDigital Borrower LLC  (5)(8)(14)  First Lien Term Loan  S + 3.00%  7.13%  7/2/2031   2,494    2,494    2,497    0.35 
Pareto Health Intermediate Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 4.75%  8.73%  6/1/2030   2,732    2,720    2,718    0.39 
Pareto Health Intermediate Holdings, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  6/1/2030   653    (1)   (3)    
Patriot Growth Insurance Services, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  10/16/2028   7,995    7,963    7,995    1.14 
Patriot Growth Insurance Services, LLC  (8)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  10/16/2028   1,398    1,393    1,398    0.20 
Patriot Growth Insurance Services, LLC  (7)(13)  First Lien Revolver  S + 5.00%  9.08%  10/16/2028   534    (2)        
Riser Interco, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  10/31/2029   899    899    899    0.13 
Riser Interco, LLC  (8)(13)  First Lien Term Loan  SON + 4.75%  8.72%  10/31/2029  GBP 1,512    2,000    2,033    0.29 
Riser Interco, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  10/31/2029   1,493    (2)        
Riser Interco, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  10/31/2029   600    136    136    0.02 
Simplicity Financial Marketing Group Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  12/31/2031   6,735    6,706    6,701    0.95 
Simplicity Financial Marketing Group Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  12/31/2031   1,803    531    526    0.07 
Simplicity Financial Marketing Group Holdings, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  12/31/2031   903    (5)   (5)    
THG Acquisition, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  10/31/2031   2,946    2,946    2,946    0.42 
THG Acquisition, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  10/31/2031   660    107    107    0.01 
THG Acquisition, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  10/31/2031   330    25    25     
Trucordia Insurance Holdings, LLC  (5)(8)(15)  First Lien Term Loan  S + 3.25%  7.38%  6/17/2032   271    270    272    0.04 
World Insurance Associates, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  4/3/2030   4,063    4,061    4,053    0.58 
World Insurance Associates, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  4/3/2030   2,859    606    604    0.09 
World Insurance Associates, LLC  (7)(12)  First Lien Revolver  S + 5.00%  8.98%  4/3/2030   209    (1)   (1)    
                        86,521    86,569    12.31 

 

24

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025
(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
IT Services                                   
BigTime Software, Inc.  (13)  First Lien Term Loan  S + 6.25%  10.23%  6/30/2028  $200   $200   $198    0.03%
Cardinal Parent, Inc.  (5)(8)(13)  First Lien Term Loan  S + 4.50%  8.63%  11/12/2027   198    187    197    0.03 
DT1 Midco Corp  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  12/30/2031   6,456    6,427    6,423    0.91 
DT1 Midco Corp  (13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  12/30/2031   2,000    1,996    1,990    0.28 
DT1 Midco Corp  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  12/30/2031   2,540    10    5     
DT1 Midco Corp  (7)(13)  First Lien Revolver  S + 5.00%  9.13%  12/30/2030   1,183    (4)        
Govdelivery Holdings, LLC  (8)(13)  First Lien Term Loan  S + 3.50%  9.73% (Incl. 2.25% PIK)  1/17/2031   201    201    201    0.03 
Marco Technologies, LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.38%  11/24/2026   200    200    200    0.03 
Medallia, Inc.  (8)(13)  First Lien Term Loan  S + 2.50%  10.45% (Incl. 4.00% PIK)  10/29/2028   104    102    92    0.01 
Noble Midco 3 Limited  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  6/10/2031   5,056    5,056    5,056    0.72 
Noble Midco 3 Limited  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  6/10/2031   824             
Noble Midco 3 Limited  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  12/10/2030   1,120             
Oeconnection LLC  (8)(13)  First Lien Term Loan  S + 5.25%  9.38%  4/22/2031   4,385    4,385    4,399    0.62 
Oeconnection LLC  (13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  4/22/2031   765    757    768    0.11 
Oeconnection LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.38%  4/22/2031   2,138        7     
Oeconnection LLC  (7)(13)  First Lien Revolver  S + 5.25%  9.38%  4/22/2031   482             
PDI TA Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.50%  9.48%  2/3/2031   206    206    206    0.03 
Ridge Trail US Bidco, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.35%  9/30/2031   8,621    8,567    8,556    1.22 
Ridge Trail US Bidco, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.35%  9/30/2031   2,995    (20)   (22)    
Ridge Trail US Bidco, Inc.  (7)(13)  First Lien Revolver  S + 4.50%  8.35%  3/31/2031   998    263    262    0.04 
Safety Borrower Holdings LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.88%  9/1/2027   3,466    3,466    3,451    0.49 
Safety Borrower Holdings LLC  (7)(15)  First Lien Revolver  S + 4.75%  8.73%  9/1/2027   499    162    160    0.02 
Saturn Borrower Inc  (8)(12)  First Lien Term Loan  S + 6.00%  9.98%  11/13/2028   3,891    3,868    3,881    0.55 
Saturn Borrower Inc  (7)(12)  First Lien Delayed Draw Term Loan  S + 6.00%  9.98%  11/13/2028   1,422    (4)   (4)    
Saturn Borrower Inc  (7)(12)  First Lien Revolver  S + 6.00%  10.13%  11/13/2028   640    149    152    0.02 
Spirit RR Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.58%  9/13/2028   3,227    3,221    3,211    0.46 
Spirit RR Holdings, Inc.  (13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.58%  9/13/2028   464    463    462    0.06 
Spirit RR Holdings, Inc.  (12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.58%  9/13/2028   267    267    267    0.04 
Spirit RR Holdings, Inc.  (7)(13)  First Lien Revolver  S + 4.50%  8.58%  9/13/2028   272    (1)   (1)    
Storable, Inc.  (5)(7)(15)  First Lien Revolver  S + 2.75%  6.73%  4/16/2029   100             
Trunk Acquisition, Inc.  (8)(12)  First Lien Term Loan  S + 6.00%  10.13%  2/19/2030   1,998    1,993    1,998    0.28 
Trunk Acquisition, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 6.00%  10.13%  2/19/2030   1,836    1,555    1,561    0.22 
VS Buyer, LLC  (5)(7)(15)  First Lien Revolver  S + 2.25%  6.23%  4/12/2029   100             
Welocalize, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  6/23/2026   198    198    197    0.03 
                        43,870    43,873    6.23 

 

25

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Life Sciences Tools & Services                                   
Kwol Acquisition, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  12/12/2029  $6,097   $6,097   $6,067    0.86%
Kwol Acquisition, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  12/12/2029   1,918    (5)   (9)    
Kwol Acquisition, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  12/12/2029   1,066    (1)   (5)    
LSCS Holdings, Inc.  (5)(8)(15)  First Lien Term Loan  S + 4.50%  8.48%  3/4/2032   1,493    1,485    1,473    0.21 
Sotera Health Holdings, LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 2.50%  6.63%  5/30/2031   1,791    1,791    1,796    0.26 
                        9,367    9,322    1.33 
Machinery                                   
CD&R Hydra Buyer, Inc.  (5)(8)(15)  First Lien Term Loan  S + 4.00%  8.23%  3/25/2031   1,980    1,991    1,970    0.28 
Clyde Industries Us Holdco, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  12/18/2026   165    165    165    0.02 
Dynatect Group Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.58%  9/30/2026   191    191    191    0.03 
Flow Control Solutions, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  3/29/2029   5,238    1,224    1,255    0.18 
Flow Control Solutions, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  3/29/2029   936    208    214    0.03 
Madison IAQ LLC  (5)(8)(14)  First Lien Term Loan  S + 3.25%  7.10%  5/6/2032   823    815    828    0.12 
Merlin Buyer, Inc.  (5)(8)(14)  First Lien Term Loan  S + 4.75%  8.73%  12/14/2028   9,383    9,373    9,375    1.33 
Merlin Buyer, Inc.  (5)(7)(15)  First Lien Revolver  S + 3.75%  7.73%  12/14/2026   1,450    (12)   (1)    
Process Equipment, Inc.  (8)(12)  First Lien Term Loan  S + 5.25%  9.35%  9/6/2026   197    197    194    0.03 
Process Insights Acquisition, Inc.  (8)(12)  First Lien Term Loan  S + 6.25%  10.23%  7/18/2029   198    198    183    0.03 
RFI Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.58%  8/5/2030   3,468    3,451    3,451    0.49 
RFI Buyer, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.58%  8/5/2030   2,601    (6)   (13)    
RFI Buyer, Inc.  (7)(13)  First Lien Revolver  S + 4.50%  8.58%  8/5/2030   600    (3)   (3)    
SPX Flow, Inc.  (5)(8)(14)  First Lien Term Loan  S + 2.75%  6.88%  4/5/2029   556    556    559    0.08 
Victory Buyer LLC  (5)(7)(15)  First Lien Revolver  S + 3.75%  7.99%  11/19/2028   100    55    56    0.01 
                        18,403    18,424    2.63 
Media                                   
Klick, Inc.  (6)(8)(12)  First Lien Term Loan  S + 4.50%  8.63%  3/31/2028   727    721    727    0.10 
MH Sub I, LLC  (5)(8)(14)  First Lien Term Loan  S + 4.25%  8.38%  12/31/2031   2,481    2,459    2,289    0.33 
Planet US Buyer LLC  (5)(8)(15)  First Lien Term Loan  S + 3.00%  6.98%  2/7/2031   2,382    2,387    2,398    0.34 
Red Ventures, LLC (New Imagitas, Inc.)  (5)(8)(15)  First Lien Term Loan  S + 2.75%  6.88%  3/4/2030   1,713    1,711    1,618    0.23 
                        7,278    7,032    1.00 
Oil, Gas and Consumable Fuels                                   
CPPIB OVM Member U.S. LLC  (5)(8)(15)  First Lien Term Loan  S + 2.50%  6.48%  8/20/2031   3,109    3,109    3,119    0.44 
Valicor PPC Intermediate II LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  7/24/2028   5,117    5,109    5,077    0.72 
Valicor PPC Intermediate II LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  7/24/2028   438    437    434    0.06 
Valicor PPC Intermediate II LLC  (7)(12)  First Lien Revolver  S + 5.00%  9.13%  1/24/2028   710    84    80    0.01 
                        8,739    8,710    1.23 
Personal Care Products                                   
Apothecary Products, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.85%  7/27/2026   189    189    187    0.03 
Swanson Health Products, Incorporated  (8)(12)  First Lien Term Loan  S + 5.75%  9.99%  6/30/2027   183    183    181    0.03 
                        372    368    0.06 

 

26

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Pharmaceuticals                                   
Amneal Pharmaceuticals LLC  (5)(6)(8)(14)  First Lien Term Loan  S + 3.50%  7.63%  8/1/2032  $1,509   $1,510   $1,511    0.21%
Bamboo US BidCo LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  9/30/2030   3,001    3,001    2,971    0.42 
Bamboo US BidCo LLC  (8)(12)  First Lien Term Loan  E + 5.25%  7.28%  9/30/2030  EUR 2,700    2,952    3,137    0.45 
Bamboo US BidCo LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  9/30/2030   714    (2)   (7)    
Bamboo US BidCo LLC  (12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  9/30/2030   463    463    459    0.07 
Bamboo US BidCo LLC  (7)(12)  First Lien Revolver  S + 5.25%  9.38%  9/30/2030   714    653    651    0.09 
Bamboo US BidCo LLC  (7)(12)  First Lien Revolver  S + 5.25%  9.23%  10/1/2029   826        (8)    
Bridges Consumer Healthcare Intermediate LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  12/22/2031   4,673    4,652    4,673    0.66 
Bridges Consumer Healthcare Intermediate LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.10%  12/22/2031   2,226    1,774    1,779    0.25 
Bridges Consumer Healthcare Intermediate LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  12/22/2031   2,000    (5)        
Bridges Consumer Healthcare Intermediate LLC  (7)(12)  First Lien Revolver  S + 5.25%  9.23%  12/22/2031   894    (4)        
Exactcare Parent, Inc.  (8)(12)  First Lien Term Loan  S + 5.50%  9.48%  11/5/2029   198    198    198    0.03 
Puma Buyer, LLC  (8)(14)  First Lien Term Loan  S + 4.25%  8.23%  3/29/2032   8,119    8,089    8,119    1.15 
Puma Buyer, LLC  (7)(14)  First Lien Revolver  S + 4.25%  8.23%  3/29/2032   1,313    (5)        
Tersera Therapeutics, LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  4/4/2029   2,486    2,476    2,486    0.35 
Tersera Therapeutics, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.73%  4/4/2029   3,845    3,845    3,845    0.55 
Tersera Therapeutics, LLC  (7)(12)  First Lien Revolver  S + 5.75%  9.73%  4/4/2029   116             
                        29,597    29,814    4.23 
Professional Services                                   
ABC Legal Holdings, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  8/13/2032   1,312    1,305    1,305    0.19 
ABC Legal Holdings, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  8/13/2032   393    (1)   (2)    
ABC Legal Holdings, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  8/13/2032   255    (1)   (1)    
Access CIG, LLC  (5)(8)(14)  First Lien Term Loan  S + 4.00%  8.13%  8/19/2030   1,247    1,247    1,252    0.18 
Analytic Partners, LP  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  4/4/2030   3,883    3,877    3,883    0.55 
Analytic Partners, LP  (7)(15)  First Lien Revolver  S + 4.50%  8.63%  4/4/2030   502    (2)        
Applied Technical Services, LLC  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  4/8/2031   6,376    6,348    6,376    0.91 
Applied Technical Services, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  4/8/2031   645    174    180    0.03 
Applied Technical Services, LLC  (7)(13)  First Lien Revolver  S + 5.25%  9.23%  4/8/2031   645    97    103    0.01 
AQ Carver Buyer, Inc.  (5)(7)(15)  First Lien Revolver  S + 5.25%  9.33%  8/2/2028   100             
Carr, Riggs & Ingram Capital, L.L.C.  (8)(14)  First Lien Term Loan  S + 4.25%  8.23%  11/18/2031   2,861    2,849    2,861    0.41 
Carr, Riggs & Ingram Capital, L.L.C.  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.25%  8.23%  11/18/2031   1,457    304    308    0.04 
Carr, Riggs & Ingram Capital, L.L.C.  (7)(14)  First Lien Revolver  S + 4.25%  8.23%  11/18/2031   667    (3)        
Clinical Education Alliance, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  12/21/2026   99    98    99    0.01 
Crisis Prevention Institute, Inc.  (5)(7)(14)  First Lien Revolver  S + 4.75%  8.73%  4/9/2029   100             
Disa Holdings Corp.  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  9/9/2028   2,832    2,832    2,802    0.40 
Disa Holdings Corp.  (8)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  9/9/2028   551    551    546    0.08 
Disa Holdings Corp.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  9/9/2028   588    571    565    0.08 
Foreigner Bidco Inc.  (8)(12)  First Lien Term Loan  S + 5.50%  9.73%  4/19/2028   200    200    200    0.03 
Grant Thornton Advisors LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 2.50%  6.63%  6/2/2031   3,328    3,330    3,312    0.47 

 

27

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Professional Services (continued)                                   
HSI Halo Acquisition, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  6/30/2031  $7,767   $7,751   $7,767    1.10%
HSI Halo Acquisition, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  6/30/2031   1,396    694    697    0.10 
HSI Halo Acquisition, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  9.13%  6/28/2030   932    (2)        
IG Investments Holdings, LLC  (13)  First Lien Term Loan  S + 5.00%  8.98%  9/22/2028   2,589    2,589    2,589    0.37 
IG Investments Holdings, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  9/22/2028   293             
Iris Buyer LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  10/2/2030   198    195    198    0.03 
KENE Acquisition, Inc.  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  2/7/2031   198    198    196    0.03 
Keng Acquisition, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.48%  8/1/2029   198    196    197    0.03 
Marina Acquisition, Inc.  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  7/1/2030   2,130    2,112    2,082    0.30 
Marina Acquisition, Inc.  (7)(12)  First Lien Revolver  S + 5.00%  8.98%  7/1/2030   307    77    73    0.01 
MHE Intermediate Holdings, LLC  (8)(12)  First Lien Term Loan  S + 6.00%  10.13%  7/21/2027   200    200    199    0.03 
Monarch Buyer, Inc.  (8)(14)  First Lien Term Loan  S + 4.75%  8.88%  6/2/2032   4,922    4,898    4,898    0.70 
Monarch Buyer, Inc.  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  6/2/2032   2,051    (5)   (10)    
Monarch Buyer, Inc.  (7)(14)  First Lien Revolver  S + 4.75%  8.88%  6/2/2032   923    (4)   (5)    
OMNIA Partners, LLC  (5)(8)(15)  First Lien Term Loan  S + 2.50%  6.48%  7/25/2030   4,135    4,148    4,142    0.59 
Propio LS, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  5/10/2030   7,282    7,246    7,227    1.03 
Propio LS, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  5/10/2030   200    (1)   (1)    
Rimkus Consulting Group, Inc.  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  4/1/2031   8,894    8,894    8,627    1.23 
Rimkus Consulting Group, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  4/1/2031   2,248    476    409    0.06 
Rimkus Consulting Group, Inc.  (7)(13)  First Lien Revolver  S + 5.25%  9.23%  4/1/2030   1,201    300    264    0.04 
Ruppert Landscape, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  12/3/2029   4,598    4,590    4,577    0.65 
Ruppert Landscape, LLC  (8)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  12/3/2029   605    605    603    0.08 
Ruppert Landscape, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  12/3/2029   6,414    2,307    2,331    0.33 
Ruppert Landscape, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  12/3/2029   865    235    234    0.03 
Sedgwick Claims Management Services, Inc. (Lightning Cayman Merger Sub, Ltd.)  (5)(8)(15)  First Lien Term Loan  S + 2.50%  6.63%  7/31/2031   2,977    2,984    2,977    0.42 
Skopima Consilio Parent LLC  (5)(8)(14)  First Lien Term Loan  S + 3.75%  7.88%  5/12/2028   4,141    4,145    3,529    0.50 
TRC Companies LLC  (5)(8)(15)  First Lien Term Loan  S + 3.00%  7.13%  12/8/2028   2,982    2,984    2,990    0.42 
USRP Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  12/31/2029   8,610    8,577    8,610    1.22 
USRP Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  12/31/2029   2,769    1,215    1,226    0.17 
USRP Holdings, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  9.13%  12/31/2029   900    (4)        
Vaco Holdings, LLC  (5)(7)(13)  First Lien Revolver  S + 5.00%  8.98%  1/21/2027   100        (14)    
Vensure Employer Services, Inc.  (8)(14)  First Lien Term Loan  S + 5.00%  8.98%  9/27/2031   2,320    2,311    2,309    0.33 
Vensure Employer Services, Inc.  (7)(14)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  9/27/2031   164    (1)   (1)    
VT Topco, Inc.  (5)(8)(14)  First Lien Term Loan  S + 3.00%  7.13%  8/9/2030   995    993    966    0.14 
YA Intermediate Holdings II, LLC  (8)(13)  First Lien Term Loan  S + 4.75%  8.60%  10/1/2031   5,378    5,355    5,378    0.76 
YA Intermediate Holdings II, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.60%  10/1/2031   2,256    234    238    0.03 
YA Intermediate Holdings II, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.60%  10/1/2031   1,084    95    99    0.01 
                        100,363    99,390    14.13 

 

28

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Real Estate Management and Development                                   
Sako and Partners Lower Holdings LLC  (8)(12)  First Lien Term Loan  S + 4.50%  8.48%  9/15/2028  $10,151   $10,122   $10,103    1.44%
Sako and Partners Lower Holdings LLC  (7)(12)  First Lien Revolver  S + 4.75%  8.73%  9/15/2028   1,091    (4)   (5)    
                        10,118    10,098    1.44 
Software                                   
365 Retail Markets, LLC  (8)(12)  First Lien Term Loan  S + 4.50%  8.48%  12/23/2028   3,846    3,846    3,846    0.55 
365 Retail Markets, LLC  (8)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  12/23/2028   1,739    1,739    1,739    0.25 
365 Retail Markets, LLC  (12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  12/23/2028   906    906    906    0.13 
Adelaide Borrower, LLC  (13)  First Lien Term Loan  S + 3.38%  10.73% (Incl. 3.38% PIK)  5/8/2030   202    200    200    0.03 
Ahead DB Holdings, LLC  (5)(8)(13)  First Lien Term Loan  S + 2.75%  6.73%  2/1/2031   998    1,000    1,000    0.14 
Alta Buyer, LLC  (8)(12)  First Lien Term Loan  S + 5.00%  8.98%  12/21/2027   198    197    198    0.03 
AQA Acquisition Holding, Inc.  (5)(7)(15)  First Lien Revolver  S + 3.25%  7.23%  3/3/2028   100             
Artifact Bidco, Inc.  (8)(14)  First Lien Term Loan  S + 4.25%  8.23%  7/28/2031   3,354    3,333    3,354    0.48 
Artifact Bidco, Inc.  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.25%  8.23%  7/28/2031   821    (5)        
Artifact Bidco, Inc.  (7)(14)  First Lien Revolver  S + 4.25%  8.23%  7/26/2030   587    (3)        
Banker's Toolbox, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  7/27/2027   198    197    197    0.03 
Bluecat Networks (USA) Inc.  (6)(8)(13)  First Lien Term Loan  S + 5.00%  9.98% (Incl. 1.00% PIK)  8/8/2028   1,477    1,468    1,477    0.21 
Boxer Parent Company Inc.  (5)(8)(15)  First Lien Term Loan  S + 3.00%  6.98%  7/30/2031   4,975    4,980    4,973    0.71 
Camelot U.S. Acquisition LLC  (5)(6)(8)(15)  First Lien Term Loan  S + 2.75%  6.88%  1/31/2031   4,260    4,269    4,239    0.60 
Catalis Intermediate, Inc.  (8)(13)  First Lien Term Loan  S + 5.50%  9.63%  8/4/2027   99    98    99    0.01 
Central Parent LLC  (5)(8)(15)  First Lien Term Loan  S + 3.25%  7.23%  7/6/2029   3,453    3,434    2,996    0.42 
Cloud Software Group, Inc.  (5)(6)(7)(15)  First Lien Revolver  S + 3.25%  7.23%  9/28/2029   100             
Concord Global Acquisition, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  12/29/2031   3,946    3,928    3,946    0.56 
Concord Global Acquisition, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  12/29/2031   1,715    408    412    0.06 
Concord Global Acquisition, LLC  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  12/29/2031   686    (3)        
Digital.AI Software Holdings, Inc.  (8)(12)  First Lien Term Loan  S + 6.00%  9.98%  8/10/2028   99    99    99    0.01 
DS Admiral Bidco, LLC  (5)(7)(15)  First Lien Revolver  S + 3.75%  7.73%  6/26/2029   100             
DT Intermediate Holdco, Inc.  (8)(13)  First Lien Term Loan  S + 2.75%  9.98% (Incl. 3.25% PIK)  2/24/2028   3,381    3,369    3,381    0.48 
DT Intermediate Holdco, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.50%  9.48%  2/24/2028   1,658    (6)        
e-Discovery AcquireCo, LLC  (8)(12)  First Lien Term Loan  S + 6.00%  9.98%  8/29/2029   200    200    200    0.03 
Eagan Parent, Inc.  (8)(14)  First Lien Term Loan  S + 4.50%  8.48%  9/8/2032   5,765    5,751    5,751    0.82 
Eagan Parent, Inc.  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  9/8/2032   1,441    (2)   (4)    
Eagan Parent, Inc.  (7)(14)  First Lien Revolver  S + 4.50%  8.48%  9/8/2032   769    (2)   (2)    
Eclipse Buyer, Inc.  (8)(14)  First Lien Term Loan  S + 4.50%  8.63%  9/8/2031   7,862    7,830    7,862    1.12 
Eclipse Buyer, Inc.  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  9/8/2031   1,333    (6)        
Eclipse Buyer, Inc.  (7)(14)  First Lien Revolver  S + 4.50%  8.63%  9/8/2031   676    (3)        
Emburse, Inc.  (8)(13)  First Lien Term Loan  S + 4.25%  8.23%  5/28/2032   7,368    7,350    7,351    1.04 
Emburse, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.25%  8.23%  5/28/2032   1,316    (2)   (3)    
Emburse, Inc.  (7)(13)  First Lien Revolver  S + 4.25%  8.23%  5/28/2032   1,316    (3)   (3)    

 

29

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Software (continued)                                   
Empyrean Solutions, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  11/26/2031  $1,382   $1,377   $1,382    0.20%
Empyrean Solutions, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  11/26/2031   553    (1)        
Empyrean Solutions, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.48%  11/26/2031   207    (1)        
Enverus Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 5.50%  9.63%  12/24/2029   2,069    2,069    2,069    0.29 
Enverus Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.50%  9.63%  12/24/2029   38             
Enverus Holdings, Inc.  (7)(13)  First Lien Revolver  S + 5.50%  9.63%  12/24/2029   214    9    9     
ESG Investments, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  3/11/2028   2,094    2,095    2,094    0.30 
Fourth Enterprises, LLC  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  3/21/2031   10,719    10,669    10,665    1.52 
Fourth Enterprises, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  3/21/2031   2,079    (10)   (10)    
Fourth Enterprises, LLC  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  3/21/2031   959    168    168    0.02 
Genesys Cloud Services Holdings I, LLC  (5)(8)(15)  First Lien Term Loan  S + 2.50%  6.63%  1/30/2032   1,630    1,627    1,622    0.23 
GS Acquisitionco, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  5/25/2028   199    74    74    0.01 
Higher Logic, LLC  (8)(13)  First Lien Term Loan  S + 5.25%  9.23%  1/10/2029   4,533    4,515    4,533    0.64 
Higher Logic, LLC  (7)(13)  First Lien Revolver  S + 5.25%  9.23%  1/10/2029   380    (2)        
Hyphen Solutions, LLC  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  8/6/2032   2,707    2,701    2,701    0.38 
Hyphen Solutions, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  8/6/2032   501    (1)   (1)    
Hyphen Solutions, LLC  (7)(12)  First Lien Revolver  S + 4.50%  8.63%  8/6/2032   301    (1)   (1)    
Inhabitiq Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.63%  1/12/2032   2,504    2,500    2,504    0.36 
Inhabitiq Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.50%  8.63%  1/12/2032   697    (1)        
Inhabitiq Inc.  (7)(13)  First Lien Revolver  S + 4.50%  8.63%  1/12/2032   436    (1)        
Innovative Systems L.L.C.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  8/20/2032   3,391    3,375    3,375    0.48 
Innovative Systems L.L.C.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  8/20/2032   1,453    (4)   (7)    
Innovative Systems L.L.C.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  8/20/2032   484    (2)   (2)    
Kaseya Inc.  (5)(7)(15)  First Lien Revolver  S + 3.25%  7.23%  3/20/2030   761    (4)        
Kipu Buyer, LLC  (8)(15)  First Lien Term Loan  S + 4.25%  8.23%  1/27/2027   198    198    198    0.03 
KPA Parent Holdings, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  3/12/2032   7,112    7,078    7,112    1.01 
KPA Parent Holdings, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.88%  3/12/2032   1,016    (2)        
KPA Parent Holdings, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  3/12/2032   711    (4)        
Litera Bidco LLC  (8)(12)  First Lien Term Loan  S + 5.00%  9.13%  5/1/2028   198    198    198    0.03 
Mastery Acquisition Corp.  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  9/7/2029   198    198    196    0.03 
McAfee Corp.  (5)(8)(14)  First Lien Term Loan  S + 3.00%  7.13%  3/1/2029   3,722    3,727    3,566    0.51 
Monotype Imaging Holdings Inc.  (8)(13)  First Lien Term Loan  S + 5.50%  9.63%  2/28/2031   1,220    1,223    1,214    0.17 
Monotype Imaging Holdings Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.50%  9.63%  2/28/2031   103    27    26     
Monotype Imaging Holdings Inc.  (7)(13)  First Lien Revolver  S + 5.50%  9.63%  2/28/2030   154        (1)    
Montana Buyer Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.88%  7/22/2029   2,643    2,639    2,643    0.38 
Montana Buyer Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.88%  7/22/2028   307    (1)        
MRI Software LLC  (8)(12)  First Lien Term Loan  S + 4.75%  8.73%  2/10/2027   6,929    6,909    6,916    0.98 
MRI Software LLC  (12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  2/10/2027   1,289    1,280    1,287    0.18 
MRI Software LLC  (7)(12)  First Lien Revolver  S + 4.75%  8.73%  2/10/2027   265    26    26     

 

30

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Software (continued)                                   
Nasuni Corporation  (8)(13)  First Lien Term Loan  S + 5.00%  8.85%  9/10/2030  $6,250   $6,208   $6,209    0.88%
Nasuni Corporation  (7)(13)  First Lien Revolver  S + 5.00%  8.85%  9/10/2030   1,302    (8)   (9)    
Navex Topco, Inc.  (8)(13)  First Lien Term Loan  S + 5.25%  9.38%  11/8/2030   5,151    5,151    5,151    0.73 
Navex Topco, Inc.  (7)(13)  First Lien Revolver  S + 5.25%  9.38%  11/9/2028   1,797             
North Star Acquisitionco, LLC  (8)(12)  First Lien Term Loan  S + 4.50%  8.48%  5/3/2029   4,374    4,366    4,374    0.62 
North Star Acquisitionco, LLC  (8)(12)  First Lien Term Loan  C + 4.50%  7.06%  5/3/2029  CAD 1,544    1,115    1,109    0.16 
North Star Acquisitionco, LLC  (7)(12)  First Lien Delayed Draw Term Loan  S + 4.50%  8.48%  5/3/2029   275    263    264    0.04 
North Star Acquisitionco, LLC  (7)(12)  First Lien Revolver  S + 4.50%  8.48%  5/3/2029   780    293    294    0.04 
OLO Parent, Inc.  (8)(14)  First Lien Term Loan  S + 4.50%  8.48%  9/13/2032   8,388    8,367    8,367    1.19 
OLO Parent, Inc.  (7)(14)  First Lien Revolver  S + 4.50%  8.48%  9/13/2032   799    (2)   (2)    
Onit, Inc.  (8)(13)  First Lien Term Loan  S + 4.50%  8.48%  1/27/2032   2,007    2,002    2,002    0.28 
Onit, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  1/27/2032   6,316    6,289    6,316    0.90 
Onit, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  1/27/2032   2,786    (6)        
Onit, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  1/27/2032   929    (5)        
Pegasus Transtech Holding, LLC  (8)(12)  First Lien Term Loan  S + 6.00%  10.13%  11/17/2026   197    197    197    0.03 
Perforce Software, Inc.  (8)(14)  First Lien Term Loan  S + 4.75%  8.88%  3/21/2031   2,020    2,022    1,806    0.26 
Prism Parent Co. Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  9/19/2028   5,523    5,435    5,468    0.78 
Prism Parent Co. Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  9/19/2028   1,416    545    552    0.08 
Proofpoint, Inc.  (5)(8)(14)  First Lien Term Loan  S + 3.00%  7.13%  8/31/2028   992    992    998    0.14 
Renaissance Holding Corp  (5)(8)(14)  First Lien Term Loan  S + 4.00%  8.13%  4/5/2030   1,980    1,981    1,721    0.24 
Routeware, Inc.  (12)  First Lien Term Loan  S + 5.25%  9.23%  9/18/2031   3,182    3,168    3,182    0.45 
Routeware, Inc.  (7)(12)  First Lien Delayed Draw Term Loan  S + 5.25%  9.23%  9/18/2031   1,477    84    91    0.01 
Routeware, Inc.  (7)(12)  First Lien Revolver  S + 5.25%  9.38%  9/18/2031   341    67    68    0.01 
Spartan Bidco PTY LTD  (6)(13)  First Lien Term Loan  S + 6.50%  10.63%  1/24/2028   4,843    4,823    4,818    0.69 
Spartan Bidco PTY LTD  (6)(7)(13)  First Lien Revolver  S + 6.50%  10.58%  1/24/2028   385    (4)   (2)    
Thunder Purchaser, Inc.  (8)(12)  First Lien Term Loan  S + 5.25%  9.38%  6/30/2028   199    199    198    0.03 
Trimech Acquisition Corp.  (8)(12)  First Lien Term Loan  S + 4.75%  8.73%  3/10/2028   4,065    4,045    4,045    0.58 
Trimech Acquisition Corp.  (12)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  3/10/2028   2,468    2,444    2,455    0.35 
Trimech Acquisition Corp.  (7)(12)  First Lien Revolver  S + 4.75%  8.73%  3/10/2028   1,550    82    85    0.01 
Ungerboeck Systems International, LLC  (12)  First Lien Term Loan  S + 5.25%  9.23%  4/30/2027   198    198    196    0.03 
Validity, Inc.  (8)(14)  First Lien Term Loan  S + 5.25%  9.23%  4/12/2032   1,832    1,797    1,800    0.26 
Validity, Inc.  (7)(15)  First Lien Revolver  S + 4.75%  8.73%  4/10/2030   392        (7)    
Vamos Bidco, Inc  (8)(14)  First Lien Term Loan  S + 4.75%  8.73%  1/30/2032   2,646    2,634    2,646    0.38 
Vamos Bidco, Inc  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  1/30/2032   1,105    (2)        
Vamos Bidco, Inc  (7)(14)  First Lien Revolver  S + 4.75%  8.73%  1/30/2032   332    109    111    0.02 
WatchGuard Technologies, Inc.  (8)(13)  First Lien Term Loan  S + 5.25%  9.38%  7/2/2029   198    197    198    0.03 
                        174,260    173,471    24.68 

 

31

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Specialty Retail                                   
Mavis Tire Express Services Topco, Corp.  (5)(8)(13)  First Lien Term Loan  S + 3.00%  6.98%  5/4/2028  $872   $866   $872    0.12%
SCW Holdings III Corp.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  3/17/2032   5,190    5,174    5,190    0.74 
SCW Holdings III Corp.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  3/17/2032   977    (2)        
SCW Holdings III Corp.  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  3/17/2031   872    (3)        
Shock Doctor Intermediate, LLC  (8)(12)  First Lien Term Loan  S + 5.75%  9.73%  11/20/2029   198    198    198    0.03 
                        6,233    6,260    0.89 
Technology Hardware, Storage and Peripherals                                   
TA TT Buyer, LLC  (5)(8)(14)  First Lien Term Loan  S + 4.75%  8.73%  4/2/2029   198    198    196    0.03 
Ubeo, LLC  (8)(12)  First Lien Term Loan  S + 5.25%  9.23%  7/3/2028   198    198    198    0.03 
Victors Purchaser, LLC  (8)(14)  First Lien Term Loan  S + 4.75%  8.73%  8/15/2031   9,148    9,131    9,148    1.30 
Victors Purchaser, LLC  (7)(14)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  8/15/2031   2,191    466    473    0.07 
Victors Purchaser, LLC  (7)(14)  First Lien Revolver  S + 4.75%  8.73%  8/15/2031   1,254    (3)        
                        9,990    10,015    1.43 
Textiles, Apparel and Luxury Goods                                   
Gloves Buyer, Inc.  (5)(8)(14)  First Lien Term Loan  S + 4.00%  8.13%  5/21/2032   4,000    3,981    3,895    0.55 
Gloves Buyer, Inc.  (7)(14)  First Lien Revolver  S + 4.00%  8.13%  5/22/2030   420             
Team Acquisition Corporation  (7)(12)  First Lien Revolver  S + 7.00%  10.98%  11/21/2028   100    11    9     
Varsity Brands, Inc.  (5)(8)(15)  First Lien Term Loan  S + 3.00%  6.98%  8/26/2031   4,990    5,007    4,997    0.71 
                        8,999    8,901    1.26 
Trading Companies and Distributors                                   
Painters Supply and Equipment Co.  (8)(12)  First Lien Term Loan  S + 5.50%  9.58%  8/10/2027   198    196    191    0.03 
Kele Holdco, Inc.  (8)(12)  First Lien Term Loan  S + 4.50%  8.63%  2/20/2028   198    198    198    0.03 
Surfaceprep Buyer, LLC  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  2/4/2030   1,897    1,897    1,878    0.27 
SurfacePrep Buyer, LLC  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  2/4/2030   3,033    2,290    2,266    0.32 
Surfaceprep Buyer, LLC  (13)  First Lien Delayed Draw Term Loan  S + 5.00%  8.98%  2/4/2030   360    360    357    0.05 
Surfaceprep Buyer, LLC  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  2/4/2030   362    45    42    0.01 
                        4,986    4,932    0.71 
Transportation Infrastructure                                   
Psc Parent, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  9.13%  4/3/2031   1,617    1,617    1,617    0.23 
Psc Parent, Inc.  (8)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  4/3/2031   270    270    270    0.04 
Psc Parent, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 5.00%  9.13%  4/3/2031   388    178    179    0.03 
Psc Parent, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  9.13%  4/3/2030   292    101    101    0.01 
VRS Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 4.75%  8.73%  7/19/2032   9,319    9,273    9,319    1.33 
VRS Buyer, Inc.  (7)(13)  First Lien Delayed Draw Term Loan  S + 4.75%  8.73%  7/19/2032   1,908    (5)        
VRS Buyer, Inc.  (7)(13)  First Lien Revolver  S + 4.75%  8.73%  7/19/2032   1,272    (6)        
                        11,428    11,486    1.64 

 

32

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Wireless Telecommunication Services                                   
Alert Media, Inc.  (12)  First Lien Term Loan  S + 6.25%  10.23% (Incl. 9.23% PIK)  4/12/2027  $453   $453   $453    0.06%
Alert Media, Inc.  (7)(12)  First Lien Revolver  S + 5.25%  9.23%  4/12/2027   109             
CCI Buyer, Inc.  (8)(13)  First Lien Term Loan  S + 5.00%  8.98%  5/13/2032   9,926    9,877    9,877    1.40 
CCI Buyer, Inc.  (7)(13)  First Lien Revolver  S + 5.00%  8.98%  5/13/2032   580        (3)    
                        10,330    10,327    1.46 
Total Secured Debt Investments                       1,377,503    1,374,990    195.54 
                                    
Unsecured Debt Investments                                   
Diversified Consumer Services                                   
Apex Service Partners Intermediate 2, LLC  (15)  Subordinated Unsecured Delayed Draw Term Loan  N/A  14.25% PIK  4/23/2031   801    793    783    0.11 
                        793    783    0.11 
Total Unsecured Debt Investments                       793    783    0.11 
                                    
Equity Investments                                   
Automobile Components                                   
Clarity Technologies Holdings, LP  (9)  Common         6    628    628    0.09 
                        628    628    0.09 
Capital Markets                                   
Lal Group Holdings, LLC  (9)  Common         146    151    151    0.02 
Lal Group Holdings, LLC  (9)  Preferred         146    151    151    0.02 
                        302    302    0.04 
Chemicals                                   
Americhem, Inc.  (9)  Preferred         2    245    295    0.04 
Buckman Laboratories  (9)  Common         373    373    373    0.05 
                        618    668    0.09 
Commercial Services and Supplies                                   
Low Voltage Holdings Inc.  (9)  Preferred         1    1,050    1,050    0.15 
                        1,050    1,050    0.15 
Containers and Packaging                                   
KPCI Co-Invest 2, LP  (9)  Common         1    726    726    0.10 
TCB Holdings I LLC  (9)  Preferred  N/A  14.00% PIK     5    5,138    5,093    0.72 
                        5,864    5,819    0.82 
Diversified Consumer Services                                   
Seahawk Holdings, LP  (9)  Preferred         1    1,301    1,431    0.20 
                        1,301    1,431    0.20 
Electronic Equipment, Instruments and Components                                   
NSI Parent LP  (9)  Common         52    52    61    0.01 
                        52    61    0.01 

 

33

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest Rate  Maturity
Date
  Par
Amount /
Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Financial Services                                   
GTCR Momentum Aggregator LP  (9)  Preferred  N/A  12.00% PIK    $259   $280   $280    0.04%
                        280    280    0.04 
Health Care Technology                                   
DeLorean Topco, L.P.  (9)  Common         435    435    467    0.07 
F&M Buyer LLC  (9)  Preferred         365    365    467    0.07 
Goldeneye Parent, LLC  (3)(9)  Preferred             417    417    0.06 
Goldeneye Parent, LLC  (9)  Common         20             
Novacap TMT VI Co-Investment (Invita) LP  (9)  Common         202    202    202    0.03 
Unlimited Technology Holdings, LLC  (9)  Preferred         552    552    552    0.08 
                        1,971    2,105    0.31 
Healthcare Providers and Services                                   
ACG Parent Holdings, LP  (3)(9)  Preferred             279    279    0.04 
ACG Parent Holdings, LP  (9)  Common         3    3    3     
EPFS Acquisition Holdings, LP  (3)(9)  Common             156    156    0.02 
MRO Corporation  (3)(9)  Common             239    268    0.04 
                        677    706    0.10 
IT Services                                   
OMERS Apollo Investment Holdings, LLC  (9)  Preferred         1,369    1,369    1,369    0.19 
                        1,369    1,369    0.19 
Professional Services                                   
Monarch Buyer, Inc.  (9)  Common         1,376    1,376    1,376    0.20 
                        1,376    1,376    0.20 
Software                                   
Scorpion Holdings, LLC  (9)  Preferred  N/A  8.00% PIK     1    1,098    1,098    0.16 
Scorpion Holdings, LLC  (9)  Common         1,000             
                        1,098    1,098    0.16 
Specialty Retail                                   
SCW Holdings III Corp.  (9)  Preferred         1    500    588    0.08 
                        500    588    0.08 
Textiles, Apparel and Luxury Goods                                   
Gloves Buyer, Inc.  (9)  Common         1    162    218    0.03 
                        162    218    0.03 
Transportation Infrastructure                                   
VRS Parent Holdings LP  (9)  Common         3    286    286    0.04 
                        286    286    0.04 
Total Equity Investments                       17,534    17,985    2.55 
Total Investments - non-controlled/non-affiliated                       1,395,830    1,393,758    198.20 
                                    
Short-term Investments                                   
BlackRock Liquidity T-Fund - Institutional Shares  (11)                    29,010    29,010    4.12 
Total Short-term Investments                       29,010    29,010    4.12 
Total Investments at fair value                      $1,424,840   $1,422,768    202.32%

 

34

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

1.Unless otherwise indicated, issuers of debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount is presented for debt investments and the number of shares or units owned is presented for equity investments.

2.The majority of the investments bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate ("SOFR" or "S"), Prime Rate (“Prime” or “P”), Canadian Overnight Repo Rate Average ("CORRA" or "C"), Sterling Overnight Index Average ("SONIA" or "SON"), Euro Interbank Offered Rate ("EURIBOR" or "E") or other relevant benchmark, which reset daily, monthly, quarterly, semiannually or annually. For each such investment, the Company has provided the spread over reference rates and the current contractual interest rate in effect on September 30, 2025. Certain investments are subject to an interest rate floor, or rate cap. Certain investments contain a Payment-in-Kind (“PIK”) provision. SOFR based contracts may include a credit spread adjustment, which is included within the stated all-in interest rate, if applicable, that is charged in addition to the base rate and the stated spread.

3.Investments with par value / shares less than 500 shown as zero.

4.The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").

5.These investments were not valued using unobservable inputs and are not considered Level 3 investments. Fair value was determined in good faith by the Adviser as the Company’s valuation designee, subject to the oversight of the Board of Trustees (the “Board”) (see Note 2 and Note 5), pursuant to the Company’s valuation policy.

6.The investment is not a qualifying asset, in whole or in part, under Section 55(a) of the 1940 Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company’s total assets. As of September 30, 2025, non-qualifying assets represented 7.39% of total assets as calculated in accordance with regulatory requirements.

7.Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. Such commitments are subject to the satisfaction of certain conditions set forth in the documents governing these loans and letters of credit and there can be no assurance that such conditions will be satisfied. See the following page and Note 7 to the Consolidated Financial Statements for more information on the Company’s unfunded commitments.

8.Position or portion thereof is pledged as collateral under the Morgan Stanley Facility.

 

35

 

 

ANTARES PRIVATE CREDIT FUND
CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)
September 30, 2025

(in thousands)

 

9.Security exempt from registration under the Securities Act of 1933 (the “Securities Act”), and may be deemed to be “restricted securities” under the Securities Act. As of September 30, 2025, the aggregate fair value of these securities is $17,985 or 2.56% of the Company’s net assets. The acquisition dates of these restricted securities are as follows:

 

Portfolio Company   Investment   Acquisition Date
ACG Parent Holdings, LP   Preferred   July 25, 2025
ACG Parent Holdings, LP   Common   July 25, 2025
Americhem, Inc.   Preferred   February 28, 2025
Buckman Laboratories   Common   July 1, 2025
Clarity Technologies Holdings, LP   Common   September 25, 2025
DeLorean Topco, L.P.   Common   December 16, 2024
EPFS Acquisition Holdings, LP   Common   July 31, 2025
F&M Buyer LLC   Preferred   March 18, 2025
Gloves Buyer, Inc.   Common   June 6, 2025
Goldeneye Parent, LLC   Common   March 31, 2025
Goldeneye Parent, LLC   Preferred   March 31, 2025
GTCR Momentum Aggregator LP   Preferred   July 2, 2025
KPCI Co-Invest 2, LP   Common   September 26, 2025
Lal Group Holdings, LLC   Common   August 6, 2025
Lal Group Holdings, LLC   Preferred   August 6, 2025
Low Voltage Holdings Inc.   Preferred   April 28, 2025
Monarch Buyer, Inc.   Common   June 2, 2025
MRO Corporation   Common   June 9, 2025
Novacap TMT VI Co-Investment (Invita) LP   Common   August 12, 2025
NSI Parent LP   Common   December 23, 2024
OMERS Apollo Investment Holdings, LLC   Preferred   December 30, 2024
Scorpion Holdings, LLC   Preferred   December 27, 2024
Scorpion Holdings, LLC   Common   December 27, 2024
SCW Holdings III Corp.   Preferred   March 17, 2025
Seahawk Holdings, LP   Preferred   December 19, 2024
TCB Holdings I LLC   Preferred   January 31, 2025
Unlimited Technology Holdings, LLC   Preferred   March 12, 2025
VRS Parent Holdings LP   Common   July 18, 2025

 

10.These are co-investments made with the Company’s affiliates in accordance with the terms of the exemptive order the Company received from the Securities and Exchange Commission (the “SEC”) permitting the Company to do so (see Note 3 to the consolidated financial statements for discussion of the exemptive order from the SEC).

11.Short-term investments amounting to $29,010 are invested in money market funds (BlackRock Liquidity T-Fund - Institutional Shares) and would be categorized as Level 1 under the ASC 820 fair value level hierarchy as of September 30, 2025.

12.Loan includes interest floor of 1.00%.

13.Loan includes interest floor of 0.75%.

14.Loan includes interest floor of 0.50%.

15.Loan includes interest floor of 0.00%.

 

36

 

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

As of September 30, 2025, the Company had the following commitments to fund various revolving and delayed draw loans. Such commitments, also included in the Consolidated Schedule of Investments above, are subject to the satisfaction of certain conditions set forth in the documents governing these loans. See Note 7 to the Consolidated Financial Statements for more information on the Company's unfunded commitments.

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
  Fair
Value (1)
 
123Dentist Inc.  Delayed Draw Term Loan  8/10/2026  $1,291  $(5)
1364720 B.C. LTD.  Delayed Draw Term Loan  4/3/2027   477    
AAH Topco., LLC  Delayed Draw Term Loan  4/1/2027   2,705    
AB Centers Acquisition Corporation  Delayed Draw Term Loan  7/2/2026   290   (1)
AB Centers Acquisition Corporation  Revolver  7/2/2031   428   (2)
ABC Legal Holdings, LLC  Delayed Draw Term Loan  8/14/2027   393   (2)
ABC Legal Holdings, LLC  Revolver  8/13/2032   255   (1)
Acentra Holdings, LLC  Delayed Draw Term Loan  3/20/2026   220    
Alert Media, Inc.  Revolver  4/12/2027   109    
AMBA Buyer, Inc.  Revolver  7/30/2027   223   (1)
American Residential Services LLC  Revolver  1/31/2030   870   (2)
Americhem, Inc.  Delayed Draw Term Loan  2/28/2027   2,690   (13)
Americhem, Inc.  Revolver  3/1/2032   1,906   (10)
Amerilife Holdings LLC  Delayed Draw Term Loan  6/18/2026   2,142   (5)
Amerilife Holdings LLC  Revolver  8/31/2028   463   (1)
Ampirical Solutions, LLC  Delayed Draw Term Loan  9/30/2027   2,655   (13)
Ampirical Solutions, LLC  Revolver  9/30/2032   708   (4)
Analytic Partners, LP  Revolver  4/4/2030   502    
Anchor Packaging, LLC  Revolver  4/17/2029   100    
Apex Service Partners, LLC  Revolver  10/24/2029   660    
Applied Technical Services, LLC  Delayed Draw Term Loan  4/8/2026   465    
Applied Technical Services, LLC  Revolver  4/8/2031   542    
Aprio Advisory Group, LLC  Delayed Draw Term Loan  4/26/2027   3,226   (15)
Aprio Advisory Group, LLC  Revolver  8/1/2031   1,638   (8)
AQ Carver Buyer, Inc.  Revolver  8/2/2028   100    
AQA Acquisition Holding, Inc.  Revolver  3/3/2028   100    
Arax MidCo, LLC  Delayed Draw Term Loan  11/30/2026   2,951    
Arax MidCo, LLC  Revolver  4/11/2029   379    
Arrow Management Acquisition, LLC  Delayed Draw Term Loan  7/27/2027   785   (4)
Arrow Management Acquisition, LLC  Revolver  7/26/2032   262   (1)
Artifact Bidco, Inc.  Delayed Draw Term Loan  7/27/2027   821    
Artifact Bidco, Inc.  Revolver  7/26/2030   587    
Athenahealth Group Inc.  Revolver  2/15/2027   100    
Aurora Plastics, LLC  Delayed Draw Term Loan  4/10/2027   1,140   (5)
Ave Holdings III, Corp.  Revolver  2/25/2028   514   (15)
AWP Group Holdings, Inc.  Revolver  12/23/2030   184   (2)
Bamboo US BidCo LLC  Delayed Draw Term Loan  11/20/2026   714   (7)
Bamboo US BidCo LLC  Revolver  10/1/2029   826   (8)
Bamboo US BidCo LLC  Revolver  9/30/2030   55   (1)
BC Group Holdings, Inc.  Delayed Draw Term Loan  8/21/2027   2,156   (10)
BCPE North Star US Holdco 2, Inc.  Revolver  3/10/2028   61    
Bellwether Buyer, L.L.C.  Delayed Draw Term Loan  10/16/2027   2,178   (5)
Bellwether Buyer, L.L.C.  Revolver  4/15/2032   653   (2)

 

37

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
  Fair
Value (1)
 
Beyond Risk Parent Holdings, Inc.  Delayed Draw Term Loan  4/9/2026  $5,843  $ 
Blackbird Purchaser, Inc.  Delayed Draw Term Loan  12/19/2025   76    
Blackbird Purchaser, Inc.  Revolver  12/19/2029   37    
Blackhawk Industrial Distribution, Inc.  Revolver  9/17/2026   565   (7)
Bracket Intermediate Holding Corp.  Revolver  2/7/2028   100    
BradyPlus Holdings, LLC  Delayed Draw Term Loan  11/1/2025   471    
Bridges Consumer Healthcare Intermediate LLC  Delayed Draw Term Loan  12/21/2026   447    
Bridges Consumer Healthcare Intermediate LLC  Delayed Draw Term Loan  3/31/2027   2,000    
Bridges Consumer Healthcare Intermediate LLC  Revolver  12/22/2031   894    
Bulab Holdings, Inc.  Delayed Draw Term Loan  7/1/2032   1,931   (10)
Bulab Holdings, Inc.  Revolver  7/1/2032   1,862   (9)
Carr, Riggs & Ingram Capital, L.L.C.  Delayed Draw Term Loan  11/18/2026   1,149    
Carr, Riggs & Ingram Capital, L.L.C.  Revolver  11/18/2031   667    
CCI Buyer, Inc.  Revolver  5/13/2032   580   (3)
CDL Parent, Inc.  Delayed Draw Term Loan  12/7/2027   702   (4)
Cerity Partners Equity Holding LLC  Delayed Draw Term Loan  1/21/2027   4,646    
Cerity Partners Equity Holding LLC  Revolver  7/28/2028   475    
CFGI Holdings, LLC  Revolver  11/2/2027   270   (2)
CFs Brands, LLC  Revolver  10/2/2029   493    
ClearCapital Holdings, LLC  Delayed Draw Term Loan  7/6/2027   1,024   (6)
ClearCapital Holdings, LLC  Revolver  6/30/2032   410   (2)
Cloud Software Group, Inc.  Revolver  9/28/2029   100    
Clydesdale Acquisition Holdings, Inc.  Delayed Draw Term Loan  4/1/2032   33    
Cold Chain Technologies, LLC  Revolver  7/2/2026   248   (1)
Concord Global Acquisition, LLC  Delayed Draw Term Loan  12/28/2026   1,304    
Concord Global Acquisition, LLC  Revolver  12/29/2031   686    
Continental Buyer, Inc.  Delayed Draw Term Loan  8/15/2027   1,682   (4)
Continental Buyer, Inc.  Revolver  4/2/2031   1,398   (3)
CPC/Cirtec Holdings, Inc.  Revolver  10/31/2028   468   (2)
CRCI Longhorn Holdings, Inc.  Delayed Draw Term Loan  8/28/2026   1,529    
CRCI Longhorn Holdings, Inc.  Revolver  8/27/2031   1,020    
Crisis Prevention Institute, Inc.  Revolver  4/9/2029   100    
Crown Laundry, LLC  Delayed Draw Term Loan  5/29/2027   435   (2)
Crown Laundry, LLC  Revolver  5/28/2031   507   (2)
Cub Financing Intermediate, LLC  Delayed Draw Term Loan  6/28/2026   1,024    
CVP Holdco, Inc.  Delayed Draw Term Loan  6/29/2026   1,344   (3)
CVP Holdco, Inc.  Revolver  6/28/2030   686   (1)
CVR Management, LLC  Delayed Draw Term Loan  1/4/2027   111    
DCG Acquisition Corp.  Delayed Draw Term Loan  6/13/2026   468   (4)
DeLorean Purchaser, Inc.  Revolver  12/16/2031   653   (5)
Disa Holdings Corp.  Delayed Draw Term Loan  3/1/2026   17    
DS Admiral Bidco, LLC  Revolver  6/26/2029   100    
DT Intermediate Holdco, Inc.  Delayed Draw Term Loan  9/14/2026   1,658    
DT1 Midco Corp  Delayed Draw Term Loan  6/4/2027   2,522   (13)
DT1 Midco Corp  Revolver  12/30/2030   1,183    

 

38

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
  Fair
Value (1)
 
Dwyer Instruments, LLC  Delayed Draw Term Loan  11/21/2026  $505  $(5)
Dwyer Instruments, LLC  Revolver  7/20/2029   649   (6)
Eagan Parent, Inc.  Delayed Draw Term Loan  9/8/2027   1,441   (4)
Eagan Parent, Inc.  Revolver  9/8/2032   769   (2)
Eclipse Buyer, Inc.  Delayed Draw Term Loan  9/7/2026   1,333    
Eclipse Buyer, Inc.  Revolver  9/8/2031   676    
Edgeco Buyer, Inc.  Delayed Draw Term Loan  12/20/2026   2,433    
Edgeco Buyer, Inc.  Revolver  6/1/2028   289    
Edpo, LLC  Delayed Draw Term Loan  8/29/2027   1,657   (8)
Edpo, LLC  Revolver  12/8/2028   675   (3)
Emburse, Inc.  Delayed Draw Term Loan  5/29/2027   1,316   (3)
Emburse, Inc.  Revolver  5/28/2032   1,316   (3)
Empower Payments Investor, LLC  Delayed Draw Term Loan  6/28/2027   1,805   (14)
Empower Payments Investor, LLC  Revolver  3/12/2030   163   (1)
Empyrean Solutions, LLC  Delayed Draw Term Loan  11/25/2026   553    
Empyrean Solutions, LLC  Revolver  11/26/2031   207    
Ensemble RCM, LLC  Revolver  6/27/2028   100    
Enthusiast Auto Holdings, LLC  Revolver  12/19/2026   64    
Enverus Holdings, Inc.  Delayed Draw Term Loan  12/22/2025   38    
Enverus Holdings, Inc.  Revolver  12/24/2029   205    
EPFS Buyer, Inc.  Delayed Draw Term Loan  7/31/2027   1,029   (5)
EPFS Buyer, Inc.  Revolver  7/31/2031   686   (3)
Essential Services Holding Corporation  Delayed Draw Term Loan  6/17/2026   395   (1)
Essential Services Holding Corporation  Revolver  6/17/2030   197    
Excelitas Technologies Corp.  Delayed Draw Term Loan  5/1/2026   2,522   (3)
Eyesouth Eye Care Holdco, LLC  Delayed Draw Term Loan  4/1/2026   1,840    
F&M Buyer LLC  Delayed Draw Term Loan  3/19/2027   1,194    
F&M Buyer LLC  Revolver  3/18/2032   522    
Flint Opco, LLC  Delayed Draw Term Loan  6/27/2027   3,219    
Flint Opco, LLC  Delayed Draw Term Loan  6/1/2026   1,117    
Flow Control Solutions, Inc.  Delayed Draw Term Loan  6/28/2026   3,984    
Flow Control Solutions, Inc.  Revolver  3/29/2029   722    
Foreside Financial Group, LLC  Delayed Draw Term Loan  3/13/2026   10,285    
Foundation Risk Partners, Corp.  Delayed Draw Term Loan  2/26/2027   4,079    
Fourth Enterprises, LLC  Delayed Draw Term Loan  3/21/2027   2,079   (10)
Fourth Enterprises, LLC  Revolver  3/21/2031   786   (4)
FR Vision Holdings Inc  Delayed Draw Term Loan  1/20/2026   2,134    
FR Vision Holdings Inc  Revolver  1/22/2030   248    
Frazier & Deeter Advisory, LLC  Delayed Draw Term Loan  5/2/2027   937    
Frazier & Deeter Advisory, LLC  Revolver  5/2/2031   325    
Gloves Buyer, Inc.  Revolver  5/22/2030   420   (11)
Goldeneye Parent, LLC  Revolver  3/31/2032   1,744    
GS Acquisitionco, Inc.  Delayed Draw Term Loan  3/26/2026   125    
GSV Holding, LLC  Revolver  10/18/2030   217    
Harvey Tool Company, LLC  Delayed Draw Term Loan  6/28/2026   3,424   (25)
Harvey Tool Company, LLC  Revolver  8/6/2032   1,179   (8)

 

39

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
  Fair
Value (1)
 
Health Buyer LLC  Delayed Draw Term Loan  5/15/2026  $2,643  $ 
HeartLand PPC Buyer, LLC  Delayed Draw Term Loan  12/13/2025   113    
HeartLand PPC Buyer, LLC  Revolver  12/12/2029   183    
Heights Buyer, LLC  Delayed Draw Term Loan  6/25/2027   1,254   (6)
Heights Buyer, LLC  Revolver  8/25/2028   677    
Hercules Borrower LLC  Delayed Draw Term Loan  12/16/2025   2,092   (10)
Hercules Borrower LLC  Revolver  12/15/2028   589   (3)
Higher Logic, LLC  Revolver  1/10/2029   380    
HighTower Holding, LLC  Revolver  2/1/2030   110    
HP RSS Buyer, Inc.  Delayed Draw Term Loan  7/2/2027   4,391   (21)
HSI Halo Acquisition, Inc.  Delayed Draw Term Loan  6/28/2026   699    
HSI Halo Acquisition, Inc.  Revolver  6/28/2030   932    
HT Intermediary III, Inc.  Delayed Draw Term Loan  11/13/2026   1,527   (8)
HT Intermediary III, Inc.  Revolver  11/12/2030   554   (3)
Hydraulic Technologies USA LLC  Revolver  6/3/2030   62   (1)
Hyphen Solutions, LLC  Delayed Draw Term Loan  8/6/2027   501   (1)
Hyphen Solutions, LLC  Revolver  8/6/2032   301   (1)
IG Investments Holdings, LLC  Revolver  9/22/2028   293    
ImageFirst Holdings, LLC  Revolver  3/12/2030   2,800    
Imagine 360 LLC  Delayed Draw Term Loan  9/20/2026   767    
Imagine 360 LLC  Revolver  9/30/2028   327    
IMO Investor Holdings, Inc.  Revolver  5/11/2028   370    
Inhabitiq Inc.  Delayed Draw Term Loan  1/11/2027   697    
Inhabitiq Inc.  Revolver  1/12/2032   436    
Innovative Systems L.L.C.  Delayed Draw Term Loan  8/21/2027   1,453   (7)
Innovative Systems L.L.C.  Revolver  8/20/2032   484   (2)
Innovetive Petcare, Inc.  Delayed Draw Term Loan  7/23/2027   1,342   (13)
Integrated Power Services Holdings, Inc.  Delayed Draw Term Loan  5/7/2026   5,106   (10)
Invictus Buyer, LLC  Delayed Draw Term Loan  6/4/2026   3,266    
Invictus Buyer, LLC  Revolver  6/3/2031   1,210    
JHCC Holdings LLC  Revolver  9/9/2027   101   (1)
JKC Parent, Inc.  Delayed Draw Term Loan  6/2/2027   702   (4)
JKC Parent, Inc.  Revolver  2/13/2032   87    
Kaseya Inc.  Revolver  3/20/2030   761    
Kenco PPC Buyer LLC  Revolver  11/15/2029   287    
KPA Parent Holdings, Inc.  Delayed Draw Term Loan  3/15/2027   1,016    
KPA Parent Holdings, Inc.  Revolver  3/12/2032   711    
Kriv Acquisition Inc.  Delayed Draw Term Loan  10/1/2027   2,042   (10)
Kriv Acquisition Inc.  Revolver  7/31/2031   168   (1)
Kwol Acquisition, Inc.  Delayed Draw Term Loan  8/25/2027   1,918   (9)
Kwol Acquisition, Inc.  Revolver  12/12/2029   1,066   (5)
Lido Advisors, LLC  Delayed Draw Term Loan  5/10/2027   2,260   (11)
Lido Advisors, LLC  Revolver  5/10/2032   256   (1)
Lightbeam Bidco Inc.  Revolver  5/4/2029   491    
Low Voltage Holdings Inc.  Delayed Draw Term Loan  10/28/2027   3,223   (8)

 

40

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
  Fair
Value (1)
 
Low Voltage Holdings Inc.  Revolver  4/28/2032  $1,421  $(4)
Low Voltage Holdings Inc.  Revolver  4/28/2032   128    
Lubricant Engineers  Delayed Draw Term Loan  3/31/2027   1,372    
Lubricant Engineers  Revolver  9/1/2029   885    
Marina Acquisition, Inc.  Revolver  7/1/2030   227   (5)
Mclarens Midco Inc.  Delayed Draw Term Loan  12/19/2027   200   (1)
Mclarens Midco Inc.  Revolver  12/19/2027   287   (1)
MDC Interior Acquisition Inc  Revolver  4/26/2030   42    
Merlin Buyer, Inc.  Revolver  12/14/2026   1,450    
Minotaur Acquisition, Inc.  Delayed Draw Term Loan  6/4/2026   1,455   (12)
Minotaur Acquisition, Inc.  Revolver  6/3/2030   873   (7)
Monarch Buyer, Inc.  Delayed Draw Term Loan  6/3/2027   2,051   (10)
Monarch Buyer, Inc.  Revolver  6/2/2032   923   (5)
Monotype Imaging Holdings Inc.  Delayed Draw Term Loan  2/28/2026   76    
Monotype Imaging Holdings Inc.  Revolver  2/28/2030   154   (1)
Montana Buyer Inc.  Revolver  7/22/2028   307    
Movati Athletic (Group) Inc.  Delayed Draw Term Loan  5/30/2026   659   (2)
MRI Software LLC  Revolver  2/10/2027   239    
MRO Corporation  Delayed Draw Term Loan  6/9/2027   795   (6)
MRO Corporation  Revolver  6/9/2032   795   (6)
Nasuni Corporation  Revolver  9/10/2030   1,302   (9)
Navex Topco, Inc.  Revolver  11/9/2028   1,797    
Nelipak Holding Company  Delayed Draw Term Loan  3/29/2027   2,486   (37)
Nelipak Holding Company  Revolver  3/26/2031   705   (11)
Net Health Acquisition Corp.  Revolver  7/7/2031   973   (5)
Noble Midco 3 Limited  Delayed Draw Term Loan  6/12/2027   824    
Noble Midco 3 Limited  Revolver  12/10/2030   1,120    
North Star Acquisitionco, LLC  Delayed Draw Term Loan  5/1/2026   11    
North Star Acquisitionco, LLC  Revolver  5/3/2029   486    
Oakbridge Insurance Agency, LLC  Delayed Draw Term Loan  6/21/2027   1,871    
Oeconnection LLC  Delayed Draw Term Loan  12/30/2026   2,138   7 
Oeconnection LLC  Revolver  4/22/2031   482    
OLO Parent, Inc.  Revolver  9/13/2032   799   (2)
Onit, Inc.  Delayed Draw Term Loan  1/28/2027   2,786    
Onit, Inc.  Revolver  1/27/2032   929    
ONS MSO, LLC  Revolver  7/7/2028   17    
Onsite Holdings, LLC  Delayed Draw Term Loan  12/19/2025   938   (5)
Onyx-Fire Protection Services Inc.  Delayed Draw Term Loan  7/31/2026   618    
Onyx-Fire Protection Services Inc.  Revolver  7/31/2031   1,441    
Orsini Pharmaceutical Services, LLC  Revolver  5/22/2030   226   (2)
Packaging Coordinators Midco, Inc.  Delayed Draw Term Loan  4/23/2026   4,882   (24)
Packaging Coordinators Midco, Inc.  Revolver  1/22/2032   926   (5)
Pareto Health Intermediate Holdings, Inc.  Delayed Draw Term Loan  12/31/2027   653   (3)
Pathstone Family Office LLC  Delayed Draw Term Loan  6/22/2026   1,454   (4)
Pathstone Family Office LLC  Revolver  5/15/2028   374   (1)
Patriot Growth Insurance Services, LLC  Revolver  10/16/2028   534    

 

41

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
  Fair
Value (1)
 
Phantom Purchaser, Inc.  Revolver  9/19/2031  $1,465  $(7)
Phoenix 1 Buyer Corp.  Revolver  11/20/2029   1,142    
Plaskolite PPC Intermediate II LLC  Revolver  2/7/2030   90   (6)
Potters Industries LLC  Revolver  9/14/2027   100    
Power Grid Holdings, Inc.  Revolver  12/2/2030   783   (9)
Premise Health Holding Corp.  Revolver  3/1/2030   712    
Prism Parent Co. Inc.  Delayed Draw Term Loan  9/19/2026   849   (8)
Proampac PG Borrower LLC  Revolver  6/16/2028   53    
Project Accelerate Parent LLC  Revolver  2/24/2031   100    
Propio LS, LLC  Revolver  5/10/2030   200   (1)
Psc Parent, Inc.  Delayed Draw Term Loan  4/3/2026   208    
Psc Parent, Inc.  Revolver  4/3/2030   191    
Puma Buyer, LLC  Revolver  3/29/2032   1,313    
Quality Automotive Services, LLC  Delayed Draw Term Loan  1/30/2027   282   (1)
Quality Automotive Services, LLC  Delayed Draw Term Loan  7/16/2027   2,000   (10)
Quality Automotive Services, LLC  Revolver  7/16/2027   257   (1)
Quick Quack Car Wash Holdings, LLC  Delayed Draw Term Loan  6/12/2027   4,134   (15)
Raven Acquisition Holdings, LLC  Delayed Draw Term Loan  11/19/2026   333    
Red Fox CD Acquisition Corporation  Delayed Draw Term Loan  11/23/2026   2,142   (11)
Resonetics, LLC  Revolver  6/18/2029   100    
RFI Buyer, Inc.  Delayed Draw Term Loan  8/29/2027   2,601   (13)
RFI Buyer, Inc.  Revolver  8/5/2030   600   (3)
Ridge Trail US Bidco, Inc.  Delayed Draw Term Loan  3/31/2027   2,995   (22)
Ridge Trail US Bidco, Inc.  Revolver  3/31/2031   729   (5)
Rimkus Consulting Group, Inc.  Delayed Draw Term Loan  4/1/2026   1,771   (53)
Rimkus Consulting Group, Inc.  Revolver  4/1/2030   901   (27)
Riser Interco, LLC  Delayed Draw Term Loan  4/16/2027   1,493    
Riser Interco, LLC  Revolver  10/31/2029   464    
Routeware, Inc.  Delayed Draw Term Loan  9/19/2026   1,386    
Routeware, Inc.  Revolver  9/18/2031   273    
Ruppert Landscape, LLC  Delayed Draw Term Loan  4/30/2026   4,054   (19)
Ruppert Landscape, LLC  Revolver  12/3/2029   627   (3)
RxSense Holdings LLC  Revolver  3/12/2027   619    
Ryan, LLC  Revolver  11/14/2028   51    
Safety Borrower Holdings LLC  Revolver  9/1/2027   337   (1)
Sako and Partners Lower Holdings LLC  Revolver  9/15/2028   1,091   (5)
Saturn Borrower Inc  Delayed Draw Term Loan  1/24/2027   1,422   (4)
Saturn Borrower Inc  Revolver  11/13/2028   486   (1)
SCW Holdings III Corp.  Delayed Draw Term Loan  3/18/2027   977    
SCW Holdings III Corp.  Revolver  3/17/2031   872    
Seahawk Bidco, LLC  Delayed Draw Term Loan  12/19/2026   671    
Seahawk Bidco, LLC  Revolver  12/19/2030   545    
Service Logic Acquisition, Inc.  Revolver  10/30/2025   100    
Simplicity Financial Marketing Group Holdings, Inc.  Delayed Draw Term Loan  12/31/2026   1,268   (6)

 

 

42

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
  Fair
Value (1)
 
Simplicity Financial Marketing Group Holdings, Inc.  Revolver  12/31/2031  $902  $(5)
Soleo Holdings, Inc.  Delayed Draw Term Loan  2/2/2027   704    
Soleo Holdings, Inc.  Revolver  1/30/2032   704    
Southpaw Ap Buyer, LLC  Delayed Draw Term Loan  5/1/2026   55    
Southpaw Ap Buyer, LLC  Revolver  3/2/2028   195    
Spartan Bidco PTY LTD  Revolver  1/24/2028   385    
Specialtycare, Inc.  Delayed Draw Term Loan  8/27/2027   1,353   (7)
Specialtycare, Inc.  Revolver  12/18/2029   188   (1)
Spirit RR Holdings, Inc.  Revolver  9/13/2028   272   (1)
St Athena Global LLC  Delayed Draw Term Loan  6/26/2026   213   (2)
St Athena Global LLC  Revolver  6/26/2029   448   (4)
STCH Acquisition Inc.  Revolver  10/30/2026   196    
Storable, Inc.  Revolver  4/16/2029   100    
Sugar Ppc Buyer LLC  Delayed Draw Term Loan  7/10/2026   4,760   (23)
SurfacePrep Buyer, LLC  Delayed Draw Term Loan  1/15/2027   737   (7)
Surfaceprep Buyer, LLC  Revolver  2/4/2030   317   (3)
Swoop Intermediate III, Inc.  Delayed Draw Term Loan  10/12/2027   3,643   (9)
Swoop Intermediate III, Inc.  Revolver  4/12/2032   1,214   (3)
Team Acquisition Corporation  Revolver  11/21/2028   89   (2)
Tersera Therapeutics, LLC  Revolver  4/4/2029   116    
The Chartis Group, LLC  Delayed Draw Term Loan  9/17/2026   388   (2)
The Chartis Group, LLC  Revolver  9/17/2031   194   (1)
The Hiller Companies, LLC  Delayed Draw Term Loan  6/22/2026   141    
The Hiller Companies, LLC  Delayed Draw Term Loan  7/17/2027   708   (4)
The Hiller Companies, LLC  Revolver  6/20/2030   1,299    
The Ultimus Group Midco, LLC  Delayed Draw Term Loan  1/1/2028   1,356    
The Ultimus Group Midco, LLC  Revolver  7/1/2032   509    
THG Acquisition, LLC  Delayed Draw Term Loan  10/30/2026   553    
THG Acquisition, LLC  Revolver  10/31/2031   306    
TPC Engineering Holdings, Inc.  Revolver  2/16/2027   264    
Trilon Group, LLC  Delayed Draw Term Loan  3/13/2027   1,436   (11)
Trilon Group, LLC  Revolver  5/29/2029   1,212   (10)
Trimech Acquisition Corp.  Revolver  3/10/2028   1,457   (7)
Truck-Lite Co., LLC  Delayed Draw Term Loan  2/13/2026   993   (4)
Truck-Lite Co., LLC  Delayed Draw Term Loan  12/17/2026   1,130   (4)
Truck-Lite Co., LLC  Revolver  2/13/2031   176   (1)
Trunk Acquisition, Inc.  Delayed Draw Term Loan  12/20/2026   275    
Unlimited Technology Holdings, LLC  Revolver  3/12/2032   747   (2)
US Fitness Holdings, LLC  Delayed Draw Term Loan  9/4/2026   1,764    
US Fitness Holdings, LLC  Revolver  9/4/2030   172    
USHV Management, LLC  Delayed Draw Term Loan  9/9/2027   1,016   (5)
USHV Management, LLC  Revolver  9/8/2031   549   (3)
USRP Holdings, Inc.  Delayed Draw Term Loan  8/28/2026   1,543    
USRP Holdings, Inc.  Revolver  12/31/2029   900    
Vaco Holdings, LLC  Revolver  1/21/2027   100   (14)
Valet Waste Holdings, Inc.  Delayed Draw Term Loan  3/8/2026   7,213    

 

43

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Unaudited)(Continued)

September 30, 2025

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
Valicor PPC Intermediate II LLC  Revolver  1/24/2028  $624   $(4)
Validity, Inc.  Revolver  4/10/2030   392     
Vamos Bidco, Inc  Delayed Draw Term Loan  1/30/2027   1,105     
Vamos Bidco, Inc  Revolver  1/30/2032   221     
Vensure Employer Services, Inc.  Delayed Draw Term Loan  9/27/2026   164    (1)
Vertex Service Partners, LLC  Delayed Draw Term Loan  10/2/2026   201    (7)
Vessco Midco Holdings, LLC  Delayed Draw Term Loan  7/24/2026   756     
Vessco Midco Holdings, LLC  Revolver  7/24/2031   552     
Victors Purchaser, LLC  Delayed Draw Term Loan  8/15/2026   1,718     
Victors Purchaser, LLC  Revolver  8/15/2031   1,254     
Victory Buyer LLC  Revolver  11/19/2028   43     
Vital Care Buyer, LLC  Revolver  7/30/2031   696    (3)
VPP Intermediate Holdings, LLC  Delayed Draw Term Loan  1/19/2027   2,584    (19)
VPP Intermediate Holdings, LLC  Revolver  12/1/2027   228    (1)
VRS Buyer, Inc.  Delayed Draw Term Loan  7/18/2027   1,908     
VRS Buyer, Inc.  Revolver  7/19/2032   1,272     
VS Buyer, LLC  Revolver  4/12/2029   100     
WST USA Holdco, Inc.  Delayed Draw Term Loan  12/30/2025   373    (1)
Wealth Enhancement Group, LLC  Delayed Draw Term Loan  12/30/2026   10,585    (25)
Wealth Enhancement Group, LLC  Revolver  10/2/2028   323    (1)
Wildcat Topco, Inc.  Delayed Draw Term Loan  11/16/2026   270    (1)
Wildcat Topco, Inc.  Revolver  11/17/2031   263    (1)
Wisdom Purchaser, LLC  Revolver  7/24/2032   636    (2)
World Insurance Associates, LLC  Delayed Draw Term Loan  8/14/2026   2,249    (6)
World Insurance Associates, LLC  Revolver  4/3/2030   209    (1)
WPP Bullet Buyer, LLC  Revolver  12/7/2029   83    (1)
WRE Holding Corp.  Revolver  7/2/2030   316    (2)
Wu Holdco, Inc.  Delayed Draw Term Loan  4/16/2027   2,497    (6)
Wu Holdco, Inc.  Revolver  4/19/2032   777    (2)
YA Intermediate Holdings II, LLC  Delayed Draw Term Loan  10/2/2026   2,018     
YA Intermediate Holdings II, LLC  Revolver  10/1/2031   984     
YLG Holdings, Inc.  Delayed Draw Term Loan  11/26/2026   560    (4)
YLG Holdings, Inc.  Revolver  12/23/2030   1,141    (9)
Zelis Cost Management Buyer, Inc.  Revolver  1/17/2029   100     
Zinc Buyer Corporation  Delayed Draw Term Loan  7/24/2026   830     
Zinc Buyer Corporation  Revolver  7/24/2031   790     
Zone Climate Services, Inc.  Delayed Draw Term Loan  11/22/2025   2,780    (7)
Zone Climate Services, Inc.  Revolver  3/9/2028   334    (3)
Total Unfunded Commitments        $368,519   $(1,115)

 

(1)Foreign domiciled investments have been converted to U.S. Dollars based on prevailing rates at period-end.

 

See accompanying notes to the consolidated financial statements.

 

44

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS 

December 31, 2024 

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
  Amortized
Cost (4)
  Fair Value  Percentage
of Net Assets
 
Investments - non-controlled/non-affiliated
Secured Debt
Aerospace and Defense
Bleriot US Bidco Inc.  (5)(8)  First Lien Term Loan  S + 2.75%  0.00%  7.06%  10/31/2030  $1,675  $1,675  $1,686  0.26%
GSP Holdings, LLC  (6)(8)  First Lien Term Loan  S + 5.50%  1.00%  9.96%  11/6/2026   100   100   99  0.02 
TransDigm Inc.  (5)(6)(8)  First Lien Term Loan  S + 2.75%  0.00%  7.06%  3/22/2030   1,895   1,905   1,903  0.30 
                       3,680    3,688   0.58  
Air Freight and Logistics
Lightbeam Bidco Inc  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  5/4/2030   4,951   4,951   4,951  0.78 
Lightbeam Bidco Inc  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.00%  9.81%  5/6/2030   1,558   652   652  0.10 
Lightbeam Bidco Inc  (7)  First Lien Revolver  S + 5.25%  0.00%  9.56%  5/4/2029   491         
                       5,603    5,603   0.88  
Automobile Components
Collision Sp Subco, LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.81%  1/29/2030   1,949   1,949   1,949  0.31 
Collision Sp Subco, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.00%  9.81%  1/29/2030   1,135   571   571  0.09 
Collision Sp Subco, LLC  (7)  First Lien Revolver  S + 5.50%  0.00%  9.81%  1/29/2030   318   47   47  0.01 
Enthusiast Auto Holdings, LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.08%  12/19/2026   5,921   5,921   5,921  0.93 
Enthusiast Auto Holdings, LLC  (7)  First Lien Revolver  S + 4.75%  1.00%  9.08%  12/19/2025   64         
JHCC Holdings LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  9/9/2027   1,468   1,463   1,462  0.23 
JHCC Holdings LLC  (8)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.56%  9/9/2027   425   423   423  0.07 
JHCC Holdings LLC  (7)  First Lien Revolver  P + 5.50%  0.00%  13.00%  9/9/2027   168   83   83  0.01 
Majco LLC  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.96%  12/4/2028   199   200   199  0.03 
OAC Holdings I Corp  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.43%  3/30/2029   199   199   199  0.03 
Power Stop, LLC  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.06%  1/26/2029   199   199   190  0.03 
Quality Automotive Services, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  7/16/2027   4,694   4,671   4,670  0.73 
Quality Automotive Services, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.56%  7/16/2027   2,049   1,828   1,827  0.29 
Quality Automotive Services, LLC  (7)  First Lien Revolver  S + 6.00%  1.00%  10.31%  7/16/2027   257   (1)  (1)  
Truck-Lite Co., LLC  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.06%  2/13/2031   1,612   1,612   1,612  0.25 
Truck-Lite Co., LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.75%  0.75%  10.06%  2/13/2031   176         
Truck-Lite Co., LLC  (7)  First Lien Revolver  S + 5.75%  0.75%  10.06%  2/13/2030   176         
                       19,165    19,152   3.01  
Building Products
80/20, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  3/1/2027   200   199   200  0.03 
MDC Interior Acquisition Inc  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.31%  4/26/2030   291   290   290  0.05 
MDC Interior Acquisition Inc  (7)  First Lien Revolver  S + 5.25%  0.00%  9.56%  4/26/2030   42         
Surewerx Purchaser III Inc  (6)(8)  First Lien Term Loan  S + 5.25%  0.75%  9.56%  12/28/2029   199   199   199  0.03 
Walter Surface Technologies Inc.  (6)(8)  First Lien Term Loan  S + 5.25%  1.00%  9.66%  3/31/2027   1,725   1,725   1,725  0.27 
Walter Surface Technologies Inc.  (6)(7)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.56%  3/31/2027   588   214   214  0.03 
                           2,627    2,628   0.41  

 

45

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued) 

December 31, 2024 

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
  Amortized
Cost (4)
  Fair Value  Percentage
of Net Assets
 
Capital Markets                                  
Allworth Financial Group, L.P.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  12/23/2027  $199  $199  $199  0.03%
Arax MidCo, LLC  (6)(8)  First Lien Term Loan  S + 5.00%  1.00%  9.31%  4/11/2029   3,834   3,800   3,789  0.59 
Arax MidCo, LLC  (6)(7)  First Lien Delayed Draw Term Loan  S + 5.75%  1.00%  10.08%  4/11/2029   710   (8)  (8)  
Arax MidCo, LLC  (6)(7)  First Lien Revolver  S + 5.75%  1.00%  10.06%  4/11/2029   431   (5)  (5)  
Cub Financing Intermediate, LLC  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.06%  6/28/2030   3,780   3,762   3,763  0.59 
Cub Financing Intermediate, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.06%  6/28/2030   1,741   (8)  (8)  
Edgeco Buyer, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  6/1/2028   6,205   6,201   6,174  0.97 
Edgeco Buyer, Inc.  (8)  First Lien Term Loan  S + 4.50%  0.00%  8.81%  6/1/2028   1,149   1,143   1,143  0.18 
Edgeco Buyer, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  6/1/2028   119   119   118  0.02 
Edgeco Buyer, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  0.00%  8.81%  6/1/2028   2,771   (7)  (14)  
Edgeco Buyer, Inc.  (8)  First Lien Delayed Draw Term Loan  S + 4.50%  1.00%  8.81%  6/1/2028   101   101   101  0.02 
Edgeco Buyer, Inc.  (8)  First Lien Delayed Draw Term Loan  S + 4.50%  1.00%  8.81%  6/1/2028   544   544   541  0.08 
Edgeco Buyer, Inc.  (8)  First Lien Delayed Draw Term Loan  S + 4.50%  1.00%  8.81%  6/1/2028   240   240   238  0.04 
Edgeco Buyer, Inc.     First Lien Delayed Draw Term Loan  S + 4.50%  0.00%  8.81%  6/1/2026   484   484   482  0.08 
Edgeco Buyer, Inc.  (7)  First Lien Revolver  S + 4.50%  0.00%  8.81%  6/1/2028   304   (1)  (2)  
HighTower Holding, LLC  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  10/21/2027   100         
Lido Advisors, LLC  (8)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.31%  6/15/2029   199   198   198  0.03 
The Ultimus Group Midco, LLC  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.66%  3/7/2031   8,665   8,665   8,665  1.36 
The Ultimus Group Midco, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.66%  3/7/2031   1,302         
The Ultimus Group Midco, LLC  (7)  First Lien Revolver  S + 5.25%  0.75%  9.66%  3/7/2030   868         
                         25,427   25,374  3.99 
Chemicals                                  
Aurora Plastics, LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.18%  8/10/2028   7,684   7,674   7,647  1.20 
Aurora Plastics, LLC  (8)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.18%  8/10/2028   1,420   1,420   1,413  0.22 
Aurorium Global Holdings LLC  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.21%  12/22/2027   100   99   98  0.01 
Boulder Scientific Company, LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.21%  12/31/2027   100   99   100  0.02 
Charkit Chemical Company, LLC  (8)  First Lien Term Loan  S + 4.88%  1.00%  9.31%  12/29/2026   100   99   99  0.02 
DCG Acquisition Corp.  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.83%  6/13/2031   6,991   6,991   6,991  1.10 
DCG Acquisition Corp.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.08%  6/13/2031   1,169         
Formulations Parent Corporation  (7)  First Lien Revolver  S + 5.75%  0.00%  10.08%  11/15/2029   100         
Hasa Acquisition, LLC  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  1/10/2029   200   200   199  0.03 
Highline Aftermarket Acquisition, LLC  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  8/10/2027   100         
LTI Holdings, Inc.  (5)(8)  First Lien Term Loan  S + 4.75%  0.00%  9.08%  7/29/2029   1,995   2,005   2,001  0.31 
Lubricant Engineers  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.08%  9/1/2029   199   200   197  0.03 
Potters Industries LLC  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  9/14/2027   100   6   6   
Rocket Bidco, Inc.  (8)  First Lien Term Loan  S + 5.75%  0.00%  10.08%  11/1/2030   199   144   139  0.02 
                               18,937   18,890  2.96 

 

46

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued) 

December 31, 2024 

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
  Amortized
Cost (4)
  Fair Value  Percentage
of Net Assets
 
Commercial Services and Supplies 
Ares Holdings, LLC  (8)  First Lien Term Loan  S + 5.00%  0.00%  9.31%  11/18/2027  $3,174  $3,158  $3,160  0.50%
AWP Group Holdings, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.00%  9.08%  12/23/2030   14,359   14,288   14,323  2.25 
AWP Group Holdings, Inc.  (7)  First Lien Revolver  S + 4.75%  1.00%  9.08%  12/23/2030   320   14   15   
CoolSys, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.32%  8/11/2028   199   197   195  0.03 
Denali Buyerco LLC  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.71%  9/15/2028   4,824   4,824   4,804  0.75 
Denali Buyerco LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.71%  9/15/2028   7,572   6,442   6,409  1.01 
Ext Acquisitions, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  6/26/2026   199   199   199  0.03 
FL Hawk Intermediate Holdings, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  2/22/2030   502   499   499  0.08 
FL Hawk Intermediate Holdings, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  2/22/2030   466   464   464  0.07 
Fresh Holdco, Inc.  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.75%  1/24/2026   199   199   199  0.03 
HeartLand PPC Buyer, LLC  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.56%  12/12/2029   5,822   5,756   5,808  0.91 
HeartLand PPC Buyer, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.56%  12/12/2029   865   527   534  0.08 
HeartLand PPC Buyer, LLC  (7)  First Lien Revolver  S + 5.25%  0.75%  9.56%  12/12/2029   297   29   32  0.01 
Hercules Borrower LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.91%  12/14/2026   3,216   3,188   3,216  0.50 
Hercules Borrower LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.91%  12/14/2026   46   45   46  0.01 
Hercules Borrower LLC  (8)  First Lien Delayed Draw Term Loan  S + 5.50%  1.00%  9.91%  12/14/2026   270   268   270  0.04 
Hercules Borrower LLC  (7)  First Lien Revolver  S + 6.25%  1.00%  10.66%  12/14/2026   459   (4)     
High Bar Brands Operating, LLC  (6)(8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  12/19/2029   199   198   199  0.03 
HP RSS Buyer, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  12/11/2029   1,604   1,589   1,592  0.25 
HP RSS Buyer, Inc.     First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.31%  12/11/2029   851   842   844  0.13 
HP RSS Buyer, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.06%  12/11/2029   3,496   893   902  0.14 
Liquid Environmental Solutions Corporation  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.41%  5/31/2026   100   99   99  0.02 
Monarch Landscape Holdings, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  10/2/2028   200   198   198  0.03 
Onyx-Fire Protection Services Inc.  (6)(8)  First Lien Term Loan  C + 4.50%  0.00%  7.75%  7/31/2031  CAD 8,646   6,218   5,981  0.94 
Onyx-Fire Protection Services Inc.  (6)(7)  First Lien Delayed Draw Term Loan  C + 4.50%  0.00%  7.75%  7/31/2031  CAD 1,361   (5)  (5)  
Onyx-Fire Protection Services Inc.  (6)(7)  First Lien Revolver  C + 4.50%  0.75%  7.75%  7/31/2031  CAD 2,149   (7)  (7)  
Palmetto Acquisitionco Inc  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.06%  9/18/2029   199   199   199  0.03 
Pavion Corp.  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.06%  10/30/2030   199   199   199  0.03 
Service Logic Acquisition, Inc.  (7)  First Lien Revolver  S + 4.00%  0.00%  8.33%  10/30/2025   100         
The Hiller Companies, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  6/20/2030   7,450   7,414   7,432  1.17 
The Hiller Companies, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.33%  6/20/2030   2,055   507   512  0.08 
The Hiller Companies, LLC  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  6/20/2030   1,299   (6)  (3)  

 

47

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued) 

December 31, 2024 

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
  Amortized
Cost (4)
  Fair Value  Percentage
of Net Assets
 
Commercial Services and Supplies (continued) 
Thermostat Purchaser III, Inc.  (8)  First Lien Term Loan  S + 4.25%  0.75%  8.56%  8/31/2028  $199  $199  $199  0.03%
Valet Waste Holdings, Inc.  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.08%  5/1/2029   5,224   5,172   5,224  0.82 
Valet Waste Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.75%  1.00%  10.08%  5/1/2029   7,213   (70)     
WRE Holding Corp.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.25%  7/2/2031   2,310   2,299   2,298  0.36 
WRE Holding Corp.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.25%  7/2/2031   592   175   175  0.03 
WRE Holding Corp.  (7)  First Lien Revolver  S + 5.00%  0.00%  9.25%  7/2/2030   316   (1)  (2)  
YLG Holdings, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.00%  9.06%  12/23/2030   9,407   9,377   9,362  1.47 
YLG Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.06%  10/30/2026   1,379   603   600  0.09 
YLG Holdings, Inc.  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  10/30/2026   1,214   (2)  (6)  
Zinc Buyer Corporation     First Lien Term Loan  S + 4.75%  0.75%  9.06%  7/24/2031   6,397   6,358   6,349  1.00 
Zinc Buyer Corporation  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.06%  7/24/2031   1,613   (11)  (12)  
Zinc Buyer Corporation  (7)  First Lien Revolver  S + 4.75%  0.75%  9.06%  7/24/2031   790   (6)  (6)  
Zone Climate Services, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 6.00%  1.00%  10.33%  3/9/2028   3,182   (39)  (38) (0.01) 
Zone Climate Services, Inc.  (7)  First Lien Revolver  S + 5.75%  1.00%  10.21%  3/9/2028   636   306   306  0.05 
                          82,791   82,764  12.99 
Construction & Engineering 
CLS Management Services, LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.31%  3/27/2030   199   198   199  0.03 
FR Vision Holdings Inc  (8)  First Lien Term Loan  S + 5.50%  0.75%  9.81%  1/20/2031   3,048   3,048   3,048  0.48 
FR Vision Holdings Inc  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.00%  9.81%  1/20/2031   988   416   416  0.07 
FR Vision Holdings Inc  (7)  First Lien Revolver  S + 5.50%  0.00%  9.81%  1/20/2030   248         
Hydraulic Technologies USA LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.81%  6/3/2031   836   822   826  0.13 
Hydraulic Technologies USA LLC  (7)  First Lien Revolver  S + 5.50%  1.00%  9.81%  6/3/2030   114   14   15   
Kleinfelder Intermediate LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  9/18/2030   199   200   200  0.03 
Mei Buyer LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  6/29/2029   199   200   199  0.03 
Trilon Group, LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.96%  5/29/2029   1,203   1,195   1,196  0.19 
Trilon Group, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  1.00%  9.96%  5/25/2029   4,041   847   848  0.13 
Trilon Group, LLC  (7)  First Lien Revolver  S + 5.50%  0.00%  9.96%  5/25/2029   1,212   143   144  0.02 
                          7,083   7,091  1.11 
Construction Materials                                  
Arrow Tru-Line Holding, LLC  (8)  First Lien Term Loan  S + 5.63%  1.00%  10.08%  9/20/2027   200   199   199  0.03 
Pearlman Enterprises Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.93%  5/5/2027   200   196   198  0.03 
Red Fox CD Acquisition Corporation  (7)  First Lien Delayed Draw Term Loan  S + 6.00%  0.00%  10.31%  3/4/2030   10,735   6,639   6,692  1.05 
                          7,034   7,089  1.11 
Containers and Packaging 
Anchor Packaging, LLC  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  4/17/2029   100         
CFs Brands, LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  10/2/2030   3,330   3,330   3,296  0.52 
CFs Brands, LLC  (7)  First Lien Delayed Draw Term Loan  S + 6.00%  1.00%  10.33%  10/2/2030   169      (2)  

 

48

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued) 

December 31, 2024 

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
  Amortized
Cost (4)
  Fair Value  Percentage
of Net Assets
 
Containers and Packaging (continued) 
CFs Brands, LLC  (7)  First Lien Revolver  S + 5.75%  1.00%  10.08%  10/2/2029  $493  $  $(5) %
Cold Chain Technologies, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.06%  7/2/2026   2,307   2,307   2,302  0.36 
Cold Chain Technologies, LLC  (8)  First Lien Term Loan  S + 5.75%  0.00%  10.06%  7/2/2026   4,155   4,155   4,145  0.65 
Cold Chain Technologies, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.06%  7/2/2026   2,500   2,494   2,495  0.39 
Cold Chain Technologies, LLC  (7)  First Lien Revolver  S + 5.00%  1.00%  9.31%  7/2/2026   522   (1)  (1)  
Nelipak Holding Company  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.83%  3/26/2031   6,408   6,408   6,312  0.99 
Nelipak Holding Company  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  1.00%  9.83%  3/26/2031   2,486      (37) (0.01)
Nelipak Holding Company  (7)  First Lien Revolver  S + 5.50%  0.00%  9.83%  3/26/2031   1,855   779   751  0.12 
Packaging Coordinators Midco, Inc.  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  8/31/2027   100         
PG Buyer, LLC  (8)  First Lien Term Loan  S + 4.25%  1.00%  8.50%  3/2/2026   199   199   199  0.03 
PLZ Corp.  (8)  First Lien Term Loan  S + 3.75%  0.75%  8.20%  8/3/2026   100   94   91  0.01 
Proampac PG Borrower LLC  (7)  First Lien Revolver  S + 2.75%  0.00%  7.08%  6/16/2028   100   12   11   
Rohrer Corporation  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.50%  3/15/2027   200   200   200  0.03 
St Athena Global LLC  (6)(8)  First Lien Term Loan  S + 5.25%  0.75%  9.56%  6/26/2030   3,938   3,900   3,889  0.61 
St Athena Global LLC  (6)(8)  First Lien Term Loan  SON + 5.25%  0.00%  9.95%  6/26/2030  GBP2,291   2,958   2,832  0.44 
St Athena Global LLC  (6)(7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.56%  6/26/2030   164   (2)  (2)  
St Athena Global LLC  (6)(7)  First Lien Revolver  S + 5.25%  0.00%  9.56%  6/26/2029   590   137   135  0.02 
Tank Holding Corp.  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.25%  3/31/2028   199   197   196  0.03 
Tricorbraun Holdings, Inc.  (8)  First Lien Term Loan  S + 3.25%  0.50%  7.70%  3/3/2028   100   98   100  0.02 
                          27,265   26,907  4.21 
Distributors                                  
Aurora Parts & Accessories LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.96%  1/13/2029   100   99   99  0.02 
BC Group Holdings, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  12/21/2026   2,171   2,151   2,155  0.34 
BC Group Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.56%  12/21/2026   6,746   790   802  0.13 
Blackbird Purchaser, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.75%  9.81%  12/19/2030   185   66   66  0.01 
Blackbird Purchaser, Inc.  (7)  First Lien Revolver  S + 5.50%  0.75%  9.81%  12/19/2029   124   31   31   
Blackhawk Industrial Distribution, Inc.  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.71%  9/17/2026   5,352   5,330   5,330  0.84 
Blackhawk Industrial Distribution, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.71%  9/17/2026   607   112   112  0.02 
Blackhawk Industrial Distribution, Inc.  (7)  First Lien Revolver  S + 5.25%  1.00%  9.71%  9/17/2026   1,028   171   176  0.03 
BradyPlus Holdings, LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.31%  10/31/2029   6,298   6,298   6,238  0.98 
BradyPlus Holdings, LLC  (7)  First Lien Delayed Draw Term Loan  S + 6.00%  1.00%  10.31%  10/31/2029   702   149   144  0.02 
Component Hardware Group, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  7/1/2026   97   97   97  0.01 
DFS Holding Company, Inc.  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.50%  1/31/2029   199   197   199  0.03 
Vessco Midco Holdings, LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  7/24/2031   4,970   4,946   4,945  0.78 
Vessco Midco Holdings, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.08%  7/24/2031   1,657   428   428  0.07 
Vessco Midco Holdings, LLC  (7)  First Lien Revolver  S + 4.25%  0.75%  8.58%  7/24/2031   552   (3)  (3)  
                          20,862   20,819  3.28 

 

49

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued) 

December 31, 2024 

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
  Amortized
Cost (4)
  Fair Value  Percentage
of Net Assets
 
Diversified Consumer Services 
Apex Service Partners, LLC     First Lien Term Loan  11.59% (Incl. 2.00% PIK)  1.00%  11.59% (Incl. 2.00% PIK)  10/24/2030  $4,850  $4,826  $4,827  0.76%
Apex Service Partners, LLC     First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.31%  10/24/2030   780   776   776  0.12 
Apex Service Partners, LLC  (7)  First Lien Revolver  S + 5.00%  1.00%  9.33%  10/24/2029   660   445   446  0.07 
Ave Holdings III, Corp     First Lien Term Loan  S + 5.25%  0.75%  9.81%  2/25/2028   6,302   6,178   6,223  0.98 
Ave Holdings III, Corp     First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.81%  2/25/2028   168   165   166  0.03 
Ave Holdings III, Corp  (7)  First Lien Revolver  S + 5.50%  0.75%  9.81%  2/25/2028   514   (10)  (6)  
AVG Intermediate Holdings LLC  (8)  First Lien Delayed Draw Term Loan  S + 6.00%  1.00%  10.41%  3/16/2027   199   195   194  0.03 
Cop Hometown Acquisitions, Inc. (fka Cop Airco Acquisitions, Inc.)  (8)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.71%  7/16/2027   281   279   279  0.04 
Cop Hometown Acquisitions, Inc. (fka Cop Airco Acquisitions, Inc.)  (8)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.71%  7/16/2027   2,530   2,511   2,514  0.39 
Cop Hometown Acquisitions, Inc. (fka Cop Airco Acquisitions, Inc.)  (8)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.71%  7/16/2027   530   526   526  0.08 
Cop Hometown Acquisitions, Inc. (fka Cop Airco Acquisitions, Inc.)  (8)  First Lien Delayed Draw Term Loan  S + 5.50%  1.00%  9.96%  7/16/2027   659   658   658  0.10 
CVP Holdco, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  6/30/2031   6,459   6,443   6,444  1.01 
CVP Holdco, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.33%  6/28/2031   1,715   (4)  (4)  
CVP Holdco, Inc.  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  6/28/2030   686   (2)  (2)  
Eos Fitness Opco Holdings, LLC  (8)  First Lien Term Loan  S + 5.25%  0.00%  9.56%  1/5/2028   4,531   4,497   4,520  0.71 
Eos Fitness Opco Holdings, LLC     First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.56%  1/5/2028   2,255   2,238   2,249  0.35 
Eos Fitness Opco Holdings, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.56%  1/5/2028   929   281   286  0.04 
Eos Fitness Opco Holdings, LLC  (7)  First Lien Revolver  S + 4.75%  1.00%  9.06%  1/5/2028   384   (3)  (1)  
Essential Services Holding Corporation  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  6/17/2031   2,014   2,009   2,009  0.32 
Essential Services Holding Corporation  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  6/17/2031   395   (1)  (1)  
Essential Services Holding Corporation  (7)  First Lien Revolver  S + 5.00%  0.00%  9.31%  6/17/2030   247   (1)  (1)  
Flint Opco, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  1.00%  9.08%  8/15/2030   3,047   940   955  0.15 
FSHS I, LLC  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.08%  11/18/2028   199   197   196  0.03 
GS Seer Group Borrower LLC  (8)  First Lien Term Loan  S + 6.75%  1.00%  11.06%  4/29/2030   100   98   98  0.02 
GSV Holding, LLC  (8)  First Lien Term Loan  S + 2.63%  1.00%  10.06% (Incl. 3.13% PIK)  10/18/2030   4,856   4,832   4,833  0.76 
GSV Holding, LLC  (7)  First Lien Revolver  S + 4.25%  1.00%  8.56%  10/18/2030   217   (1)  (1)  
Health Buyer LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.75%  9.81%  4/27/2029   3,304   645   646  0.10 
Home Service Topco IV, Inc.  (8)  First Lien Term Loan  S + 6.00%  1.00%  10.41%  12/31/2027   199   199   199  0.03 
Innovetive Petcare, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  6/30/2028   5,462   5,462   5,393  0.85 
Innovetive Petcare, Inc.     First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.46%  6/30/2028   1,520   1,521   1,501  0.24 
Innovetive Petcare, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.46%  6/30/2028   6,279   4,387   4,324  0.68 
Intel 471 INC.     First Lien Term Loan  S + 5.25%  1.00%  9.56%  9/27/2028   200   200   200  0.03 
Quick Quack Car Wash Holdings, LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  6/10/2031   200   200   200  0.03 
Seahawk Bidco, LLC  (8)  First Lien Term Loan  S + 4.75%  0.00%  9.06%  12/19/2031   5,818   5,797   5,797  0.91 
Seahawk Bidco, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.06%  12/19/2031   1,818   (3)  (7)  
Seahawk Bidco, LLC  (7)  First Lien Revolver  S + 4.75%  0.00%  9.06%  12/19/2030   545   (2)  (2)  

 

50

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued) 

December 31, 2024 

(in thousands)

 

Investments (1)   Footnotes   Asset Type   Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
  Amortized
Cost (4)
  Fair Value   Percentage
of Net Assets
 
Diversified Consumer Services (continued)                                          
Taymax Group Acquisition, LLC   (8)   First Lien Term Loan   S + 6.00%   1.00%   10.43%   7/31/2026   $ 199   $ 199   $ 199   0.03 %
Trackforce Acquireco, Inc.       First Lien Term Loan   S + 5.75%   0.75%   10.06%   6/23/2028     200     200     200   0.03  
US Fitness Holdings, LLC   (8)   First Lien Term Loan   S + 5.50%   0.75%   9.81%   9/4/2031     8,822     8,780     8,781   1.38  
US Fitness Holdings, LLC   (7)   First Lien Delayed Draw Term Loan   S + 5.50%   0.75%   9.81%   9/4/2031     2,206     (11 )   (10 )  
US Fitness Holdings, LLC   (7)   First Lien Revolver   S + 5.50%   0.75%   9.81%   9/4/2030     172     34     34   0.01  
Vertex Service Partners, LLC   (8)   First Lien Term Loan   S + 5.75%   0.75%   10.08%   11/8/2030     199     199     199   0.03  
Vertex Service Partners, LLC   (7)   First Lien Delayed Draw Term Loan   S + 5.50%   0.00%   9.81%   11/8/2030     250     5     5    
VPP Intermediate Holdings, LLC   (8)   First Lien Term Loan   S + 5.75%   1.00%   10.18%   12/1/2027     1,866     1,856     1,861   0.29  
VPP Intermediate Holdings, LLC   (8)   First Lien Delayed Draw Term Loan   S + 5.75%   1.00%   10.18%   12/1/2027     560     557     558   0.09  
VPP Intermediate Holdings, LLC   (8)   First Lien Delayed Draw Term Loan   S + 5.75%   1.00%   10.18%   12/1/2027     1,689     1,681     1,685   0.26  
VPP Intermediate Holdings, LLC   (7)   First Lien Delayed Draw Term Loan   S + 5.75%   0.00%   10.18%   12/1/2027     2,643     2,514     2,515   0.39  
VPP Intermediate Holdings, LLC   (7)   First Lien Revolver   S + 5.25%   0.00%   9.68%   12/1/2027     229     (1 )   (1 )  
                                  72,491     72,460   11.37  
Diversified Telecommunication Services                                          
Guardian US Holdco LLC   (5)(8)   First Lien Term Loan   S + 3.50%   0.50%   7.81%   1/31/2030     2,244     2,253     2,252   0.35  
Virgin Media Bristol LLC   (5)(6)(8)   First Lien Term Loan   S + 3.18%   0.00%   7.53%   3/31/2031     2,000     1,988     1,984   0.31  
                                  4,241     4,236   0.66  
Electrical Equipment                                          
Infinite Bidco LLC   (8)   First Lien Term Loan   S + 6.25%   1.00%   10.56%   3/2/2028     100     100     100   0.02  
Power Grid Holdings, Inc.   (8)   First Lien Term Loan   S + 4.75%   0.75%   9.06%   12/2/2030     6,095     6,095     6,095   0.96  
Power Grid Holdings, Inc.   (7)   First Lien Revolver   S + 4.75%   0.75%   9.06%   12/2/2030     890            
TPC Engineering Holdings, Inc.   (8)   First Lien Term Loan   S + 5.50%   0.00%   9.93%   2/16/2027     556     551     551   0.09  
TPC Engineering Holdings, Inc.   (8)   First Lien Term Loan   S + 5.50%   0.00%   9.83%   2/16/2028     4,036     3,996     3,996   0.63  
TPC Engineering Holdings, Inc.   (8)   First Lien Term Loan   S + 5.50%   0.00%   9.93%   2/16/2027     1,950     1,931     1,931   0.30  
TPC Engineering Holdings, Inc.   (7)   First Lien Revolver   S + 5.25%   0.00%   9.58%   2/16/2027     441     289     288   0.05  
                                  12,962     12,961   2.05  
Electronic Equipment, Instruments and Components                                          
Dwyer Instruments, LLC   (8)   First Lien Term Loan   S + 4.75%   0.75%   9.06%   7/23/2029     3,889     3,851     3,851   0.60  
Dwyer Instruments, LLC   (7)   First Lien Delayed Draw Term Loan   S + 4.75%   0.75%   9.06%   7/23/2029     505     (2 )   (5 )  
Dwyer Instruments, LLC   (7)   First Lien Revolver   S + 7.75%   0.00%   12.06%   7/23/2029     706     (7 )   (7 )  
Excelitas Technologies Corp.   (7)   First Lien Delayed Draw Term Loan   S + 5.25%   0.75%   9.58%   8/12/2029     2,522     (12 )   (6 )  
Phoenix 1 Buyer Corporation   (8)   First Lien Term Loan   S + 4.75%   0.75%   9.08%   11/20/2030     5,858     5,858     5,858   0.92  
Phoenix 1 Buyer Corporation   (7)   First Lien Revolver   S + 5.50%   0.75%   9.83%   11/20/2029     1,142            
Wildcat Topco, Inc.   (8)   First Lien Term Loan   S + 5.00%   0.75%   9.33%   11/17/2031     1,513     1,506     1,506   0.24  
Wildcat Topco, Inc.   (7)   First Lien Delayed Draw Term Loan   S + 5.00%   0.75%   9.33%   11/17/2031     270     (1 )   (1 )  
Wildcat Topco, Inc.   (7)   First Lien Revolver   S + 5.00%   0.75%   9.33%   11/17/2031     270     (1 )   (1 )  
                                  11,192     11,195   1.76  

 

51

 

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Energy Equipment and Services                                      
 CRCI Longhorn Holdings, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  8/27/2031  $6,118   $6,089   $6,111    0.96%
CRCI Longhorn Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.33%  8/27/2031   1,530    (7)   (2)    
CRCI Longhorn Holdings, Inc.  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  8/27/2031   1,020    454    458    0.07 
DMC Holdco, LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.08%  7/13/2029   199    198    199    0.03 
Integrated Power Services Holdings, Inc.  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.95%  11/22/2028   4,523    4,516    4,514    0.71 
Integrated Power Services Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  0.75%  8.83%  11/22/2028   7,978    (19)   (16)    
Phillips & Temro Industries Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  9/8/2025   200    200    200    0.03 
                           11,431    11,464    1.80 
Financial Services                                      
1364720 B.C. LTD.  (8)  First Lien Term Loan  S + 4.50%  0.00%  8.81%  9/9/2028   199    199    199    0.03 
Cerity Partners Equity Holding LLC     First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.56%  7/28/2029   1,317    1,314    1,317    0.21 
Cerity Partners Equity Holding LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.56%  7/28/2029   10,139    4,503    4,527    0.71 
Cerity Partners Equity Holding LLC  (7)  First Lien Revolver  S + 5.75%  0.75%  10.06%  7/28/2028   543    (1)        
CFGI Holdings, LLC  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.83%  11/2/2027   6,711    6,659    6,661    1.04 
CFGI Holdings, LLC  (7)  First Lien Revolver  S + 4.50%  0.75%  8.83%  11/2/2027   270    (2)   (2)    
Cherry Bekaert Advisory LLC  (8)  First Lien Term Loan  S + 5.25%  0.00%  9.58%  6/30/2028   199    199    199    0.03 
Citrin Cooperman Advisors, LLC  (8)  First Lien Term Loan  S + 5.25%  0.00%  9.60%  10/1/2027   579    579    579    0.09 
Contractual Buyer, LLC  (8)  First Lien Term Loan  S + 6.00%  0.75%  10.33%  10/10/2030   199    199    199    0.03 
Foreside Financial Group, LLC     First Lien Term Loan  S + 5.25%  1.00%  9.68%  9/30/2027   569    569    569    0.09 
Foreside Financial Group, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  1.00%  9.83%  9/30/2027   11,650             
Heights Buyer, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.16%  8/25/2028   5,348    5,348    5,348    0.84 
Heights Buyer, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.75%  1.00%  10.16%  8/25/2028   874             
Heights Buyer, LLC  (7)  First Lien Revolver  S + 5.75%  0.00%  10.16%  8/25/2028   764             
Kriv Acquisition Inc.  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.08%  7/6/2029   199    199    198    0.03 
Kriv Acquisition Inc.  (7)  First Lien Delayed Draw Term Loan  S + 6.50%  1.00%  10.83%  7/6/2029   1,338    (6)   (7)    
Minotaur Acquisition, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  6/3/2030   8,706    8,620    8,645    1.36 
Minotaur Acquisition, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.33%  6/3/2030   1,455    (14)   (10)    
Minotaur Acquisition, Inc.  (8)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.33%  6/3/2030   1,455    1,440    1,445    0.23 
Minotaur Acquisition, Inc.  (7)  First Lien Revolver  S + 5.00%  1.00%  9.33%  6/3/2030   873    (9)   (6)    
Neon Maple Purchaser Inc.  (5)(6)(8)  First Lien Term Loan  S + 3.00%  0.00%  7.33%  11/15/2031   2,000    2,008    2,007    0.31 
Pathstone Family Office LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.43%  5/15/2029   152    151    152    0.02 
Pathstone Family Office LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.43%  5/15/2029   3,648    3,611    3,629    0.57 
Pathstone Family Office LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.43%  5/15/2029   1,454    (11)   (7)    
Pathstone Family Office LLC  (7)  First Lien Revolver  S + 5.00%  0.00%  9.33%  5/15/2028   374    (2)   (2)    

 

52

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net
Assets
 
Financial Services (continued)                                      
Petrus Buyer, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.89%  10/17/2029  $199   $199   $199    0.03%
Project Accelerate Parent LLC  (7)  First Lien Revolver  S + 5.25%  0.75%  9.58%  2/22/2031   100             
Ryan, LLC  (7)  First Lien Revolver  S + 4.50%  0.00%  8.83%  11/14/2028   100    6    6     
The Chartis Group, LLC  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.81%  9/17/2031   1,266    1,260    1,260    0.20 
The Chartis Group, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  0.75%  8.81%  9/17/2031   388    (2)   (2)    
The Chartis Group, LLC  (7)  First Lien Revolver  S + 4.50%  0.75%  8.81%  9/17/2031   194    (1)   (1)    
Wealth Enhancement Group, LLC  (8)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.31%  10/2/2028   200    199    199    0.03 
Wealth Enhancement Group, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.33%  10/2/2028   9,677    (13)   (69)   (0.01)
Wealth Enhancement Group, LLC  (7)  First Lien Revolver  S + 5.25%  0.00%  9.58%  10/2/2028   323        (2)    
                           37,201    37,230    5.84 
Food Products                                      
BCPE North Star US Holdco 2, Inc.  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  6/10/2026   100    81    82    0.01 
Chg Ppc Parent LLC  (7)  First Lien Revolver  S + 2.75%  0.00%  7.08%  12/8/2026   100             
Fiesta Purchaser, Inc.  (5)(8)  First Lien Term Loan  S + 3.25%  0.00%  7.58%  2/12/2031   2,250    2,257    2,255    0.35 
Primary Products Finance LLC  (5)(8)  First Lien Term Loan  S + 3.25%  0.00%  7.58%  4/1/2029   2,244    2,257    2,253    0.35 
RB Holdings Interco, LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.43%  5/4/2028   199    196    199    0.03 
Sigma Holdco B.V.  (5)(6)(8)  First Lien Term Loan  S + 4.25%  0.00%  8.74%  1/3/2028   1,995    2,006    2,005    0.31 
Sugar Ppc Buyer LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.58%  10/2/2030   6,800    (31)   (34)   (0.01)
WPP Bullet Buyer, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  12/7/2030   888    875    877    0.14 
WPP Bullet Buyer, LLC  (7)  First Lien Revolver  S + 5.25%  1.00%  9.56%  12/7/2029   83    64    64    0.01 
                           7,705    7,701    1.19 
Ground Transportation                                      
AMS Parent, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.45%  10/25/2028   199    197    197    0.03 
                           197    197    0.03 
Health Care Technology                                      
Acentra Holdings, LLC  (8)  First Lien Term Loan  S + 5.50%  0.50%  9.81%  12/17/2029   76    76    76    0.01 
Acentra Holdings, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.50%  9.81%  12/17/2029   220        (1)    
Athenahealth Group Inc.  (7)  First Lien Revolver  S + 3.50%  0.00%  7.83%  2/15/2027   100             
Bracket Intermediate Holding Corp.  (7)  First Lien Revolver  S + 5.00%  0.00%  9.33%  2/7/2028   100        (2)    
Caerus US 1 Inc.  (6)(8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  5/25/2029   199    197    199    0.03 
Continental Buyer, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.50%  4/2/2031   4,860    4,860    4,792    0.75 
Continental Buyer, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.50%  4/2/2031   1,911        (27)    
Continental Buyer, Inc.  (7)  First Lien Revolver  S + 5.25%  0.75%  9.50%  4/2/2031   717        (10)    
DeLorean Purchaser, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.06%  12/16/2031   4,356    4,324    4,324    0.68 
DeLorean Purchaser, Inc.  (7)  First Lien Revolver  S + 4.75%  0.75%  9.06%  12/16/2031   653    (5)   (5)    

 

53

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Health Care Technology (continued)                                      
Empower Payments Investor, LLC  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.83%  3/12/2031  $2,145   $2,145   $2,145    0.34%
Empower Payments Investor, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.58%  3/12/2031   306             
Empower Payments Investor, LLC  (7)  First Lien Revolver  S + 5.25%  0.75%  9.58%  3/12/2030   163             
Ensemble RCM, LLC  (7)  First Lien Revolver  S + 3.00%  0.00%  7.33%  6/27/2028   100             
HT Intermediary III, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  11/12/2030   6,300    6,270    6,270    0.98 
HT Intermediary III, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  1.00%  9.08%  11/12/2030   1,527    (4)   (7)    
HT Intermediary III, Inc.  (7)  First Lien Revolver  S + 4.75%  1.00%  9.08%  11/12/2030   573    74    74    0.01 
IMO Investor Holdings, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  5/11/2029   3,235    3,235    3,235    0.51 
IMO Investor Holdings, Inc.     First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  5/11/2029   388    388    388    0.06 
IMO Investor Holdings, Inc.  (7)  First Lien Revolver  S + 5.00%  0.00%  9.31%  5/11/2028   370    11    11     
Invictus Buyer, LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.06%  6/3/2031   7,819    7,819    7,819    1.23 
Invictus Buyer, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.33%  6/3/2031   3,266             
Invictus Buyer, LLC  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  6/3/2031   1,210             
Net Health Acquisition Corp.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  7/5/2031   7,588    7,552    7,588    1.19 
Net Health Acquisition Corp.  (7)  First Lien Revolver  S + 4.75%  0.75%  9.08%  7/3/2031   973    151    156    0.02 
SDS Buyer, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.91%  9/30/2027   199    199    199    0.03 
Zelis Cost Management Buyer, Inc.  (7)  First Lien Revolver  S + 2.75%  0.00%  7.08%  1/17/2029   100             
                           37,292    37,224    5.84 
Healthcare Equipment and Supplies                                      
Alcor Scientific LLC  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.93%  1/31/2028   200    200    200    0.03 
Aspen Medical Products, LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.08%  6/10/2028   1,421    1,421    1,418    0.22 
Aspen Medical Products, LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.08%  6/10/2028   426    426    425    0.07 
Belmont Instrument, LLC  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.56%  8/19/2028   199    199    199    0.03 
Blades Buyer, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.41%  3/28/2028   200    199    199    0.03 
BVI Medical, Inc.  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  8/28/2025   100    94    90    0.01 
Cadence, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  5/21/2026   199    199    199    0.03 
CDL Parent, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  12/7/2027   200    200    199    0.03 
CPC/Cirtec Holdings, Inc  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  1/30/2029   1,665    1,657    1,661    0.26 
CPC/Cirtec Holdings, Inc  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  10/31/2028   558    (3)   (1)    
Resonetics, LLC  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  6/18/2029   100    (1)        
TIDI Legacy Products, Inc.  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.58%  12/19/2029   199    199    199    0.03 
                           4,790    4,788    0.74 

 

54

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Healthcare Providers and Services                                      
123Dentist Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.75%  0.75%  10.08%  8/10/2029  $10,132   $1,789   $1,750    0.27%
AB Centers Acquisition Corporation  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.56%  7/2/2031   2,491    2,473    2,473    0.39 
AB Centers Acquisition Corporation  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.56%  7/2/2031   453    28    28     
AB Centers Acquisition Corporation  (7)  First Lien Revolver  S + 5.25%  0.75%  9.56%  7/2/2031   226    (2)   (2)    
ACI Group Holdings, Inc.  (8)  First Lien Term Loan  S + 2.75%  0.75%  10.43% (Incl.
3.25% PIK)
  8/2/2028   200    199    195    0.03 
Arrow Management Acquisition, LLC     First Lien Delayed Draw Term Loan  S + 4.75%  1.00%  9.06%  10/14/2027   6,982    6,899    6,902    1.08 
Cardiology Management Holdings, LLC  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.56%  1/31/2029   199    199    199    0.03 
Community Medical Acquisition Corp.  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.25%  12/15/2028   100    98    98    0.02 
Crown Laundry, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.70%  3/8/2027   2,867    2,867    2,838    0.45 
Crown Laundry, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.58%  3/8/2027   521    521    516    0.08 
Crown Laundry, LLC  (8)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.58%  3/8/2027   602    602    596    0.09 
CVR Management, LLC  (8)  First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.18%  1/4/2027   200    200    200    0.03 
DCA Investment Holding LLC  (8)  First Lien Term Loan  S + 6.41%  0.75%  10.71%  4/3/2028   199    196    193    0.03 
Docs, MSO, LLC  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.18%  6/1/2028   100    99    99    0.02 
ENT MSO, LLC  (8)  First Lien Term Loan  S + 6.50%  1.00%  10.81%  12/31/2025   199    199    199    0.03 
Eyesouth Eye Care Holdco, LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.93%  10/5/2029   2,134    2,134    2,112    0.33 
Eyesouth Eye Care Holdco, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  1.00%  9.83%  10/5/2029   4,300    44    1     
Golden State Buyer, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.18%  6/22/2026   199    200    200    0.03 
ImageFirst Holdings, LLC  (7)  First Lien Revolver  S + 4.00%  0.75%  8.31%  4/27/2028   100    20    20     
IvyRehab Intermediate II, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.41%  4/23/2029   199    199    199    0.03 
NJEYE LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.31%  3/14/2025   200    200    200    0.03 
OB Hospitalist Group, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.68%  9/27/2027   199    199    198    0.03 
OIS Management Services, LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.06%  11/16/2028   3,831    3,757    3,793    0.60 
OIS Management Services, LLC     First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.06%  10/24/2031   3,151    3,090    3,119    0.49 
ONS MSO, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.75%  1.00%  10.06%  7/8/2026   221    106    107    0.02 
ONS MSO, LLC  (7)  First Lien Revolver  P + 5.25%  0.00%  12.75%  7/8/2026   24    13    13     
Onsite Holdings, LLC  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.66%  12/28/2027   339    338    337    0.05 
Onsite Holdings, LLC  (7)  First Lien Revolver  S + 6.25%  1.00%  10.68%  12/28/2025   93    19    18     
Orsini Pharmaceutical Services, LLC  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.68%  5/2/2029   199    199    199    0.03 
Phantom Purchaser, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  9/19/2031   2,989    2,982    2,982    0.47 
Phantom Purchaser, Inc.  (7)  First Lien Revolver  S + 5.00%  0.75%  9.31%  9/19/2031   382    (1)   (1)    
Phynet Dermatology LLC  (8)  First Lien Term Loan  S + 6.50%  1.00%  10.81%  10/20/2029   199    199    198    0.03 
Premise Health Holding Corp.  (8)  First Lien Term Loan  S + 5.50%  0.75%  9.81%  3/3/2031   6,088    6,088    6,088    0.96 
Premise Health Holding Corp.  (7)  First Lien Revolver  S + 5.50%  0.00%  9.81%  3/1/2030   712             
RxSense Holdings LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.41%  3/13/2026   199    199    199    0.03 

 

55

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Healthcare Providers and Services (continued)                                      
SM Wellness Holdings, Inc.  (8)  First Lien Term Loan  S + 4.50%  0.75%  9.07%  4/17/2028  $199   $199   $199    0.03%
Smile Doctors LLC  (8)  First Lien Term Loan  S + 5.90%  0.75%  10.31%  12/23/2028   100    99    99    0.02 
Specialized Dental Holdings II, LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.08%  11/1/2027   199    199    200    0.03 
SpecialtyCare, Inc.  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.32%  6/18/2028   100    95    96    0.02 
STCH Acquisition Inc.  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.66%  10/30/2026   2,298    2,288    2,287    0.36 
STCH Acquisition Inc.  (7)  First Lien Revolver  S + 6.25%  1.00%  10.66%  10/30/2026   196    (1)   (1)    
The GI Alliance Management, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.00%  10.00%  9/15/2028   8,455    1,813    1,919    0.30 
TurningPoint Healthcare Solutions, LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.18%  7/14/2027   199    198    198    0.03 
United Digestive MSO Parent, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.06%  3/30/2029   199    199    199    0.03 
Urology Management Holdings, Inc.  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.81%  6/15/2027   199    198    198    0.03 
USHV Management, LLC  (8)  First Lien Term Loan  S + 6.38%  1.00%  10.78%  12/23/2027   100    98    98    0.02 
Vital Care Buyer, LLC  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.81%  7/30/2031   5,289    5,265    5,264    0.83 
Vital Care Buyer, LLC  (7)  First Lien Revolver  S + 4.75%  0.75%  9.08%  7/30/2031   696    (3)   (3)    
                           46,999    47,019    7.38 
Hotels, Restaurants and Leisure                                      
BJH Holdings III Corp.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.31%  8/19/2027   199    198    198    0.03 
Movati Athletic (Group) Inc.  (6)(8)  First Lien Term Loan  C + 4.75%  0.00%  8.32%  5/29/2030  CAD 7,533    5,394    5,197    0.82 
Movati Athletic (Group) Inc.  (6)(7)  First Lien Delayed Draw Term Loan  C + 5.25%  1.00%  8.82%  5/29/2030  CAD 918    (7)   (5)    
Southpaw Ap Buyer, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.71%  3/2/2028   2,798    2,785    2,798    0.44 
Southpaw Ap Buyer, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.71%  3/2/2028   630    438    441    0.07 
Southpaw Ap Buyer, LLC  (7)  First Lien Revolver  S + 4.50%  0.00%  8.81%  3/2/2028   252    (1)        
Ungerboeck Systems International, LLC     First Lien Term Loan  S + 5.75%  1.00%  10.06%  4/30/2027   199    199    200    0.03 
                           9,006    8,829    1.39 
Household Durables                                      
Stanton Carpet Intermediate Holdings II, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  10/1/2027   200    200    200    0.03 
                           200    200    0.03 
Household Products                                      
TPC US Parent, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.21%  11/22/2025   200    199    199    0.03 
Wu Holdco, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.31%  3/26/2027   3,520    2,456    2,453    0.38 
Wu Holdco, Inc.  (7)  First Lien Revolver  S + 5.50%  0.00%  9.81%  3/26/2027   362    123    122    0.02 
                           2,778    2,774    0.43 
Industrial Conglomerates                                      
Harvey Tool Company, LLC  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.58%  10/26/2027   8,161    8,142    8,143    1.28 
Harvey Tool Company, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.75%  9.83%  10/26/2027   3,213    (8)   (7)    
Harvey Tool Company, LLC  (7)  First Lien Revolver  S + 5.50%  0.75%  9.83%  10/26/2027   964    (2)   (2)    
                           8,132    8,134    1.28 

 

56

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Insurance                                      
Accession Risk Management, Inc     First Lien Term Loan  S + 4.75%  0.00%  9.29%  11/1/2029  $22   $22   $23    %
Accession Risk Management, Inc  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.06%  11/1/2029   1,767    (8)   2     
Accession Risk Management, Inc  (7)  First Lien Revolver  S + 5.50%  0.75%  9.81%  11/1/2029   231    (1)        
Alera Group, Inc.  (8)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.58%  10/2/2028   199    197    198    0.03 
Allied Benefit Systems Intermediate LLC  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.58%  10/31/2030   3,372    3,372    3,372    0.53 
Allied Benefit Systems Intermediate LLC     First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.58%  10/31/2030   618    618    618    0.10 
AMBA Buyer, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.66%  7/30/2027   2,903    2,882    2,883    0.45 
AMBA Buyer, Inc.  (8)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.66%  7/30/2027   865    858    859    0.13 
AMBA Buyer, Inc.  (7)  First Lien Revolver  S + 5.50%  0.75%  9.91%  7/30/2027   223    (2)   (2)    
Amerilife Holdings LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.25%  8/31/2029   12,276    5,925    5,953    0.93 
AQ Sunshine, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.56%  7/24/2031   199    199    199    0.03 
Ardonagh Midco 3 PLC  (6)(8)  First Lien Term Loan  SON + 4.75%  0.00%  9.45%  2/15/2031  GBP 1,984    2,168    2,054    0.32 
Ardonagh Midco 3 PLC  (6)(8)  First Lien Term Loan  S + 4.75%  0.50%  9.00%  2/17/2031   5,016    5,016    5,016    0.79 
Asurion, LLC  (5)(8)  First Lien Term Loan  S + 3.25%  0.00%  7.70%  12/23/2026   2,000    2,003    2,001    0.31 
Beyond Risk Parent Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  0.00%  8.93%  10/8/2027   6,373    514    482    0.08 
Galway Borrower LLC  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.81%  9/29/2028   199    198    198    0.03 
Imagine 360 LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.06%  9/30/2028   1,400    1,393    1,393    0.22 
Imagine 360 LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.33%  9/30/2028   767    (4)   (4)    
Imagine 360 LLC  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  9/30/2028   327    (3)   (2)    
Integrity Marketing Acquisition, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  8/25/2028   7,660    7,629    7,584    1.19 
Mclarens Midco Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  0.75%  8.81%  12/19/2025   663    71    71    0.01 
Oakbridge Insurance Agency LLC  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.08%  11/1/2029   199    199    199    0.03 
Pareto Health Intermediate Holdings, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.00%  9.25%  5/31/2030   2,752    2,740    2,739    0.43 
Pareto Health Intermediate Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.25%  6/1/2030   653    (2)   (3)    
Patriot Growth Insurance Services, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.46%  10/16/2028   5,041    5,016    5,041    0.79 
Patriot Growth Insurance Services, LLC  (8)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.46%  10/16/2028   1,409    1,402    1,409    0.22 
Patriot Growth Insurance Services, LLC  (7)  First Lien Revolver  S + 5.00%  0.75%  9.46%  10/16/2028   534    264    267    0.04 
Riser Interco LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.31%  10/31/2029   11,576    9,715    9,644    1.51 
Simplicity Financial Marketing Group Holdings, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.25%  12/31/2031   6,769    6,735    6,735    1.06 
Simplicity Financial Marketing Group Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.25%  12/31/2031   1,805    (5)   (9)    
Simplicity Financial Marketing Group Holdings, Inc.  (7)  First Lien Revolver  S + 5.00%  0.00%  9.25%  12/31/2031   903    (5)   (5)    
THG Acquisition, LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  10/31/2031   2,961    2,961    2,947    0.46 
THG Acquisition, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.08%  10/31/2031   660    (2)   (3)    
THG Acquisition, LLC  (7)  First Lien Revolver  S + 4.75%  0.75%  9.08%  10/31/2031   330    23    23     
World Insurance Associates, LLC  (8)  First Lien Term Loan  S + 6.00%  1.00%  10.31%  4/3/2028   199    198    198    0.03 
                           62,286    62,080    9.72 

 

57

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
IT Services                                      
BigTime Software, Inc.     First Lien Term Loan  S + 6.25%  0.00%  10.58%  6/30/2028  $200   $200   $200    0.03%
Cardinal Parent, Inc.  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.96%  11/12/2027   199    187    191    0.03 
DCert Buyer, Inc.  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  10/16/2026   100             
DT1 Midco Corp  (8)  First Lien Term Loan  S + 5.00%  0.00%  9.31%  12/30/2031   5,749    5,720    5,720    0.90 
DT1 Midco Corp  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.31%  12/30/2031   2,005    (5)   (10)    
DT1 Midco Corp  (7)  First Lien Revolver  S + 5.00%  0.00%  9.31%  12/30/2030   802    (4)   (4)    
Govdelivery Holdings, LLC  (8)  First Lien Term Loan  S + 3.50%  0.75%  10.86% (Incl.
2.25% PIK)
  1/17/2031   200    199    200    0.03 
Marco Technologies, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  11/24/2026   200    200    200    0.03 
Medallia, Inc.  (8)  First Lien Term Loan  S + 2.50%  0.75%  6.91%  10/29/2028   99    96    97    0.02 
Noble Midco 3 Limited  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  6/24/2031   5,056    5,056    5,043    0.79 
Noble Midco 3 Limited  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  6/11/2031   824        (2)    
Noble Midco 3 Limited  (7)  First Lien Revolver  S + 5.25%  0.75%  9.56%  12/11/2030   1,120        (3)    
Oeconnection LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  4/22/2031   4,418    4,418    4,410    0.69 
Oeconnection LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.58%  4/22/2031   2,138        (4)    
Oeconnection LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.00%  0.00%  8.33%  4/22/2031   771    (9)   (1)    
Oeconnection LLC  (7)  First Lien Revolver  S + 4.00%  0.75%  8.33%  4/22/2031   482    (2)   (1)    
Passageways, Inc.     First Lien Term Loan  S + 5.00%  1.00%  9.46%  7/21/2027   200    200    200    0.03 
PDI TA Holdings, Inc.  (8)  First Lien Term Loan  S + 5.50%  0.75%  9.81%  1/29/2031   199    199    199    0.03 
Ridge Trail US Bidco, Inc.  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.81%  9/30/2031   8,686    8,626    8,621    1.35 
Ridge Trail US Bidco, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.06%  9/30/2031   2,995    (21)   (22)    
Ridge Trail US Bidco, Inc.  (7)  First Lien Revolver  S + 4.50%  0.00%  8.81%  3/31/2031   998    263    262    0.04 
Safety Borrower Holdings LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.70%  9/1/2027   3,492    3,492    3,473    0.54 
Safety Borrower Holdings LLC  (7)  First Lien Revolver  P + 4.25%  0.00%  11.75%  9/1/2027   499    125    122    0.02 
Sailpoint Technologies Holdings, Inc.  (6)(8)  First Lien Term Loan  S + 6.00%  0.75%  10.31%  8/16/2029   131    131    131    0.02 
Spirit RR Holdings, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.16%  9/13/2028   3,252    3,245    3,228    0.51 
Spirit RR Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.16%  9/13/2028   467    231    229    0.04 
Spirit RR Holdings, Inc.  (7)  First Lien Revolver  S + 4.00%  0.75%  8.31%  9/13/2028   272    (1)   (2)    
Storable, Inc.  (7)  First Lien Revolver  S + 2.75%  0.00%  7.08%  4/16/2026   100    25    25     
Trunk Acquisition, Inc.  (8)  First Lien Term Loan  S + 6.00%  1.00%  10.46%  2/19/2030   199    199    198    0.03 
Trunk Acquisition, Inc.  (8)  First Lien Term Loan  S + 6.00%  0.00%  10.46%  2/19/2030   1,814    1,807    1,805    0.28 
Trunk Acquisition, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 6.00%  0.00%  10.46%  2/19/2030   1,845    (5)   (9)    
VS Buyer, LLC  (7)  First Lien Revolver  S + 3.25%  0.00%  7.58%  4/12/2029   100             
Welocalize, Inc.  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  6/23/2026   200    199    200    0.03 
                           34,771    34,696    5.44 

 

58

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Life Sciences Tools & Services                                      
Kwol Acquisition, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.00%  12/12/2029  $6,144   $6,144   $6,052    0.95%
Kwol Acquisition, Inc.  (7)  First Lien Revolver  S + 6.25%  0.75%  10.50%  12/12/2029   841        (13)    
Sotera Health Holdings, LLC  (5)(6)(8)  First Lien Term Loan  S + 3.25%  0.00%  7.56%  5/30/2031   1,895    1,905    1,902    0.30 
                           8,049    7,941    1.25 
Machinery                                      
CD&R Hydra Buyer, Inc.  (5)(8)  First Lien Term Loan  S + 4.00%  0.00%  8.43%  3/25/2031   1,995    2,007    2,004    0.31 
Clyde Industries Us Holdco, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  12/18/2025   197    197    197    0.03 
Dynatect Group Holdings, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.91%  9/30/2026   200    200    200    0.03 
Flow Control Solutions, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  3/30/2029   5,241    75    76    0.01 
Flow Control Solutions, Inc.  (7)  First Lien Revolver  S + 6.00%  0.75%  10.31%  3/31/2029   936    (7)   (7)    
Merlin Buyer, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.06%  12/14/2028   5,536    5,536    5,536    0.87 
Merlin Buyer, Inc.  (7)  First Lien Revolver  S + 0.50%  0.00%  4.81%  12/14/2026   1,450    (14)   (14)    
Process Equipment, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.00%  9.75%  9/6/2026   199    199    199    0.03 
Process Insights Acquisition, Inc.  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.56%  7/18/2029   199    199    198    0.03 
Victory Buyer LLC  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  11/19/2026   100    44    45    0.01 
                           8,436    8,434    1.32 
Media                                      
Fitness International LLC  (8)  First Lien Term Loan  S + 5.25%  0.00%  9.58%  2/12/2029   10,853    10,844    10,938    1.72 
Getty Images, Inc.  (5)(6)(8)  First Lien Term Loan  S + 4.50%  0.00%  8.85%  2/19/2026   1,991    1,994    1,989    0.31 
Klick Inc.  (6)(8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  3/31/2028   732    725    725    0.11 
Learfield Communications, LLC  (7)  First Lien Revolver  S + 3.25%  0.00%  7.58%  12/31/2027   100             
MH Sub I, LLC  (5)(8)  First Lien Term Loan  S + 4.25%  0.00%  8.58%  12/11/2031   2,500    2,475    2,482    0.39 
W2O Holdings, Inc.  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.00%  6/12/2028   1,604    1,597    1,600    0.25 
W2O Holdings, Inc.     First Lien Delayed Draw Term Loan  S + 4.75%  1.00%  9.06%  6/12/2028   688    682    687    0.11 
W2O Holdings, Inc.  (7)  First Lien Revolver  S + 4.75%  1.00%  9.00%  6/12/2028   132    39    39    0.01 
                           18,356    18,460    2.90 
Oil, Gas and Consumable Fuels                                      
Edpo, LLC  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.83%  12/8/2027   6,901    6,901    6,884    1.08 
Edpo, LLC  (7)  First Lien Revolver  S + 4.50%  0.75%  8.83%  12/8/2026   81    28    28     
Valicor PPC Intermediate II LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  7/24/2028   2,656    2,650    2,650    0.42 
Valicor PPC Intermediate II LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  7/24/2028   930    928    928    0.15 
Valicor PPC Intermediate II LLC  (8)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.33%  7/24/2028   442    441    441    0.07 
Valicor PPC Intermediate II LLC  (7)  First Lien Revolver  S + 4.00%  1.00%  8.33%  1/24/2028   710    75    75    0.01 
                           11,023    11,006    1.73 
Personal Care Products                                      
Apothecary Products, LLC  (6)(8)  First Lien Term Loan  S + 5.75%  1.00%  10.10%  7/27/2025   194    194    194    0.03 
Swanson Health Products, Incorporated  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.82%  6/30/2025   199    199    200    0.03 
                           393    394    0.06 

 

59

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Pharmaceuticals                                      
Bamboo US BidCo LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  12.93% (Incl.
3.38% PIK)
  9/30/2030  $3,023   $3,023   $3,008    0.47%
Bamboo US BidCo LLC  (8)  First Lien Term Loan  E + 5.25%  1.00%  12.93% (Incl.
3.38% PIK)
  9/30/2030  EUR 2,697    2,948    2,779    0.44 
Bamboo US BidCo LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.00%  9.58%  9/30/2030   1,892    270    264    0.04 
Bamboo US BidCo LLC  (7)  First Lien Revolver  S + 6.00%  0.00%  10.31%  10/1/2029   826        (4)    
Bridges Consumer Healthcare Intermediate LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.56%  12/20/2031   4,708    4,685    4,684    0.73 
Bridges Consumer Healthcare Intermediate LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  1.00%  9.56%  12/20/2031   2,235        (11)    
Bridges Consumer Healthcare Intermediate LLC  (7)  First Lien Revolver  S + 5.25%  0.00%  9.56%  12/20/2031   894        (4)    
Exactcare Parent Inc  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.81%  11/5/2029   199    199    199    0.03 
Tersera Therapeutics, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.06%  4/4/2029   3,874    3,874    3,874    0.61 
Tersera Therapeutics, LLC  (7)  First Lien Revolver  S + 6.75%  1.00%  11.06%  4/4/2029   116             
TWL Holdings Corp  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.71%  11/6/2026   200    200    200    0.03 
                           15,199    14,989    2.35 
Professional Services                                      
Analytic Partners, LP  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  4/4/2030   199    199    199    0.03 
Analytic Partners, LP  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  4/4/2030   3,713    3,702    3,699    0.58 
Analytic Partners, LP  (7)  First Lien Revolver  S + 4.75%  0.00%  9.08%  4/4/2030   502    (2)   (2)    
Applied Technical Services, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.21%  12/29/2026   199    196    196    0.03 
Aprio Advisory Group, LLC  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.06%  8/1/2031   7,536    7,518    7,518    1.18 
Aprio Advisory Group, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.75%  9.06%  8/1/2031   3,277    1,505    1,504    0.24 
Aprio Advisory Group, LLC  (7)  First Lien Revolver  S + 4.75%  0.75%  9.06%  8/1/2031   1,638    520    520    0.08 
AQ Carver Buyer, Inc.  (7)  First Lien Revolver  S + 5.25%  0.00%  9.58%  8/2/2028   100             
Carr, Riggs & Ingram Capital, L.L.C.  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.06%  11/18/2031   2,875    2,861    2,861    0.45 
Carr, Riggs & Ingram Capital, L.L.C.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.50%  9.06%  11/18/2031   1,458    (4)   (7)    
Carr, Riggs & Ingram Capital, L.L.C.  (7)  First Lien Revolver  S + 3.75%  0.50%  8.06%  11/18/2031   667    80    80    0.01 
Clinical Education Alliance, LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.46%  12/21/2026   100    99    98    0.02 
Crisis Prevention Institute, Inc.  (7)  First Lien Revolver  S + 4.75%  0.50%  9.08%  4/9/2029   100             
Disa Holdings Corp.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  9/9/2028   2,854    2,854    2,817    0.44 
Disa Holdings Corp.  (8)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  9/9/2028   556    556    549    0.09 
Disa Holdings Corp.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  9/11/2028   591    68    60    0.01 
DTI Holdco, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.08%  4/26/2029   199    201    201    0.03 
Foreigner Bidco Inc.  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.93%  4/19/2028   200    200    199    0.03 
Grant Thornton Advisors LLC  (5)(6)(8)  First Lien Term Loan  S + 2.75%  0.00%  7.06%  6/2/2031   1,202    1,202    1,204    0.19 
Grant Thornton Advisors LLC  (5)(6)(7)(8)  First Lien Delayed Draw Term Loan  S + 2.75%  0.00%  7.06%  6/2/2031   147             

 

60

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Professional Services (continued)                                      
Ground Penetrating Radar Systems, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.58%  4/2/2031  $9,041   $9,041   $9,041    1.42%
Ground Penetrating Radar Systems, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.75%  1.00%  10.08%  4/2/2031   2,158             
Ground Penetrating Radar Systems, LLC  (7)  First Lien Revolver  P + 4.25%  1.00%  11.75%  4/2/2031   1,151    144    144    0.02 
HSI Halo Acquisition Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  6/30/2031   7,825    7,806    7,806    1.22 
HSI Halo Acquisition Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  6/28/2031   1,397    239    239    0.04 
HSI Halo Acquisition Inc.  (7)  First Lien Revolver  S + 5.00%  0.00%  9.31%  6/28/2030   932    (2)   (2)    
IG Investments Holdings, LLC     First Lien Term Loan  S + 5.00%  0.75%  9.31%  9/22/2028   2,608    2,596    2,596    0.41 
IG Investments Holdings, LLC  (7)  First Lien Revolver  S + 4.00%  0.75%  8.31%  9/22/2028   293    (1)   (1)    
Iris Buyer LLC  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.56%  10/2/2030   199    197    199    0.03 
KENE Acquisition, Inc.  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.58%  2/8/2031   199    200    200    0.03 
Keng Acquisition, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  8/1/2029   199    197    199    0.03 
Marina Acquisition, Inc.  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.31%  7/1/2030   2,146    2,125    2,125    0.33 
Marina Acquisition, Inc.  (7)  First Lien Revolver  S + 4.00%  0.00%  8.31%  7/1/2030   307    (3)   (3)    
MHE Intermediate Holdings, LLC  (8)  First Lien Term Loan  S + 6.00%  1.00%  10.46%  7/21/2027   200    200    200    0.03 
Propio LS, LLC  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.75%  7/17/2030   7,064    7,030    7,046    1.11 
Propio LS, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  0.00%  8.75%  7/17/2030   3,409    (17)   (9)    
Propio LS, LLC  (7)  First Lien Revolver  S + 6.00%  0.75%  10.25%  7/17/2029   1,704    (8)   (4)    
Rimkus Consulting Group, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.50%  4/1/2031   8,962    8,962    8,917    1.40 
Rimkus Consulting Group, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.50%  4/1/2031   2,251    239    228    0.04 
Rimkus Consulting Group, Inc.  (7)  First Lien Revolver  S + 5.25%  0.75%  9.50%  4/1/2030   1,201        (6)    
Ruppert Landscape, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.75%  0.75%  10.06%  12/1/2028   4,804    748    728    0.11 
Ruppert Landscape, LLC  (7)  First Lien Revolver  S + 5.75%  0.75%  10.06%  12/1/2028   320    (3)   (4)    
Skopima Consilio Parent LLC  (5)(8)  First Lien Term Loan  S + 3.75%  0.50%  8.08%  5/12/2028   2,172    2,178    2,183    0.34 
Tempo Buyer Corp.  (8)  First Lien Term Loan  S + 4.75%  0.75%  9.06%  8/26/2028   199    199    199    0.03 
USRP Holdings, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  12/31/2029   8,677    8,635    8,677    1.36 
USRP Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.33%  12/31/2029   2,773    (12)        
USRP Holdings, Inc.  (7)  First Lien Revolver  S + 5.50%  0.75%  9.83%  12/31/2029   900    (4)        
Vaco Holdings, LLC  (7)  First Lien Revolver  S + 5.00%  0.00%  9.33%  1/21/2027   100             
Vensure Employer Services, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.50%  9.31%  9/27/2031   1,947    1,937    1,938    0.30 
Vensure Employer Services, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.00%  9.31%  9/27/2031   476    (2)   (2)    
YA Intermediate Holdings II, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.31%  10/1/2031   5,419    5,392    5,392    0.85 
YA Intermediate Holdings II, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  10/1/2031   2,258    (6)   (11)    
YA Intermediate Holdings II, LLC  (7)  First Lien Revolver  S + 4.00%  0.75%  8.31%  10/1/2031   1,084    49    49    0.01 
                           79,811    79,760    12.52 
Real Estate Management and Development                                      
Sako and Partners Lower Holdings LLC.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  9/15/2028   6,566    6,551    6,549    1.03 
Sako and Partners Lower Holdings LLC.  (7)  First Lien Revolver  S + 6.00%  1.00%  10.31%  9/15/2028   418    (1)   (1)    
                           6,550    6,548    1.03 

 

61

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Software                                      
365 Retail Markets, LLC  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.81%  12/22/2028  $3,876   $3,876   $3,852    0.60%
365 Retail Markets, LLC  (8)  First Lien Delayed Draw Term Loan  S + 4.50%  1.00%  8.81%  12/22/2028   1,753    1,753    1,742    0.27 
365 Retail Markets, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  1.00%  8.81%  12/22/2028   1,371    914    906    0.14 
Adelaide Borrower, LLC     First Lien Term Loan  S + 6.25%  0.75%  10.56%  5/8/2030   200    198    198    0.03 
Alta Buyer, LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.31%  12/21/2027   199    199    199    0.03 
AQA Acquisition Holding, Inc.  (7)  First Lien Revolver  S + 3.50%  0.00%  7.83%  3/3/2028   100             
Artifact Bidco, Inc.  (8)  First Lien Term Loan  S + 4.50%  0.50%  8.81%  7/28/2031   3,354    3,331    3,329    0.52 
Artifact Bidco, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.50%  0.50%  8.81%  7/25/2031   821    (6)   (6)    
Artifact Bidco, Inc.  (7)  First Lien Revolver  S + 4.50%  0.50%  8.81%  7/26/2030   399    (3)   (3)    
Artifact Bidco, Inc.  (7)  First Lien Revolver  S + 4.50%  0.50%  8.81%  7/26/2030   188    (1)   (1)    
Banker's Toolbox, Inc.  (8)  First Lien Term Loan  S + 4.50%  0.75%  8.81%  7/27/2027   199    199    199    0.03 
Bluecat Networks (USA) Inc.  (6)(8)  First Lien Term Loan  S + 5.00%  0.00%  9.31%  8/8/2028   1,473    1,462    1,462    0.23 
Camelot U.S. Acquisition LLC  (5)(6)(8)  First Lien Term Loan  S + 2.75%  0.00%  7.08%  1/31/2031   3,067    3,075    3,068    0.48 
Catalis Intermediate, Inc.  (8)  First Lien Term Loan  S + 5.50%  0.00%  9.96%  8/4/2027   100    99    98    0.02 
Central Parent LLC  (5)(8)  First Lien Term Loan  S + 3.25%  0.00%  7.58%  7/6/2029   1,746    1,737    1,725    0.27 
Cloud Software Group, Inc.  (7)  First Lien Revolver  S + 3.75%  0.00%  8.08%  9/30/2027   100             
Concord Global Acquisition, LLC,  (8)  First Lien Term Loan  S + 4.75%  0.00%  9.06%  12/29/2031   3,946    3,926    3,926    0.62 
Concord Global Acquisition, LLC,  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.06%  12/29/2031   1,715    (4)   (9)    
Concord Global Acquisition, LLC,  (7)  First Lien Revolver  S + 4.75%  0.00%  9.06%  12/29/2031   686    (3)   (3)    
Digital.AI Software Holdings, Inc.  (8)  First Lien Term Loan  S + 6.00%  1.00%  10.31%  8/10/2028   100    100    100    0.02 
DS Admiral Bidco, LLC  (7)  First Lien Revolver  S + 4.00%  0.00%  8.33%  6/26/2029   100    23    23     
DT Intermediate Holdco, Inc.  (8)  First Lien Term Loan  10.59% (Incl.
3.25% PIK)
  0.75%  10.59% (Incl.
3.25% PIK)
  2/24/2028   3,299    3,283    3,274    0.51 
DT Intermediate Holdco, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.75%  9.81%  2/24/2028   1,658    (8)   (12)    
e-Discovery AcquireCo, LLC  (8)  First Lien Term Loan  S + 6.25%  1.00%  10.56%  8/29/2029   200    200    199    0.03 
Eclipse Buyer, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.08%  9/8/2031   7,862    7,823    7,823    1.23 
Eclipse Buyer, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.50%  9.08%  9/5/2031   1,333    (7)   (7)    
Eclipse Buyer, Inc.  (7)  First Lien Revolver  S + 4.75%  0.50%  9.08%  9/5/2031   676    (3)   (3)    
Empyrean Solutions, LLC  (8)  First Lien Term Loan  S + 4.75%  0.00%  9.06%  11/26/2031   1,382    1,376    1,376    0.22 
Empyrean Solutions, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.00%  9.06%  11/26/2031   553    (1)   (3)    
Empyrean Solutions, LLC  (7)  First Lien Revolver  S + 4.75%  0.00%  9.06%  11/26/2031   207    (1)   (1)    
Enverus Holdings, Inc.  (8)  First Lien Term Loan  S + 5.50%  0.75%  9.83%  12/24/2029   1,979    1,979    1,979    0.31 
Enverus Holdings, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.75%  9.83%  12/22/2029   142             
Enverus Holdings, Inc.  (7)  First Lien Revolver  S + 5.50%  0.00%  9.83%  12/22/2029   214    6    6     
ESG Investments, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.96%  3/11/2028   199    199    199    0.03 
Governmentjobs.Com, Inc.  (8)  First Lien Term Loan  S + 5.00%  0.00%  9.33%  12/1/2028   200    199    200    0.03 
GS Acquisitionco, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.31%  5/25/2028   200    44    44    0.01 
Hyphen Solutions, LLC  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.93%  10/27/2026   199    199    199    0.03 
Kipu Buyer, LLC  (8)  First Lien Term Loan  S + 4.25%  1.00%  8.56%  1/27/2027   199    199    199    0.03 

 

62

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Software (continued)                                      
KPA Parent Holdings, Inc.  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.18%  7/19/2026  $5,289   $5,289   $5,289    0.83%
KPA Parent Holdings, Inc.  (8)  First Lien Delayed Draw Term Loan  S + 5.75%  1.00%  10.18%  7/19/2026   1,018    1,018    1,018    0.16 
KPA Parent Holdings, Inc.  (7)  First Lien Revolver  S + 5.50%  1.00%  9.93%  7/17/2026   677             
Litera Bidco LLC  (8)  First Lien Term Loan  S + 5.00%  1.00%  9.33%  5/1/2028   199    199    199    0.03 
LogicMonitor, Inc.  (8)  First Lien Term Loan  S + 5.50%  0.75%  9.83%  11/19/2031   200    200    199    0.03 
Mastery Acquisition Corp.  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.50%  9/7/2029   199    199    200    0.03 
McAfee Corp.  (5)(8)  First Lien Term Loan  S + 3.00%  0.50%  7.33%  3/1/2029   2,500    2,506    2,505    0.39 
Monotype Imaging Holdings Inc.  (8)  First Lien Term Loan  S + 5.50%  0.75%  9.81%  2/28/2031   1,229    1,233    1,229    0.19 
Monotype Imaging Holdings Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.50%  0.00%  9.81%  2/28/2031   103    24    24     
Monotype Imaging Holdings Inc.  (7)  First Lien Revolver  S + 5.50%  0.75%  9.81%  2/28/2030   154             
Montana Buyer Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  7/22/2029   2,664    2,657    2,664    0.42 
Montana Buyer Inc.  (7)  First Lien Revolver  P + 5.75%  0.00%  13.25%  7/21/2028   307    52    53    0.01 
MRI Software LLC  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.06%  2/10/2027   6,984    6,951    7,001    1.10 
MRI Software LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  1.00%  9.06%  2/10/2027   1,293    117    127    0.02 
MRI Software LLC  (7)  First Lien Revolver  S + 4.75%  1.00%  9.16%  2/10/2026   265    13    15     
Nasuni Corporation  (8)  First Lien Term Loan  S + 5.75%  0.75%  10.06%  9/10/2030   6,250    6,204    6,206    0.97 
Nasuni Corporation  (7)  First Lien Revolver  S + 5.75%  0.75%  10.06%  9/10/2030   1,302    (10)   (9)    
Navex Topco, Inc.  (8)  First Lien Term Loan  S + 5.50%  0.75%  9.83%  11/8/2030   5,190    5,190    5,190    0.81 
Navex Topco, Inc.  (7)  First Lien Revolver  S + 5.75%  0.75%  10.08%  11/7/2028   1,797             
North Star Acquisitionco, LLC  (6)(8)  First Lien Term Loan  S + 4.75%  1.00%  9.06%  5/3/2029   4,385    4,374    4,385    0.69 
North Star Acquisitionco, LLC  (6)(8)  First Lien Term Loan  C + 4.75%  0.00%  8.00%  5/3/2029  CAD1,545    1,115    1,074    0.17 
North Star Acquisitionco, LLC  (6)(7)  First Lien Delayed Draw Term Loan  S + 5.00%  1.00%  9.31%  5/3/2029   276    264    264    0.04 
North Star Acquisitionco, LLC  (6)(7)  First Lien Revolver  S + 6.00%  1.00%  10.31%  5/3/2029   780    (2)        
Pegasus Transtech Holding, LLC  (8)  First Lien Term Loan  S + 6.00%  1.00%  10.33%  11/17/2026   199    199    199    0.03 
Perforce Software, Inc.  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.08%  3/21/2031   2,036    2,038    2,013    0.32 
Prism Parent Co. Inc.  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  9/19/2028   5,566    5,458    5,454    0.86 
Prism Parent Co. Inc.  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.33%  9/19/2028   1,420    544    542    0.09 
Renaissance Holding Corp  (5)(8)  First Lien Term Loan  S + 4.00%  0.50%  8.33%  4/5/2030   1,995    1,996    1,993    0.31 
Routeware, Inc.     First Lien Term Loan  S + 5.25%  1.00%  9.56%  9/18/2031   3,182    3,167    3,174    0.50 
Routeware, Inc.  (7)  First Lien Delayed Draw Term Loan  S + 8.00%  1.00%  12.31%  9/18/2031   1,477    (7)   (4)    
Routeware, Inc.  (7)  First Lien Revolver  S + 8.00%  1.00%  12.31%  9/18/2031   341    (2)   (1)    
Spartan Bidco PTY LTD  (6)(8)  First Lien Term Loan  S + 0.75%  0.00%  11.21% (Incl.
6.00% PIK)
  1/24/2028   4,815    4,778    4,771    0.75 
Spartan Bidco PTY LTD  (6)(7)  First Lien Revolver  S + 6.75%  0.00%  11.06%  1/24/2028   385    (4)   (4)    
Thunder Purchaser, Inc.  (8)  First Lien Term Loan  S + 5.50%  0.00%  9.96%  6/30/2028   200    200    200    0.03 
Trimech Acquisition Corp.  (8)  First Lien Term Loan  S + 4.75%  1.00%  9.06%  3/10/2028   925    917    916    0.14 
Trimech Acquisition Corp.  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  1.00%  9.06%  3/10/2028   2,480    (24)   (25)    
Trimech Acquisition Corp.  (7)  First Lien Revolver  S + 4.75%  0.00%  9.06%  3/10/2028   1,550    78    78    0.01 
Validity, Inc.  (6)(8)  First Lien Term Loan  S + 5.25%  1.00%  9.68%  5/30/2026   200    200    200    0.03 
WatchGuard Technologies, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.58%  7/2/2029   199    198    198    0.03 
                           93,691    93,614    14.68 

 

63

 

 

ANTARES PRIVATE CREDIT FUND 

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued) 

December 31, 2024 

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Specialty Retail                                      
Shock Doctor Intermediate, LLC  (8)  First Lien Term Loan  S + 5.75%  1.00%  10.06%  11/20/2029  $199   $199   $199    0.03%
                           199    199    0.03 
Technology Hardware, Storage and Peripherals                                      
TA TT Buyer, LLC  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.06%  4/2/2029   199    199    200    0.03 
Ubeo, LLC  (8)  First Lien Term Loan  S + 5.25%  1.00%  9.71%  4/3/2026   199    199    199    0.03 
Victors Purchaser, LLC  (8)  First Lien Term Loan  S + 4.75%  0.50%  9.06%  8/15/2031   9,217    9,195    9,194    1.44 
Victors Purchaser, LLC  (7)  First Lien Delayed Draw Term Loan  S + 4.75%  0.50%  9.06%  8/15/2031   2,194    (5)   (5)    
Victors Purchaser, LLC  (7)  First Lien Revolver  S + 4.75%  0.00%  9.06%  8/15/2031   1,254    184    180    0.03 
                           9,772    9,768    1.53 
Textiles, Apparel and Luxury Goods                                      
MTI Group Acquisition Company  (6)(8)  First Lien Term Loan  S + 6.00%  1.00%  14.93% (Incl.
4.50% PIK)
  3/31/2025   100    100    100    0.02 
Team Acquisition Corporation  (7)  First Lien Revolver  S + 5.50%  1.00%  9.83%  11/21/2028   100        (4)    
Varsity Brands, Inc.  (5)(8)  First Lien Term Loan  S + 3.75%  0.00%  8.06%  8/26/2031   2,000    2,010    2,005    0.31 
                           2,110    2,101    0.33 
Trading Companies and Distributors                                      
Graffiti Buyer, Inc.  (8)  First Lien Term Loan  S + 5.50%  1.00%  9.91%  8/10/2027   199    197    194    0.03 
Kele Holdco, Inc.  (8)  First Lien Term Loan  S + 4.50%  1.00%  8.83%  2/21/2028   200    200    200    0.03 
Surfaceprep Buyer, LLC  (8)  First Lien Term Loan  S + 5.00%  0.75%  9.33%  2/4/2030   1,911    1,911    1,887    0.30 
Surfaceprep Buyer, LLC  (7)  First Lien Delayed Draw Term Loan  S + 5.00%  0.75%  9.33%  2/4/2030   362    212    207    0.03 
Surfaceprep Buyer, LLC  (7)  First Lien Revolver  S + 5.00%  0.75%  9.33%  2/4/2030   362    45    41    0.01 
                           2,565    2,529    0.40 
Transportation Infrastructure                                      
Psc Parent, Inc.  (8)  First Lien Term Loan  S + 5.25%  0.75%  9.58%  4/3/2031   1,630    1,630    1,630    0.26 
Psc Parent, Inc.  (7)(8)  First Lien Delayed Draw Term Loan  S + 5.25%  0.75%  9.58%  4/3/2031   661    272    272    0.04 
Psc Parent, Inc.  (7)  First Lien Revolver  S + 4.25%  0.00%  8.58%  4/3/2030   292    208    208    0.03 
                           2,110    2,110    0.33 
Wireless Telecommunication Services                                      
Alert Media, Inc.     First Lien Term Loan  S + 6.50%  1.00%  11.06% (Incl.
10.06% PIK)
  4/12/2027   420    419    420    0.07 
Alert Media, Inc.  (7)  First Lien Revolver  S + 5.00%  1.00%  9.31%  4/12/2027   109             
CCI Buyer, Inc.  (5)(8)  First Lien Term Loan  S + 4.00%  0.75%  8.33%  12/17/2027   2,239    2,251    2,244    0.35 
                           2,670    2,664    0.42 
Total Secured Debt Investments                          845,082    843,710    132.36 

 

64

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments (1)  Footnotes  Asset Type  Reference
Rate and
Spread (2)
  Interest
Rate
Floor
  Interest
Rate (2)
  Maturity
Date
  Par Amount
/ Shares
   Amortized
Cost (4)
   Fair
Value
   Percentage
of Net Assets
 
Unsecured Debt Investments                                      
                                       
Diversified Consumer Services                                      
Apex Service Partners Intermediate 2, LLC     Subordinated Unsecured
Delayed Draw Term Loan
  N/A  0.00%  14.25%  4/23/2031  $721   $713   $703    0.11%
                           713    703    0.11 
Total Unsecured Debt Investments                          713    703    0.11 
                                       
Equity Investments                                      
Diversified Consumer Services                                      
Seahawk Bidco, LLC  (9)  LP Units               1    1,301    1,301    0.20 
                           1,301    1,301    0.20 
Electronic Equipment, Instruments and Components                                      
Wildcat Topco, Inc.  (9)  LP Units               52    52    52    0.01 
                           52    52    0.01 
Health Care Technology                                      
DeLorean Purchaser, Inc.  (9)  Common               435    435    435    0.07 
                           435    435    0.07 
IT Services                                      
DT1 Midco Corp  (9)  Common               1,159    1,159    1,159    0.18 
                           1,159    1,159    0.18 
Software                                      
Concord Global Acquisition, LLC,  (9)  LP Units               1    1,000    1,000    0.16 
                           1,000    1,000    0.16 
Total Equity Investments                          3,947    3,947    0.62 
Total Investments - non-controlled/non-affiliated                          849,742    848,360    133.09 
                                       
Cash Equivalents                                      
BlackRock Liquidity T-Fund - Institutional Shares  (11)                       39,527    39,527    6.20 
Total Cash Equivalents                          39,527    39,527    6.20 
Total Portfolio Investments and Cash Equivalents                         $889,269   $887,887    139.29%

 

65

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

1.Unless otherwise indicated, issuers of debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount is presented for debt investments and the number of shares or units owned is presented for equity investments.

 

2.The majority of the investments bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate ("SOFR" or "S"), Prime Rate (“Prime” or “P”), Canadian Dollar Offered Rate ("CDOR" or "C"), Sterling Overnight Index Average ("SONIA" or "SON"), Euro Interbank Offered Rate ("EURIBOR" or "E") or other relevant benchmark, which reset daily, monthly, quarterly, semiannually or annually. For each such investment, the Company has provided the spread over reference rates and the current contractual interest rate in effect on December 31, 2024. Certain investments are subject to an interest rate floor, or rate cap. Certain investments contain a Payment-in-Kind (“PIK”) provision. SOFR based contracts may include a credit spread adjustment, which is included within the stated all-in interest rate, if applicable, that is charged in addition to the base rate and the stated spread.

 

3.Investments with par value / shares less than 500 shown as zero.

 

4.The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").

 

5.These investments were not valued using unobservable inputs and are not considered Level 3 investments. Fair value was determined in good faith by the Adviser as the Company’s valuation designee, subject to the oversight of the Board of Trustees (the “Board”) (see Note 2 and Note 5), pursuant to the Company’s valuation policy.

 

6.The investment is not a qualifying asset, in whole or in part, under Section 55(a) of the 1940 Act. The Company may not acquire any non-qualifying asset unless, at the time of acquisition, qualifying assets represent at least 70% of the Company’s total assets. As of December 31, 2024, non-qualifying assets represented 6.65% of total assets as calculated in accordance with regulatory requirements.

 

7.Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion, although the investment may be subject to unused commitment fees. Negative cost and fair value results from unamortized fees, which are capitalized to the investment cost. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. Such commitments are subject to the satisfaction of certain conditions set forth in the documents governing these loans and letters of credit and there can be no assurance that such conditions will be satisfied. See the following page for more information on the Company’s unfunded commitments.

 

8.Position or portion thereof is pledged as collateral under the Morgan Stanley Facility.

 

9.Security exempt from registration under the Securities Act of 1933 (the “Securities Act”), and may be deemed to be “restricted securities” under the Securities Act. As of December 31, 2024, the aggregate fair value of these securities is $3,947 or 0.62% of the Company’s net assets. The acquisition date of DeLorean Purchaser, Inc. was December 16, 2024. The acquisition date of Seahawk Bidco, LLC was December 19, 2024. The acquisition date of Wildcat Topco, Inc. was December 23, 2024. The acquisition date of Concord Global Acquisition, LLC was December 27, 2024. The acquisition date of DT1 Midco Corp was December 30, 2024.

 

10.These are co-investments made with the Company’s affiliates in accordance with the terms of the exemptive order the Company received from the Securities and Exchange Commission (the “SEC”) permitting us to do so (see Note 3 to the consolidated financial statements for discussion of the exemptive order from the SEC).

 

11.Cash equivalents amounting to $39,527 are invested in money market funds (BlackRock Liquidity T-Fund - Institutional Shares) and would be categorized as Level 1 under the ASC 820 fair value level hierarchy as of December 31, 2024.

 

66

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands) 

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
123Dentist Inc.  Delayed Draw Term Loan  8/10/2026  $5,260   $(25)
365 Retail Markets, LLC  Delayed Draw Term Loan  6/15/2025   457    (3)
AB Centers Acquisition Corporation  Revolver  7/2/2031   226    (2)
AB Centers Acquisition Corporation  Delayed Draw Term Loan  7/2/2026   422    (3)
Accession Risk Management, Inc  Revolver  11/1/2029   231     
Accession Risk Management, Inc  Delayed Draw Term Loan  8/16/2026   1,766    2 
Acentra Holdings, LLC  Delayed Draw Term Loan  3/20/2026   220    (1)
Alert Media, Inc.  Revolver  4/12/2027   109     
AMBA Buyer, Inc.  Revolver  7/30/2027   223    (2)
Amerilife Holdings LLC  Delayed Draw Term Loan  6/18/2026   6,322     
Analytic Partners, LP  Revolver  4/4/2030   502    (2)
Anchor Packaging, LLC  Revolver  4/17/2029   100     
Apex Service Partners, LLC  Revolver  10/24/2029   211    (1)
Aprio Advisory Group, LLC  Delayed Draw Term Loan  8/2/2026   1,764    (4)
Aprio Advisory Group, LLC  Revolver  8/1/2031   1,114    (3)
AQ Carver Buyer, Inc.  Revolver  8/2/2028   100     
AQA Acquisition Holding, Inc.  Revolver  3/3/2028   100     
Arax MidCo, LLC  Delayed Draw Term Loan  10/14/2025   710    (8)
Arax MidCo, LLC  Revolver  4/11/2029   431    (5)
Artifact Bidco, Inc.  Revolver  7/26/2030   399    (3)
Artifact Bidco, Inc.  Delayed Draw Term Loan  7/27/2027   821    (6)
Artifact Bidco, Inc.  Revolver  7/26/2030   188    (1)
Athenahealth Group Inc.  Revolver  2/16/2027   100     
Ave Holdings III, Corp  Revolver  2/25/2028   514    (6)
AWP Group Holdings, Inc.  Revolver  12/23/2030   303    (1)
Bamboo US BidCo LLC  Revolver  10/1/2029   826    (4)
Bamboo US BidCo LLC  Delayed Draw Term Loan  3/29/2025   1,619    (8)
BC Group Holdings, Inc.  Delayed Draw Term Loan  12/21/2026   5,893    (44)
BCPE North Star US Holdco 2, Inc.  Revolver  6/10/2026   14    (1)
Beyond Risk Parent Holdings, Inc.  Delayed Draw Term Loan  4/9/2026   5,843    (44)
Blackbird Purchaser, Inc.  Delayed Draw Term Loan  12/19/2025   119     
Blackbird Purchaser, Inc.  Revolver  12/19/2029   93     
Blackhawk Industrial Distribution, Inc.  Revolver  9/17/2026   848    (3)
Blackhawk Industrial Distribution, Inc.  Delayed Draw Term Loan  5/13/2025   492    (2)
Bracket Intermediate Holding Corp.  Revolver  2/7/2028   100    (2)
BradyPlus Holdings, LLC  Delayed Draw Term Loan  11/1/2025   551    (5)
Bridges Consumer Healthcare Intermediate LLC  Delayed Draw Term Loan  12/21/2026   2,235    (11)
Bridges Consumer Healthcare Intermediate LLC  Revolver  12/22/2031   894    (4)

 

67

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
BVI Medical, Inc.  Revolver  8/28/2025  $14   $ 
Carr, Riggs & Ingram Capital, L.L.C.  Revolver  11/18/2031   583    (3)
Carr, Riggs & Ingram Capital, L.L.C.  Delayed Draw Term Loan  11/18/2026   1,458    (7)
Cerity Partners Equity Holding LLC  Revolver  7/28/2028   542     
Cerity Partners Equity Holding LLC  Delayed Draw Term Loan  6/7/2026   5,612     
CFGI Holdings, LLC  Revolver  11/2/2027   270    (2)
CFs Brands, LLC  Delayed Draw Term Loan  4/2/2025   169    (2)
CFs Brands, LLC  Revolver  10/2/2029   493    (5)
Chg Ppc Parent LLC  Revolver  12/8/2026   98    (1)
Cloud Software Group, Inc.  Revolver  12/15/2028   100     
Cold Chain Technologies, LLC  Revolver  7/2/2026   522    (1)
Collision Sp Subco, LLC  Delayed Draw Term Loan  1/30/2026   564     
Collision Sp Subco, LLC  Revolver  1/29/2030   271     
Concord Global Acquisition, LLC,  Delayed Draw Term Loan  12/28/2026   1,715    (9)
Concord Global Acquisition, LLC,  Revolver  12/26/2031   686    (3)
Continental Buyer, Inc.  Delayed Draw Term Loan  4/3/2026   1,911    (27)
Continental Buyer, Inc.  Revolver  4/2/2031   717    (10)
CPC/Cirtec Holdings, Inc  Revolver  10/31/2028   558    (1)
CRCI Longhorn Holdings, Inc.  Delayed Draw Term Loan  8/28/2026   1,530    (2)
CRCI Longhorn Holdings, Inc.  Revolver  8/27/2031   561    (1)
Crisis Prevention Institute, Inc.  Revolver  4/9/2029   100     
Cub Financing Intermediate, LLC  Delayed Draw Term Loan  6/28/2026   1,741    (8)
CVP Holdco, Inc.  Delayed Draw Term Loan  6/29/2026   1,715    (4)
CVP Holdco, Inc.  Revolver  6/28/2030   686    (2)
DCert Buyer, Inc.  Revolver  10/16/2026   100     
DCG Acquisition Corp.  Delayed Draw Term Loan  6/13/2026   1,169     
DeLorean Purchaser, Inc.  Revolver  12/16/2031   653    (5)
Denali Buyerco LLC  Delayed Draw Term Loan  3/6/2026   1,130    (5)
Disa Holdings Corp.  Delayed Draw Term Loan  3/1/2026   523    (7)
DS Admiral Bidco, LLC  Revolver  6/26/2029   77     
DT Intermediate Holdco, Inc.  Delayed Draw Term Loan  9/14/2026   1,658    (12)
DT1 Midco Corp  Delayed Draw Term Loan  12/30/2026   2,005    (10)
DT1 Midco Corp  Revolver  12/30/2030   802    (4)
Dwyer Instruments, LLC  Revolver  7/20/2029   706    (7)
Dwyer Instruments, LLC  Delayed Draw Term Loan  11/21/2026   505    (5)
Eclipse Buyer, Inc.  Revolver  9/6/2031   676    (3)
Eclipse Buyer, Inc.  Delayed Draw Term Loan  9/7/2026   1,333    (7)
Edgeco Buyer, Inc.  Delayed Draw Term Loan  12/20/2026   2,771    (14)
Edgeco Buyer, Inc.  Revolver  6/1/2028   304    (2)

 

68

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
Edpo, LLC  Revolver  12/8/2026  $53   $ 
Empower Payments Investor, LLC  Revolver  3/12/2030   163     
Empower Payments Investor, LLC  Delayed Draw Term Loan  3/12/2026   306     
Empyrean Solutions, LLC  Revolver  11/26/2031   207    (1)
Empyrean Solutions, LLC  Delayed Draw Term Loan  11/25/2026   553    (3)
Ensemble RCM, LLC  Revolver  6/27/2028   100     
Enthusiast Auto Holdings, LLC  Revolver  12/19/2026   64     
Enverus Holdings, Inc.  Delayed Draw Term Loan  12/22/2025   142     
Enverus Holdings, Inc.  Revolver  12/24/2029   207     
Eos Fitness Opco Holdings, LLC  Revolver  1/5/2028   384    (1)
Eos Fitness Opco Holdings, LLC  Delayed Draw Term Loan  9/25/2026   641    (2)
Essential Services Holding Corporation  Revolver  6/17/2030   247    (1)
Essential Services Holding Corporation  Delayed Draw Term Loan  6/17/2026   395    (1)
Excelitas Technologies Corp.  Delayed Draw Term Loan  5/1/2026   2,522    (6)
Eyesouth Eye Care Holdco, LLC  Delayed Draw Term Loan  4/1/2026   4,256    (43)
Flint Opco, LLC  Delayed Draw Term Loan  6/1/2026   2,093     
Flow Control Solutions, Inc.  Revolver  3/31/2029   936    (7)
Flow Control Solutions, Inc.  Delayed Draw Term Loan  6/28/2026   5,129    (35)
Foreside Financial Group, LLC  Delayed Draw Term Loan  3/13/2026   11,650     
Formulations Parent Corporation  Revolver  11/15/2029   100     
FR Vision Holdings Inc  Revolver  1/22/2030   248     
FR Vision Holdings Inc  Delayed Draw Term Loan  1/20/2026   572     
Grant Thornton Advisors LLC  Delayed Draw Term Loan  6/2/2031   147     
Ground Penetrating Radar Systems, LLC  Delayed Draw Term Loan  4/3/2027   2,158     
Ground Penetrating Radar Systems, LLC  Revolver  4/2/2031   1,007     
GS Acquisitionco, Inc.  Delayed Draw Term Loan  3/26/2026   156     
GSV Holding, LLC  Revolver  10/18/2030   217    (1)
Harvey Tool Company, LLC  Revolver  10/26/2027   964    (2)
Harvey Tool Company, LLC  Delayed Draw Term Loan  6/28/2026   3,213    (7)
Health Buyer LLC  Delayed Draw Term Loan  5/15/2026   2,643    (12)
HeartLand PPC Buyer, LLC  Delayed Draw Term Loan  12/13/2025   328    (1)
HeartLand PPC Buyer, LLC  Revolver  12/12/2029   265    (1)
Heights Buyer, LLC  Delayed Draw Term Loan  8/26/2025   874     
Heights Buyer, LLC  Revolver  8/25/2028   764     
Hercules Borrower LLC  Revolver  12/15/2026   459     
Highline Aftermarket Acquisition, LLC  Revolver  8/10/2027   100     
HighTower Holding, LLC  Revolver  10/21/2027   100     
HP RSS Buyer, Inc.  Delayed Draw Term Loan  3/12/2026   2,534    (44)
HSI Halo Acquisition Inc.  Delayed Draw Term Loan  6/28/2026   1,155    (3)

 

69

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
HSI Halo Acquisition Inc.  Revolver  6/28/2030  $932   $(2)
HT Intermediary III, Inc.  Revolver  11/12/2030   496    (2)
HT Intermediary III, Inc.  Delayed Draw Term Loan  11/13/2026   1,527    (7)
Hydraulic Technologies USA LLC  Revolver  6/3/2030   98    (1)
IG Investments Holdings, LLC  Revolver  9/22/2028   293    (1)
ImageFirst Holdings, LLC  Revolver  4/27/2028   80     
Imagine 360 LLC  Revolver  9/30/2028   327    (2)
Imagine 360 LLC  Delayed Draw Term Loan  9/20/2026   767    (4)
IMO Investor Holdings, Inc.  Revolver  5/11/2028   359     
Innovetive Petcare, Inc.  Delayed Draw Term Loan  11/19/2026   1,877    (23)
Integrated Power Services Holdings, Inc.  Delayed Draw Term Loan  5/7/2026   7,978    (16)
Invictus Buyer, LLC  Delayed Draw Term Loan  6/4/2026   3,266     
Invictus Buyer, LLC  Revolver  6/3/2031   1,210     
JHCC Holdings LLC  Revolver  9/9/2027   84     
KPA Parent Holdings, Inc.  Revolver  7/17/2026   677     
Kriv Acquisition Inc.  Delayed Draw Term Loan  9/26/2026   1,338    (7)
Kwol Acquisition, Inc.  Revolver  12/12/2029   841    (13)
Learfield Communications, LLC  Revolver  12/31/2027   100     
Lightbeam Bidco Inc  Revolver  5/4/2029   491     
Lightbeam Bidco Inc  Delayed Draw Term Loan  5/7/2025   907     
Marina Acquisition, Inc.  Revolver  7/1/2030   307    (3)
Mclarens Midco Inc.  Delayed Draw Term Loan  12/19/2025   592     
MDC Interior Acquisition Inc  Revolver  4/26/2030   42     
Merlin Buyer, Inc.  Revolver  12/14/2026   1,450    (15)
Minotaur Acquisition, Inc.  Delayed Draw Term Loan  6/4/2026   1,455    (10)
Minotaur Acquisition, Inc.  Revolver  6/3/2030   873    (6)
Monotype Imaging Holdings Inc.  Revolver  2/28/2030   154     
Monotype Imaging Holdings Inc.  Delayed Draw Term Loan  2/28/2026   79     
Montana Buyer Inc.  Revolver  7/22/2028   254     
Movati Athletic (Group) Inc.  Delayed Draw Term Loan  5/30/2026   638    (5)
MRI Software LLC  Revolver  2/10/2027   251    1 
MRI Software LLC  Delayed Draw Term Loan  8/27/2026   1,170    3 
Nasuni Corporation  Revolver  9/10/2030   1,302    (9)
Navex Topco, Inc.  Revolver  11/9/2028   1,797     
Nelipak Holding Company  Revolver  3/26/2031   1,076    (16)
Nelipak Holding Company  Delayed Draw Term Loan  3/29/2027   2,486    (37)
Net Health Acquisition Corp.  Revolver  7/3/2031   817     
Noble Midco 3 Limited  Delayed Draw Term Loan  6/12/2027   824    (2)
Noble Midco 3 Limited  Revolver  12/11/2030   1,120    (3)

 

70

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
North Star Acquisitionco, LLC  Revolver  5/3/2029  $780   $ 
North Star Acquisitionco, LLC  Delayed Draw Term Loan  5/1/2026   11     
Oeconnection LLC  Delayed Draw Term Loan  12/30/2026   2,138    (4)
Oeconnection LLC  Delayed Draw Term Loan  4/22/2026   771    (1)
Oeconnection LLC  Revolver  4/22/2031   482    (1)
ONS MSO, LLC  Revolver  7/8/2026   11     
ONS MSO, LLC  Delayed Draw Term Loan  12/13/2025   113     
Onsite Holdings, LLC  Revolver  12/28/2025   75     
Onyx-Fire Protection Services Inc.  Revolver  7/31/2031   1,494    (7)
Onyx-Fire Protection Services Inc.  Delayed Draw Term Loan  7/31/2026   946    (5)
Packaging Coordinators Midco, Inc.  Revolver  8/31/2027   100     
Pareto Health Intermediate Holdings, Inc.  Delayed Draw Term Loan  6/20/2026   653    (3)
Pathstone Family Office LLC  Revolver  5/15/2028   374    (2)
Pathstone Family Office LLC  Delayed Draw Term Loan  6/22/2026   1,454    (7)
Patriot Growth Insurance Services, LLC  Revolver  10/16/2028   267     
Phantom Purchaser, Inc.  Revolver  9/19/2031   382    (1)
Phoenix 1 Buyer Corporation  Revolver  11/20/2029   1,142     
Potters Industries LLC  Revolver  9/14/2027   94     
Power Grid Holdings, Inc.  Revolver  12/2/2030   890     
Premise Health Holding Corp.  Revolver  3/1/2030   712     
Prism Parent Co. Inc.  Delayed Draw Term Loan  9/19/2025   849    (17)
Proampac PG Borrower LLC  Revolver  6/16/2028   89     
Project Accelerate Parent LLC  Revolver  2/24/2031   100     
Propio LS, LLC  Revolver  7/17/2029   1,704    (4)
Propio LS, LLC  Delayed Draw Term Loan  7/25/2026   3,409    (9)
Psc Parent, Inc.  Revolver  4/3/2030   84     
Psc Parent, Inc.  Delayed Draw Term Loan  4/3/2025   389     
Quality Automotive Services, LLC  Revolver  7/16/2027   257    (1)
Quality Automotive Services, LLC  Delayed Draw Term Loan  1/19/2026   212    (1)
Red Fox CD Acquisition Corporation  Delayed Draw Term Loan  12/1/2025   3,963    (30)
Resonetics, LLC  Revolver  6/18/2029   100     
Ridge Trail US Bidco, Inc.  Delayed Draw Term Loan  3/31/2027   2,995    (22)
Ridge Trail US Bidco, Inc.  Revolver  3/31/2031   729    (5)
Rimkus Consulting Group, Inc.  Revolver  4/1/2030   1,201    (6)
Rimkus Consulting Group, Inc.  Delayed Draw Term Loan  4/1/2026   2,011    (10)
Riser Interco LLC  Delayed Draw Term Loan  6/5/2026   1,752    (18)
Routeware, Inc.  Delayed Draw Term Loan  9/19/2026   1,477    (4)
Routeware, Inc.  Revolver  9/18/2031   341    (1)
Ruppert Landscape, LLC  Revolver  12/1/2028   320    (4)

 

71

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
Ruppert Landscape, LLC  Delayed Draw Term Loan  4/30/2026  $4,009   $(55)
Ryan, LLC  Revolver  11/14/2028   94     
Safety Borrower Holdings LLC  Revolver  9/1/2027   374    (2)
Sako and Partners Lower Holdings LLC.  Revolver  9/15/2028   418    (1)
Seahawk Bidco, LLC  Delayed Draw Term Loan  12/19/2026   1,818    (7)
Seahawk Bidco, LLC  Revolver  12/19/2030   545    (2)
Service Logic Acquisition, Inc.  Revolver  4/30/2027   100     
Simplicity Financial Marketing Group Holdings, Inc.  Delayed Draw Term Loan  12/31/2026   1,805    (9)
Simplicity Financial Marketing Group Holdings, Inc.  Revolver  12/31/2031   903    (5)
Southpaw Ap Buyer, LLC  Revolver  3/2/2028   252     
Southpaw Ap Buyer, LLC  Delayed Draw Term Loan  5/1/2026   189     
Spartan Bidco PTY LTD  Revolver  1/24/2028   385    (4)
Spirit RR Holdings, Inc.  Revolver  9/13/2028   272    (2)
Spirit RR Holdings, Inc.  Delayed Draw Term Loan  12/19/2025   235    (2)
St Athena Global LLC  Revolver  6/26/2029   448    (6)
St Athena Global LLC  Delayed Draw Term Loan  6/26/2026   164    (2)
STCH Acquisition Inc.  Revolver  10/30/2026   196    (1)
Storable, Inc.  Revolver  4/16/2026   75     
Sugar Ppc Buyer LLC  Delayed Draw Term Loan  7/10/2026   6,800    (34)
Surfaceprep Buyer, LLC  Delayed Draw Term Loan  2/2/2026   150    (2)
Surfaceprep Buyer, LLC  Revolver  2/4/2030   317    (4)
Team Acquisition Corporation  Revolver  11/21/2028   100    (4)
Tersera Therapeutics, LLC  Revolver  4/4/2029   116     
The Chartis Group, LLC  Delayed Draw Term Loan  9/17/2026   388    (2)
The Chartis Group, LLC  Revolver  9/17/2031   194    (1)
The GI Alliance Management, LLC  Delayed Draw Term Loan  3/7/2026   6,536     
The Hiller Companies, LLC  Revolver  6/20/2030   1,299    (3)
The Hiller Companies, LLC  Delayed Draw Term Loan  6/22/2026   1,538    (4)
The Ultimus Group Midco, LLC  Delayed Draw Term Loan  3/8/2026   1,302     
The Ultimus Group Midco, LLC  Revolver  3/7/2030   868     
THG Acquisition, LLC  Revolver  10/31/2031   306    (1)
THG Acquisition, LLC  Delayed Draw Term Loan  10/30/2026   660    (3)
TPC Engineering Holdings, Inc.  Revolver  2/16/2027   148    (2)
Trilon Group, LLC  Delayed Draw Term Loan  10/16/2025   3,168    (20)
Trilon Group, LLC  Revolver  5/25/2029   1,061    (7)
Trimech Acquisition Corp.  Revolver  3/10/2028   1,457    (15)
Trimech Acquisition Corp.  Delayed Draw Term Loan  8/15/2026   2,480    (25)
Truck-Lite Co., LLC  Delayed Draw Term Loan  2/13/2026   176     
Truck-Lite Co., LLC  Revolver  2/13/2030   176     

 

72

 

 

ANTARES PRIVATE CREDIT FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (Continued)

December 31, 2024

(in thousands)

 

Investments—non-controlled/non-affiliated  Commitment Type  Commitment
Expiration Date
  Unfunded
Commitment (1)
   Fair
Value (1)
 
Trunk Acquisition, Inc.  Delayed Draw Term Loan  12/20/2026  $1,845   $(9)
US Fitness Holdings, LLC  Delayed Draw Term Loan  9/4/2026   2,205    (10)
US Fitness Holdings, LLC  Revolver  9/4/2030   138    (1)
USRP Holdings, Inc.  Revolver  12/31/2029   900     
USRP Holdings, Inc.  Delayed Draw Term Loan  8/28/2026   2,773     
Vaco Holdings, LLC  Revolver  1/21/2027   100     
Valet Waste Holdings, Inc.  Delayed Draw Term Loan  9/8/2025   7,213     
Valicor PPC Intermediate II LLC  Revolver  1/24/2028   633    (1)
Vensure Employer Services, Inc.  Delayed Draw Term Loan  9/27/2026   476    (2)
Vertex Service Partners, LLC  Delayed Draw Term Loan  10/2/2026   245    (1)
Vessco Midco Holdings, LLC  Delayed Draw Term Loan  7/24/2026   1,220    (6)
Vessco Midco Holdings, LLC  Revolver  7/24/2031   552    (3)
Victors Purchaser, LLC  Delayed Draw Term Loan  8/15/2026   2,194    (5)
Victors Purchaser, LLC  Revolver  8/15/2031   1,065    (3)
Victory Buyer LLC  Revolver  11/19/2026   54    (1)
Vital Care Buyer, LLC  Revolver  7/30/2031   696    (3)
VPP Intermediate Holdings, LLC  Revolver  12/1/2027   228    (1)
VPP Intermediate Holdings, LLC  Delayed Draw Term Loan  2/7/2025   115     
VS Buyer, LLC  Revolver  4/12/2029   100     
W2O Holdings, Inc.  Revolver  6/12/2028   92     
Walter Surface Technologies Inc.  Delayed Draw Term Loan  12/30/2025   373     
Wealth Enhancement Group, LLC  Revolver  10/2/2028   323    (2)
Wealth Enhancement Group, LLC  Delayed Draw Term Loan  12/30/2026   9,677    (69)
Wildcat Topco, Inc.  Revolver  11/17/2031   270    (1)
Wildcat Topco, Inc.  Delayed Draw Term Loan  11/16/2026   270    (1)
WPP Bullet Buyer, LLC  Revolver  12/7/2029   18     
WRE Holding Corp.  Delayed Draw Term Loan  7/2/2026   415    (2)
WRE Holding Corp.  Revolver  7/2/2030   316    (2)
Wu Holdco, Inc.  Revolver  3/26/2027   238    (1)
Wu Holdco, Inc.  Delayed Draw Term Loan  7/12/2026   1,049    (5)
YA Intermediate Holdings II, LLC  Revolver  10/1/2031   1,030    (5)
YA Intermediate Holdings II, LLC  Delayed Draw Term Loan  10/2/2026   2,258    (11)
YLG Holdings, Inc.  Revolver  12/23/2030   1,214    (6)
YLG Holdings, Inc.  Delayed Draw Term Loan  12/23/2030   772    (4)
Zelis Cost Management Buyer, Inc.  Revolver  1/17/2029   100     
Zinc Buyer Corporation  Delayed Draw Term Loan  7/24/2026   1,613    (12)
Zinc Buyer Corporation  Revolver  7/24/2031   790    (6)
Zone Climate Services, Inc.  Revolver  3/9/2028   318    (6)
Zone Climate Services, Inc.  Delayed Draw Term Loan  11/22/2025   3,182    (38)
Total Unfunded Commitments        $290,998   $(1,327)

 

(1) Foreign domiciled investments have been converted to U.S. Dollars based on prevailing rates at period-end.

 

See accompanying notes to the consolidated financial statements.

 

73

 

 

ANTARES PRIVATE CREDIT FUND

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands, except share/per share data, percentages and as otherwise noted)

 

Note 1. Business and Organization

 

Antares Private Credit Fund (the “Company”) is a Delaware statutory trust formed on May 1, 2023 which commenced investment operations on November 5, 2024. The Company was organized to provide risk-adjusted returns and current income to shareholders by investing primarily in loans to borrowers in the United States and Canada. The Company’s investment strategy focuses primarily on private credit investments structured as portfolio loans to U.S. borrowers. A “portfolio loan” is a senior secured loan, which may be first lien, second lien or unitranche loans, consisting of term loans, related delayed draw term loans and/or revolving loans. Each tranche of a senior secured loan acquired by the Company is referred to as a portfolio loan. The Company is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, the Company has elected to be treated and intends to comply with the requirements to qualify annually, as a regulated investment company (“RIC”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company is externally managed by Antares Capital Credit Advisers LLC (the “Adviser”). The Adviser is a registered investment adviser with the U.S. Securities and Exchange Commission (the “SEC”).

 

The Company is a non-exchange traded, perpetual-life BDC, whose common shares of beneficial interest (“Common Shares”) are not listed for trading on a stock exchange or other securities market and is an investment vehicle with indefinite duration.

 

While the Company’s investment strategy primarily focuses on companies in the U.S., the Company intends to also invest in companies in Canada, Europe and other locations outside the U.S, subject to compliance with BDC requirements to invest at least 70% of assets in “eligible portfolio companies”. The Company may also invest in preferred equity or debt investments that may be accompanied by equity-related securities (such as options or warrants) and/or select common equity investments.

 

The Company’s investment strategy also includes a smaller allocation to more liquid credit investments such as broadly syndicated loans and corporate bonds, which may be used primarily to maintain liquidity for the Company’s share repurchase program and manage cash before investing subscription proceeds into originated loans, while also seeking attractive investment returns. The Company may also invest in publicly traded securities of larger corporate issuers on an opportunistic basis when market conditions create compelling potential return opportunities subject to compliance with BDC requirements.

 

The Company is currently offering on a continuous basis up to $2.0 billion of its Common Shares pursuant to an offering registered with the Securities and Exchange Commission (the “Offering”). The Company expects to offer to sell any combination of three classes of Common Shares, Class I shares, Class D shares, and Class S shares, with a dollar value up to the maximum offering amount. The share classes have different ongoing shareholder servicing and/or distribution fees. The initial purchase price for the Common Shares was $25.00 per share for Class I shares; no Class S or Class D shares have been issued as of September 30, 2025. Thereafter, the purchase price per share for each class of Common Shares will equal the net asset value (“NAV”) per share, as of the effective date of the monthly share purchase date. The Company may also engage in private offerings of its Common Shares.

 

The Company may enter into interest rate, foreign exchange, and/or other derivative arrangements to hedge against interest rate, currency, and/or other credit related risks through the use of futures, swaps, options and forward contracts. These hedging activities will be subject to the applicable legal and regulatory compliance requirements; however, there can be no assurance any hedging strategy employed will be successful. The Company may also seek to borrow capital in local currencies as a means of hedging non-U.S. dollar denominated investments.

 

Engaging in commodity interest transactions such as swap transactions or futures contracts for the Company may cause the Adviser to fall within the definition of “commodity pool operator” under the Commodity Exchange Act (the “CEA”) and related Commodity Futures Trading Commission (the “CFTC”) regulations. The Adviser has claimed an exclusion from the definition of the term “commodity pool operator” under the CEA and the CFTC regulations in connection with its management of the Company and, therefore, is not subject to CFTC registration or regulation under the CEA as a commodity pool operator with respect to its management of the Company.

 

The Company has formed wholly owned subsidiaries for the purpose of holding certain investments in portfolio companies. As of September 30, 2025, the Company’s wholly owned subsidiaries were formed as Delaware limited liability companies and include: APCF Funding SPV LLC, APCF Masterfund LLC and APCF Equity Holdings LLC (collectively, the “Subsidiaries”). The Company consolidates its wholly owned subsidiaries in these consolidated financial statements from the date of the commencement of operations of the Company.

 

74

 

 

Note 2. Significant Accounting Policies

 

Basis of Presentation

 

Interim consolidated financial statements and related financial information have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the requirements for reporting on Form 10-Q and Articles 6-10 of Regulation S-X. The Company is considered an Investment Company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”), and pursuant to Regulation S-X. The current period’s results of operations will not necessarily be indicative of results that ultimately be achieved for the year ended December 31, 2025. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the periods presented, have been included.

 

Consolidation

 

As provided under ASC 946, the Company will not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidated the accounts of the wholly owned subsidiaries in the consolidated financial statements. All intercompany balances have been eliminated.

 

Segment Reporting

 

In accordance with ASC Topic 280, Segment Reporting (“ASC 280”), the Company has determined that it has a single operating and reporting segment. As a result, the Company’s segment accounting policies are the same as described herein and the Company does not have any intra-segment sales and transfers of assets.

 

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future economic and market conditions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Although the Company’s estimates contemplate current conditions and how they expect them to change in the future, it is reasonably possible that actual results could differ from those estimates and such difference could be material.

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of demand deposits and are carried at cost, which approximates fair value. The Company deposits its cash and cash equivalents with financial institutions and, at times, may exceed the Federal Deposit Insurance Corporation insured limit. The Company has made a prospective presentation change to reclassify money market fund investments as short-term investments, resulting in their exclusion from cash and cash equivalents beginning in the reporting period ended June 30, 2025.

 

Organization and Offering Expenses

 

Organization costs include costs relating to the formation and organization of the Company, and are expensed as incurred. For the three and nine months ended September 30, 2025, the Company incurred $0 and $119 in organization costs, respectively. For the three and nine months ended September 30, 2024, the Company incurred $113 and $161 in organization costs, respectively. Unreimbursed organization costs are included in accrued expenses and other liabilities on the Consolidated Statements of Assets and Liabilities as of September 30, 2025 and December 31, 2024.

 

Costs associated with the Offering are capitalized and included as deferred offering costs on the Consolidated Statements of Assets and Liabilities and are amortized over a twelve-month period beginning on the commencement of operations date, from the date of incurrence. For the three and nine months ended September 30, 2025, the Company incurred $54 and $941 of offering costs and amortized $513 and $1,457, respectively. For the three and nine months ended September 30, 2024, the Company incurred $30 and $299 of offering costs, respectively, and did not amortize offering costs.

 

As of September 30, 2025 and December 31, 2024, $428 and $943, respectively, in deferred offering costs were included on the Consolidated Statements of Assets and Liabilities.

 

Investments

 

Investment transactions are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment values, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

 

Short-term investments

 

Short-term investments consist of highly liquid investments, such as money market funds, with original maturities of three months or less. This presentation change was adopted beginning in the reporting period ended June 30, 2025.

 

75

 

 

Valuation of Investments

 

The Company is required to report its investments for which current market values are not readily available at fair value. The Company values its investments in accordance with ASC Topic 820, Fair Value Measurement (“ASC 820”), which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date. ASC 820 prioritizes the use of observable market prices derived from such prices over entity-specific inputs. Due to the inherent uncertainties of valuation, certain estimated fair values may differ significantly from the values that would have been realized had a ready market for these investments existed, and these differences could be material.

 

Investments for which market quotations are readily available are typically valued using mid-market pricing (i.e., mid-point of average bid and ask prices). The Adviser obtains these market quotations from independent pricing services, if available; otherwise from at least two principal market makers or primary market dealers. To assess the continuing appropriateness of pricing sources and methodologies, the Adviser performs, from time to time, price verification procedures and issues challenges as necessary to independent pricing services or brokers, and any differences are reviewed in accordance with the valuation procedures. The Adviser does not adjust the prices unless it has a reason to believe market quotations are not reflective of the fair value of an investment.

 

Where prices or inputs are not available, or, in the judgment of the Adviser, not reliable, valuation approaches based on the facts and circumstances of the particular investment are utilized. Securities that are not publicly traded or for which market prices are not readily available, as the case for a substantial portion of the Company’s investments, are valued at fair value as determined in good faith by the Adviser as the Company’s valuation designee under Rule 2a-5 under the 1940 Act, pursuant to the Company’s valuation policy, and under the oversight of the Board of Trustees (the “Board”), based on, among other things, the input of the Company’s management and the audit committee. In addition, the Adviser has retained independent valuation firms to review valuations on a rotational basis. These valuation approaches involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments’ complexity.

 

With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, among other procedures, as described below:

 

·The valuation process begins with each investment being preliminarily reviewed by the Adviser’s valuation team in consultation with the Adviser’s investment professionals responsible for each portfolio investment;

 

·At least once annually the valuation for each investment (subject to a de minimis threshold) is reviewed by an independent valuation firm. The independent valuation firms provide a final range of values on such investments to the Adviser. The independent valuation firms also provide analyses to support their valuation methodology and calculations;

 

·The Adviser’s valuation committee with respect to the Company (the “Valuation Committee”) reviews each valuation recommendation to confirm they have been calculated in accordance with the valuation policy and confirms the independent valuation firms’ valuation ranges when utilized are reasonable;

 

·The Adviser’s Valuation Committee then determines fair value marks for each of the Company’s portfolio investments; and

 

·The Board and audit committee of the Company periodically review the valuation process and provide oversight in accordance with the requirements of Rule 2a-5 under the 1940 Act.

 

As part of the valuation process, the Company takes into account relevant factors in determining the fair value of the Company’s investments for which reliable market quotations are not readily available, many of which are loans, including and in combination, as relevant, any of: (i) the estimated enterprise value of a portfolio company, generally based on an analysis of discounted cash flows, publicly traded comparable companies and comparable transactions, (ii) the nature and realizable value of any collateral, (iii) the portfolio company’s ability to make payments based on its earnings and cash flow, (iv) the markets in which the portfolio company does business, and (v) overall changes in the interest rate environment and the credit markets that may affect the price at which similar investments may be made in the future. When an external event such as a purchase transaction, public offering or subsequent equity or debt sale occurs, the Adviser considers whether the pricing indicated by the external event corroborates its valuation.

 

The Company’s accounting policy on the fair value of the investments is critical because the determination of fair value involves subjective judgments and estimates. Accordingly, the Company’s consolidated financial statements express the uncertainty with respect to the possible effect of these valuations, and any change in these valuations, on the consolidated financial statements.

 

76

 

 

Revenue Recognition

 

The Company generates revenue in the form of interest and fee income on debt investments, capital gains, and dividend income from equity investments in portfolio companies. The senior and subordinated debt investments bear interest at a fixed or floating rate, and is generally payable quarterly or semiannually. In some cases, some of the Company's investments provide for deferred interest payments or payment-in-kind (“PIK”) interest. The principal amount of the debt investments and any accrued but unpaid PIK interest generally become due at the maturity date. Original issue discounts and market discounts or premiums are capitalized, and the Company accretes or amortizes such amounts as interest income. In addition, the Company generates revenue from various fees in the ordinary course of business such as in the form of structuring, consent, waiver, amendment, syndication and other miscellaneous fees.

 

Interest Income

 

Interest income is recorded on an accrual basis and includes the accretion of discounts and amortization of premiums. Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the debt investments using the effective interest method. The amortized cost of debt investments represents the original cost, including loan origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any. Upon prepayment of a loan or debt investment, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income, in the current period.

 

Dividend Income

 

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.

 

PIK Income

 

The Company may have loans in its portfolio that contain PIK provisions. PIK represents interest that is accrued and recorded at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. Such income is included in payment-in-kind interest income on the Consolidated Statements of Operations. If at any point the Company believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through payment-in-kind interest income. To maintain the Company’s status as a RIC, this non-cash source of income must be paid out to shareholders in the form of distributions, even though the Company has not yet collected cash.

 

Fee Income

 

The Company may receive various fees in the ordinary course of business such as structuring, consent, waiver, amendment, syndication fees as well as fees for managerial assistance rendered by the Company to the portfolio companies. Such fees are recognized as income when earned or the services are rendered.

 

Non-Accrual Income

 

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. Accrued interest is generally reversed when a loan is placed on non-accrual status. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid current and, in management’s judgment, are likely to remain current. Management may make exceptions to this treatment and determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

 

Deferred Financing Costs

 

Deferred financing costs represent fees and other direct incremental costs incurred in connection with the Company’s borrowings. These expenses are deferred and amortized into interest expense over the life of the related debt instrument using the straight-line method. Deferred financing costs related to the Company’s borrowings are presented as an offset against the debt outstanding on the Consolidated Statements of Assets and Liabilities.

 

Foreign Currency Translations

 

The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the foreign exchange rate on the date of valuation. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.

 

77

 

 

Income Taxes

 

The Company has elected to be treated, and intends to qualify each taxable year thereafter, as a RIC under the Code. So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company’s shareholders and would not be reflected in the consolidated financial statements of the Company.

 

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more- likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.

 

To maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to maintain qualification for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of the sum of (i) its “investment company taxable income” for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) its net tax-exempt income.

 

In addition, pursuant to the excise tax distribution requirements, the Company will be subject to a 4% non-deductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (1) 98% of its ordinary income for the calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed.

 

Distributions

 

To the extent that the Company has taxable income available, the Company intends to make monthly distributions to its shareholders. Distributions to shareholders are recorded on the record date. All distributions will be paid at the discretion of the Board and will depend on the Company’s earnings, financial condition, maintenance of the Company’s tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.

 

Distributions to shareholders by the Company of ordinary income (including “market discount” realized by the Company on the sale of debt securities), and of net short-term capital gains, if any, realized by the Company are generally taxable to U.S. shareholders as ordinary income to the extent such distributions are paid out of the Company’s current or accumulated earnings and profits. Distributions, if any, of net capital gains properly reported as “capital gain dividends” will be taxable as long-term capital gains, regardless of the length of time the shareholder has owned the Company’s shares. A distribution of an amount in excess of the Company’s current and accumulated earnings and profits (as determined for U.S. federal income tax purposes) will be treated by a shareholder as a return of capital which will be applied against and reduce the shareholder’s basis in his or her shares. To the extent that the amount of any such distribution exceeds the shareholder’s basis in his or her shares, the excess will be treated by the shareholder as gain from a sale or exchange of the shares. Distributions paid by the Company generally will not be eligible for the dividends received deduction allowed to corporations or for the reduced rates applicable to certain qualified dividend income received by non-corporate shareholders.

 

Distributions will be treated in the manner described above regardless of whether such distributions are paid in cash or invested in additional shares pursuant to the distribution reinvestment plan. Shareholders receiving distributions in the form of additional shares will generally be treated as receiving a distribution in the amount of the fair market value of the distributed shares. The additional shares received by a shareholder pursuant to the distribution reinvestment plan will have a new holding period commencing on the day following the day on which the shares were credited to the shareholder’s account.

 

The Company may elect to retain its net capital gain or a portion thereof for investment and be taxed at corporate rates on the amount retained. In such case, it may designate the retained amount as undistributed capital gains in a notice to its shareholders, who will be treated as if each received a distribution of its pro rata share of such gain, with the result that each shareholder will (i) be required to report its pro rata share of such gain on its tax return as long-term capital gain, (ii) receive a refundable tax credit for its pro rata share of tax paid by the Company on the gain and (iii) increase the tax basis for its shares by an amount equal to the deemed distribution less the tax credit.

 

78

 

 

Recent Accounting Pronouncements

 

The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by the Financial Accounting Standards Board (the “FASB”).

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 2200-40),” which requires disaggregated disclosure of certain costs and expenses, including purchases of inventory, employee compensation, depreciation, amortization and depletion, in each relevant expense caption. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption and retrospective application is permitted. The Company is currently assessing the impact of this guidance, however, the Company does not expect a material impact on its consolidated financial statements.

 

Other than the aforementioned guidance, the Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying consolidated financial statements.

 

79

 

 

Note 3. Agreements and Related Party Transactions

 

Investment Advisory Agreement

 

On October 16, 2024, the Board approved an investment advisory agreement with the Adviser (“Investment Advisory Agreement”), pursuant to which the Adviser manages the Company on a day-to-day basis. Under the terms of the Investment Advisory Agreement, the Adviser is responsible for determining the composition of the Company’s portfolio, identifying investment opportunities and making investment decisions, monitoring investments, performing due diligence on prospective portfolio companies, and negotiating, obtaining and managing financing facilities and other forms of leverage.

 

The Company pays the Adviser fees for its services under the Investment Advisory Agreement. The fees consist of two components: a management fee and an incentive fee. The cost of both the management fee and the incentive fee are ultimately borne by the Company’s shareholders.

 

The Adviser agreed to waive all management and incentive fees through the first six months following the effective date of the Company’s registration statement on Form N-2, which was declared effective on February 12, 2025. As of August 13, 2025, coinciding with the end of the fee waiver period, the Company is responsible for the payment of management and incentive fees to the Adviser, pursuant to the terms of the Investment Advisory Agreement.

 

Management fees

 

The base management fee is payable monthly in arrears at an annual rate of 1.25% of the Company’s net asset value as of the first business day of the applicable month. For the three and nine months ended September 30, 2025, the Company incurred management fees of $2,180 and $6,184, respectively, before impact of waived fees. For the three and nine months ended September 30, 2025, the Adviser elected to waive $1,005 and $5,009, respectively, resulting in $1,175 in management fees net of waiver for both periods. For both the three and nine months ended September 30, 2024, no management fees were accrued as the Company had not yet commenced operations.

 

Incentive fee

 

The incentive fee consists of two components that are independent of each other, with the result that one component may be payable even if the other is not. A portion of the incentive fee is based on a percentage of income and a portion is based on a percentage of capital gains, each described below.

 

Investment income incentive fee

 

The investment income based incentive fee is based on “Pre-Incentive Fee Net Investment Income Returns” meaning dividends, cash interest or other distributions or other cash income and any third-party fees received from portfolio companies (such as upfront fees, commitment fees, origination fees, amendment fees, ticking fees and break-up fees, as well as prepayments premiums, but excluding fees for providing managerial assistance and fees earned by the Adviser or an affiliate in its capacity as an administrative agent, syndication agent, collateral agent, loan servicer or other similar capacity) accrued during the month, minus operating expenses for the month (including the management fee, taxes, any expenses payable under the Investment Advisory Agreement and Administration Agreement (as defined below), any expense of securitizations, and interest expense or other financing fees and any dividends paid on preferred shares, but excluding the incentive fee and shareholder servicing and /or distribution fees). Pre-Incentive Fee Net Investment Income Returns includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero-coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments are also excluded from Pre-Incentive Fee Net Investment Income Returns.

 

Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of net assets at the end of the preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6.0% annualized). The Company pays an incentive fee quarterly as follows:

 

·No investment income incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which the Pre-Incentive Fee Net Investment Income Returns does not exceed the hurdle rate of 1.50% per quarter (6.0% annualized).

 

·100% of the dollar amount of the Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.71% (6.86% annualized).

 

·12.5% of the dollar amount of the Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.71% (6.86% annualized).

 

80

 

 

Capital gains incentive fee

 

The second component of the incentive fee, the capital gains incentive fee, is payable at the end of each calendar year in arrears. The amount payable is equal to 12.5% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fee as calculated in accordance with U.S. GAAP. U.S. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee actually payable under the investment advisory agreement. Such accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation, net of any expense associated with cumulative unrealized capital depreciation or appreciation. If such amount is positive at the end of a period, then U.S. GAAP requires the Company to record a capital gains incentive fee equal to 12.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees paid or capital gains incentive fees accrued under U.S. GAAP in all prior periods. Gross capital gains incentive fee is net of reversal on accrued capital gains incentive fees.

 

For purposes of computing the Company’s investment income incentive fee and capital gains incentive fee, the calculation methodology looks through derivative financial instruments or swaps as if the Company owned the reference assets directly. The fees that are payable under the Investment Advisory Agreement for any partial period are appropriately prorated.

 

For the three and nine months ended September 30, 2025, the Company incurred income based incentive fees of $2,366 and $7,034, respectively, and did not incur capital gains incentive fees during the period. For the three and nine months ended September 30, 2025, the Adviser agreed to waive $1,143 and $5,811 in total incentive fees, respectively, resulting in $1,223 incentive fees payable for both periods. For both the three and nine months ended September 30, 2024, no incentive fees were accrued as the Company had not yet commenced operations.

 

Licensing Agreement

 

As part of the Investment Advisory Agreement, the Adviser, on behalf of Antares Holdings LLC, agreed to grant the Company a fully paid- up, royalty-free, non-exclusive, non-transferable license to use “Antares” for specified purposes in the Company’s business, during the term of the Investment Advisory Agreement. Other than with respect to this limited license, the Company will have no legal right to the “Antares” name.

 

Administration Agreement

 

On October 16, 2024, the Board approved the administration agreement (the “Administration Agreement”) with Antares Capital Credit Advisers LLC (in such role, the “Administrator”). Under the terms of the Administration Agreement, the Administrator provides, or oversees the performance of, administrative and compliance services, including, but not limited to, maintaining financial records, overseeing the calculation of net asset value, compliance monitoring (including diligence and oversight of the Company’s other service providers), preparing reports to shareholders and reports filed with the SEC, preparing materials and coordinating meetings of the Company’s Board, managing the payment of expenses and the performance of administrative and professional services rendered by others and providing office space, equipment and office services.

 

The Company reimburses the Administrator for its costs, expenses and allocable portion of overhead (including compensation of personnel performing administrative duties) in connection with the services performed for the Company pursuant to the terms of the Administration Agreement. For the three and nine months ended September 30, 2025, the Company incurred administrative service fees of $190 and $522, respectively. For both the three and nine months ended September 30, 2024, no administrative service fees were accrued as the Company had not yet commenced operations.

 

Sub-administration Agreement

 

In addition, pursuant to the terms of the Administration Agreement, the Administrator may delegate its obligations under the Administration Agreement to an affiliate or to a third party and the Company reimburses the Administrator for any services performed for the Company by such affiliate or third party.

 

The Administrator hired U.S. Bancorp Fund Services, LLC to assist with sub-administration and fund accounting services.

 

Acquisition of Seed Portfolio

 

On November 5, 2024, the Company acquired 100% of the equity interests in APCF Masterfund LLC and APCF Funding SPV LLC (the “Subsidiaries”) from certain affiliates of the Adviser, valued at an acquisition price of $33,889 and $341,218, respectively.

 

For the nine months ended September 30, 2025, the Company paid the Adviser $2,409 in connection with the acquisition price of APCF Masterfund LLC, and received $2,195 from the Adviser in connection with the acquisition price of APCF Funding SPV LLC.

 

For the three months ended September 30, 2025, there were no outstanding balances nor payments made in connection with the acquisition of APCF Masterfund LLC and APCF Funding SPV LLC.

 

81

 

 

Distribution and Servicing Plan

 

On October 16, 2024, the Board approved a distribution and servicing plan (the “Distribution and Servicing Plan”). The following table shows the shareholder servicing and/or distribution fees the Company pays Quasar Distributors LLC (the “Managing Dealer”) with respect to the Class I, Class S and Class D on an annualized basis as a percentage of NAV for such class. The Managing Dealer is a broker-dealer registered with the SEC and is a member of the Financial Industry Regulatory Authority ("FINRA").

 

   Shareholder
Servicing and/or
Distribution Fee as a % of NAV
 
Class I shares   N/A 
Class S shares   0.85%
Class D shares   0.25%

 

The shareholder servicing and/or distribution fees are paid monthly in arrears, calculated using the NAV of the applicable class as of the beginning of the first calendar day of the month and subject to FINRA and other limitations on underwriting compensation. As of September 30, 2025, no Class S shares or Class D shares have been issued.

 

Expense Support Agreement

 

On October 16, 2024, the Board approved an Expense Support and Conditional Reimbursement Agreement (the “Expense Support Agreement”) with the Adviser. Pursuant to the Expense Support Agreement, the Adviser is obligated to advance all of the Company’s Other Operating Expenses (defined below) (each, a “Required Expense Payment”) to the extent that such expenses do not exceed 1.00% (on an annualized basis) of the Company’s NAV. Any Required Expense Payment must be paid by the Adviser to the Company in any combination of cash or other immediately available funds and/or offset against amounts due from the Company to the Adviser or its affiliates. The Adviser may elect to pay certain additional expenses on the Company’s behalf (each, a “Voluntary Expense Payment” and together with a Required Expense Payment, the “Expense Payments”), provided that no portion of the payment will be used to pay any interest expense of the Company. Any Voluntary Expense Payment that the Adviser has committed to pay must be paid by the Adviser to the Company in any combination of cash or other immediately available funds no later than forty-five (45) days after such commitment was made in writing, and/or offset against amounts due from the Company to the Adviser or its affiliates. “Other Operating Expenses” means the Company’s total organization and offering expenses, professional fees, trustee fees, administration fees, and other general and administrative expenses (including the Company’s allocable portion of compensation (including salaries, bonuses and benefits), overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement), excluding the Management Fee and Incentive Fee owed to the Adviser, financing fees and costs, brokerage commissions, placement agent fees, costs and expenses of distributing and placing the Common Shares, extraordinary expenses and any interest expenses owed by the Company, all as determined in accordance with GAAP.

 

Following any calendar month in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Company’s shareholders based on distributions declared with respect to record dates occurring in such calendar month (the amount of such excess being hereinafter referred to as “Excess Operating Funds”), the Company shall pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Expense Payments made by the Adviser to the Company within three years prior to the last business day of such calendar month have been reimbursed. Any payments required to be made by the Company shall be referred to herein as a “Reimbursement Payment.” “Available Operating Funds” means the sum of (i) the Company's net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) the Company's net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above).

 

82

 

 

No Reimbursement Payment for any month shall be made if: (1) the Effective Rate of Distributions Per Share declared by the Company at the time of such Reimbursement Payment is less than the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, (2) the Company’s Operating Expense Ratio at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relate, or (3) the Company’s Other Operating Expenses at the time of such Reimbursement Payment exceeds 1.00% of the Company’s net asset value. “Effective Rate of Distributions Per Share” means the annualized rate (based on a 365 day year) of regular cash distributions per share exclusive of returns of capital, distribution rate reductions due to distribution and shareholder servicing fees, and declared special dividends or special distributions, if any. The “Operating Expense Ratio” is calculated by dividing Operating Expenses, less organizational and offering expenses, base management and incentive fees owed to the Adviser, shareholder servicing and/or distribution fees, and interest expense, by the Company’s net assets. “Operating Expenses” means all of the Company’s operating costs and expenses incurred, as determined in accordance with generally accepted accounting principles for investment companies.

 

The Company’s obligation to make a Reimbursement Payment shall automatically become a liability of the Company on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month. In addition, effective October 31, 2024, the Company and the Adviser entered into a waiver letter agreement (the “Waiver Letter Agreement”), pursuant to which the Adviser agreed to waive any reimbursement by the Company for any of the Company’s organization expenses, operating expenses and offering expenses the Adviser incurs or has incurred on the Company’s behalf in an aggregate amount not to exceed $2 million. The Waiver Letter Agreement includes reimbursement provisions substantially similar to the reimbursement provisions included in the Expense Support Agreement.

 

For the three and nine months ended September 30, 2025, the Company accrued organization and offering costs of $512 and $1,575, and the Adviser waived $35 and $683 in expenses pursuant to the Expense Support Agreement, resulting in $477 and $892 organization and offering costs incurred by the Company on a net basis, respectively.

 

For the three and nine months ended September 30, 2024, the Company accrued organization and offering costs of $113 and $161, and the Adviser waived $113 and $161 in expenses pursuant to the Expense Support Agreement, resulting in $0 and $0 organization and offering costs on a net basis, respectively.

 

For the three and nine months ended September 30, 2025 and 2024, no Reimbursement Payments were made by the Company to the Adviser.

 

Co-Investment Activity

 

The Company, the Adviser and certain of its affiliates received an exemptive order from the SEC on April 2, 2024 (the “Current Order”) that permits, among other things, the Company to co-invest with certain other persons, including certain affiliates of the Adviser and certain funds managed and controlled by the Adviser and its affiliates, subject to certain terms and conditions. Certain types of negotiated co-investments may be made only in accordance with the Current Order from the SEC permitting the Company to do so. Under the terms of the Current Order, a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Company’s independent trustees must be able to reach certain conclusions in connection with a co-investment transaction, including that (1) the terms of the proposed transaction are reasonable and fair to the Company and its shareholders and do not involve overreaching of the Company or its shareholders on the part of any person concerned, and (2) the transaction is consistent with the interests of the Company’s shareholders and is consistent with the Company’s Board of Trustees’ approved criteria. In certain situations where co-investment with one or more funds managed by the Adviser or its affiliates is not covered by the Current Order, the personnel of the Adviser or its affiliates will need to decide which fund will proceed with the investment. Such personnel will make these determinations based on allocation policies and procedures, which are designed to reasonably ensure that investment opportunities are allocated fairly and equitably among affiliated funds over time and in a manner that is consistent with applicable laws, rules and regulations. The Current Order is subject to certain terms and conditions so there can be no assurance that the Company will be permitted to co-invest with certain of the Company’s affiliates other than in the circumstances currently permitted by regulatory guidance and the Current Order. The Company and the Adviser have filed an application seeking, but have not yet received, a new SEC exemptive order for simplified co-investment relief (the “New Order”) that would supersede the Current Order. There is no assurance that the New Order will be granted by the SEC. In the event that the SEC grants us the New Order, we shall be required to comply with all terms and conditions required therein.

 

83

 

 

Note 4. Investments

 

The composition of the Company’s investment portfolio at amortized cost and fair value was as follows:

 

   September 30, 2025   December 31, 2024 
   Amortized
Cost
   Fair Value   % of Total
Investments
at Fair Value
   Amortized
Cost
   Fair Value   % of Total
Investments
at Fair Value
 
Secured Debt  $1,377,503   $1,374,990    96.64%  $845,082   $843,710    99.45%
Unsecured Debt   793    783    0.06    713    703    0.08 
Equity Investments   17,534    17,985    1.26    3,947    3,947    0.47 
Short-Term Investments (1)   29,010    29,010    2.04             
Total Investments at fair value  $1,424,840   $1,422,768    100.00%  $849,742   $848,360    100.00%

 

(1)Beginning in the reporting period ended June 30, 2025, the Company has made a prospective presentation change to reclassify money market fund investments as short-term investments. As of December 31, 2024, the amortized cost and fair value of money market investments held by the Company was $39,527.

 

As of September 30, 2025 and December 31, 2024, there were no portfolio companies with loans on non-accrual status.

 

84

 

 

The industry composition of the Company's non-controlled, non-affiliated investments (at fair value) was as follows:

 

   September 30, 2025    December 31, 2024  
Aerospace and Defense   0.61 %   0.43 %
Air Freight and Logistics   0.79     0.66  
Automobile Components   1.37     2.26  
Beverages   0.07       
Building Products   0.24     0.31  
Capital Markets   1.94     2.99  
Chemicals   3.91     2.23  
Commercial Services and Supplies   8.01     9.76  
Construction & Engineering   1.20     0.84  
Construction Materials   0.83     0.84  
Containers and Packaging   4.62     3.17  
Distributors   1.99     2.44  
Diversified Consumer Services   6.55     8.78  
Diversified Telecommunication Services   0.57     0.50  
Electrical Equipment   1.16     1.53  
Electronic Equipment, Instruments and Components   0.81     1.33  
Energy Equipment and Services   0.99     1.35  
Financial Services   6.66     4.39  
Food Products   1.39     0.91  
Gas Utilities   0.83       
Ground Transportation   0.01     0.02  
Health Care Technology   5.98     4.44  
Healthcare Equipment and Supplies   0.54     0.56  
Healthcare Providers and Services   7.41     5.54  
Hotels, Restaurants and Leisure   0.64     1.04  
Household Durables   0.01     0.02  
Household Products   0.75     0.33  
Industrial Conglomerates   1.10     0.96  
Insurance   6.21     7.32  
IT Services   3.25     4.23  
Life Sciences Tools & Services   0.67     0.94  
Machinery   1.32     0.99  
Media   0.50     2.18  
Oil, Gas and Consumable Fuels   0.63     1.30  
Personal Care Products   0.03     0.05  
Pharmaceuticals   2.14     1.77  
Professional Services   7.23     9.40  
Real Estate Management and Development   0.72     0.77  
Software   12.53     11.14  
Specialty Retail   0.49     0.02  
Technology Hardware, Storage and Peripherals   0.72     1.15  
Textiles, Apparel and Luxury Goods   0.65     0.25  
Trading Companies and Distributors   0.35     0.30  
Transportation Infrastructure   0.84     0.25  
Wireless Telecommunication Services   0.74     0.31  
    100.00 %   100.00 %

 

85

 

 

The geographic composition of the Company's non-controlled, non-affiliated investments (at amortized cost and fair value) was as follows:

 

   September 30, 2025 
   Amortized
Cost
   Fair Value   % of Total
Investments
at Fair Value
   Fair Value
as % of
Net Assets
 
United States  $1,363,804   $1,361,612    97.69%   193.63%
Canada   32,026    32,146    2.31    4.57 
Total  $1,395,830   $1,393,758    100.00%   198.20%

 

   December 31, 2024 
   Amortized
Cost
   Fair Value   % of Total
Investments
at Fair Value
   Fair Value
as % of
Net Assets
 
United States  $824,707   $823,915    97.12%   129.25%
Canada   17,851    17,375    2.05    2.73 
United Kingdom   7,184    7,070    0.83    1.11 
Total  $849,742   $848,360    100.00%   133.09%

 

86

 

 

Note 5. Fair Value Measurements

 

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date.

 

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the overall fair value measurement. The Adviser’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

 

In addition to using the above inputs in investment valuations, the Adviser applies the valuation policy approved by its Board that is consistent with ASC 820. Consistent with the valuation policy, the Adviser evaluates the source of the inputs, including any markets in which its investments are trading (or any markets in which securities with similar attributes are trading), in determining fair value.

 

Investments whose values are based on the listed closing price quoted on the securities’ principal exchange are classified within Level 1 and include active listed equities. The Adviser does not adjust the quoted price for such instruments, even in situations where the Company holds a large position and a sale could reasonably impact the quoted price.

 

ASC 820 specifies a fair value hierarchy that prioritizes and ranks the level of observability of inputs used in determination of fair value. In accordance with ASC 820, these levels are summarized below:

 

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Adviser has the ability to access at the measurement date.

 

Level 2 – inputs other than quoted prices included in Level 1 that are observable for the assets or liabilities, either directly or indirectly. Level 2 inputs include: quoted market prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

The following tables present the fair value hierarchy of financial instruments according to the fair value hierarchy as described in Note 2. Significant Accounting Policies of these consolidated financial statements:

 

   September 30, 2025 
   Level 1   Level 2   Level 3   Total 
Secured Debt  $   $207,241   $1,167,749   $1,374,990 
Unsecured Debt           783    783 
Equity Investments           17,985    17,985 
Total non-controlled/non-affiliated investments       207,241    1,186,517    1,393,758 
Short-Term Investments   29,010            29,010 
Total Investments at fair value  $29,010   $207,241   $1,186,517   $1,422,768 

 

   December 31, 2024 
   Level 1   Level 2   Level 3   Total 
Secured Debt  $   $45,651   $798,059   $843,710 
Unsecured Debt           703    703 
Equity Investments           3,947    3,947 
Total Investments before Cash Equivalents       45,651    802,709    848,360 
Money Market Fund   39,527            39,527 
Total Investments including Cash Equivalents  $39,527   $45,651   $802,709   $887,887 

 

87

 

 

The following tables present changes in the fair value of financial instruments for which Level 3 inputs were used to determine fair value for the three and nine months ended September 30, 2025:

 

   Three Months Ended September 30, 2025 
   Secured Debt   Unsecured
Debt
   Equity
Investments
   Total
Investments
 
Fair value, beginning of period  $1,055,288   $         755   $14,763   $1,070,806 
Purchase of investments (including received in-kind)   149,678    28    2,893    152,599 
Proceeds from sale of investments and principal repayments   (48,431)           (48,431)
Net accretion of discount and amortization of premium   477            477 
Net realized gains (losses) on investments   6            6 
Net change in unrealized appreciation (depreciation) on investments   109        329    438 
Transfers out of Level 3   (5,999)           (5,999)
Transfers to Level 3   16,621            16,621 
Fair value, end of period  $1,167,749   $783   $17,985   $1,186,517 
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held at September 30, 2025  $239   $   $329   $568 

 

   Nine Months Ended September 30, 2025 
   Secured Debt   Unsecured
Debt
   Equity
Investments
   Total
Investments
 
Fair value, beginning of period  $798,059   $         703   $3,947   $802,709 
Purchase of investments (including received in-kind)   514,555    79    13,587    528,221 
Proceeds from sale of investments and principal repayments   (129,193)           (129,193)
Net accretion of discount and amortization of premium   1,387    1        1,388 
Net realized gains (losses) on investments   22            22 
Net change in unrealized appreciation (depreciation) on investments   1,240        451    1,691 
Transfers out of Level 3   (18,321)           (18,321)
Transfers to Level 3                
Fair value, end of period  $1,167,749   $783   $17,985   $1,186,517 
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held at September 30, 2025  $1,027   $   $452   $1,479 

 

Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2025, transfers to (out of) Level 3 were a result of changes in the observability of significant inputs for certain portfolio companies.

 

88

 

 

The following tables present quantitative information about the significant unobservable inputs of the Company’s Level 3 financial instruments. The tables are not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Company’s determination of fair value.

 

   September 30, 2025 
             Range     
   Fair Value (1)   Valuation Technique  Unobservable Input  Low   High  

Weighted
Average (2)

 
Secured Debt  $889,130   Market yield analysis  Market yield discount rates   6.65%   21.38%   8.61%
    16,750   Market Quotation  Quote   89.42    100.33    98.56 
    261,869   Recent transaction  Transaction price   95.00    100.00    99.66 
Total Secured Debt   1,167,749                      
                           
Unsecured Debt   783   Market yield analysis  Market yield discount rates   15.38%   16.06%   15.72%
                           
Equity Investments   10,032   Comparable company analysis  EBITDA multiples   9.0x   23.8x   15.5x
    2,581   Recent Transaction  Transaction Price   100.00%   100.00%   100.00%
    5,372   Market yield analysis  Market yield discount rates   8.19%   15.04%   14.35%
Total Equity Investments   17,985                      
Total  $1,186,517                      

 

   December 31, 2024 
             Range     
   Fair Value (1)   Valuation Technique  Unobservable Input  Low   High   Weighted
Average (2)
 
Secured Debt  $600,570   Market yield analysis  Market yield discount rates   6.35%   13.32%   9.27%
    32,556   Market quotation  Quote   95.30    100.94    100.13 
    164,933   Recent transaction  Transaction price   91.70    100.00    99.44 
Total Secured Debt   798,059                      
                           
Unsecured Debt   703   Market yield analysis  Market yield discount rates   15.38%   16.06%   15.72%
                           
Equity Investments   3,947   Recent Transaction  Transaction Price   100.00%   100.00%   100.00%
Total  $802,709                      

 

(1)As of September 30, 2025, included within the fair value of Level 3 assets of $1,186,517 is an amount of $281,200 for which the Adviser did not develop the unobservable inputs (examples include broker quotes and transaction prices). As of December 31, 2024, included within the fair value of Level 3 assets of $802,709 is an amount of $201,436 for which the Adviser did not develop the unobservable inputs (examples include broker quotes and transaction prices).

 

(2)Weighted averages are calculated based on fair value of investments.

 

The significant unobservable input used in the yield analysis is the discount rate based on comparable market yields. The significant unobservable inputs used in the income approach are the discount rate used to discount the estimated future cash flows expected to be received from the underlying investment. The Company uses market discount rates for debt securities to determine if the effective yield on a debt security is commensurate with the market yields for that type of debt security. If a debt security’s effective yield is significantly less than the market yield for a similar debt security with a similar credit profile, the resulting fair value of the debt security may be lower. Significant increases in the discount rate would significantly lower the fair value of an investment; conversely significant decreases in the discount rate would significantly increase the fair value of an investment. The significant unobservable inputs used in the market approach are based on market comparable transactions and market multiples of publicly traded comparable companies. Increases or decreases in market comparable transactions or market multiples would result in an increase or decrease in the fair value.

 

89

 

 

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of the Company’s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned. As of September 30, 2025 and December 31, 2024, the carrying amounts of the Company’s assets and liabilities, other than investments at fair value, approximate fair value due to their short maturities. Fair value is estimated by discounting remaining payments using applicable current market rates, which take into account changes in the Company’s marketplace credit ratings, if applicable, or market quotes, if available.

 

90

 

 

Note 6. Borrowings

 

In accordance with the 1940 Act, with certain limitations, the Company is allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is at least 150% after such borrowing. As of September 30, 2025 and December 31, 2024, the Company’s asset coverage was 197.65% and 678.49%, respectively.

 

Debt outstanding

 

The Company’s outstanding debt obligations were as follows:

 

   September 30, 2025 
   Aggregate
Principal
Committed
   Outstanding
Principal
   Carrying
Value (1)
   Unused
Portion (2)
   Amount Available (3) 
Morgan Stanley Facility  $1,000,000   $720,127   $720,127   $279,873   $74,552 
Total  $1,000,000   $720,127   $720,127   $279,873   $74,552 

 

   December 31, 2024 
   Aggregate
Principal
Committed
   Outstanding
Principal
   Carrying
Value (1)
   Unused
Portion (2)
   Amount Available (3) 
Morgan Stanley Facility  $500,000   $110,194   $110,194   $389,806   $359,804 
Total  $500,000   $110,194   $110,194   $389,806   $359,804 

 

(1)The carrying value of the Company’s debt obligations is used as an approximate to fair value. The fair value of these debt obligations would be categorized as Level 3 under the ASC 820 fair value level hierarchy as of September 30, 2025 and December 31, 2024. Carrying values do not include impact of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees, if any, are based.

(3)The amount available reflects any limitations related to the respective facility’s borrowing base.

 

Morgan Stanley Facility

 

On November 6, 2024, APCF Funding SPV LLC, a wholly-owned subsidiary of the Company, as borrower, and the Company, as equity holder and servicer, entered into a loan facility (the “Morgan Stanley Facility”) for revolving and term loans pursuant to a Loan and Servicing Agreement (the “Agreement”), with the lenders from time to time party thereto, Morgan Stanley Senior Funding, Inc., as administrative agent (the “Administrative Agent”), U.S. Bank Trust Company, National Association, as collateral agent (“Collateral Agent”), and U.S. Bank National Association, as account bank and collateral custodian. Capitalized terms used herein but not otherwise defined herein shall have the meanings assigned to such terms in the Agreement.

 

Loans under the Morgan Stanley Facility initially bear interest at (i) a per annum rate equal to Term SOFR plus an additional margin calculated as a percentage of the aggregate principal balance of the underlying collateral obligations (the “Applicable Margin”) for loans denominated in U.S. Dollars, (ii) EURIBOR plus the Applicable Margin for loans denominated in Euros, (iii) Daily Compounded CORRA plus the Applicable Margin for loans denominated in Canadian Dollars, and (iv) Daily Simple SONIA plus the Applicable Margin for loans denominated in Great British Pounds, (v) BBSW plus the Applicable Margin for loans denominated in Australian Dollars and (vi) TONA plus the Applicable Margin for loans denominated in Japanese Yen. The Applicable Margin equals the product of (i) 1.65% and (ii) the lesser of: (x) aggregate principal balance of all broadly-syndicated loans divided by the aggregate principal balance of all eligible loans and (y) 35% (“Percentage”) plus the product of (i) 1.90% and (ii) 100% minus Percentage, subject to a step-up of 2.00% following the occurrence of an Event of Default or after the automatic occurrence or declaration of the Facility Maturity Date.

 

The initial maximum principal amount under the Agreement is $500 million and the Agreement includes an accordion provision to permit increases to the total facility amount up to a maximum of $1 billion, subject in each case to the satisfaction of certain conditions and the consent of the Administrative Agent and each Lender whose commitment is being increased. Proceeds from loans made under the Morgan Stanley Facility may be used to fund collateral obligations acquired by APCF Funding SPV LLC, to pay certain fees and expenses and to make distributions to the Company, subject to certain conditions set forth in the Agreement. Revolving loans borrowed under the Morgan Stanley Facility may be repaid and reborrowed until the end of the Revolving Period, which can occur no later than November 6, 2027 (unless extended), and all amounts outstanding under the Morgan Stanley Facility must be repaid by November 6, 2029. The Agreement includes customary affirmative and negative covenants, including certain limitations on the incurrence of additional indebtedness and liens, as well as usual and customary events of default for loan facilities of this nature.

 

On March 18, 2025, the Company entered into the First Amendment to Loan and Servicing Agreement (the “Amendment”), among the parties listed above. The Amendment provides for, among other things, an increase in the aggregate commitments of the lenders under the Morgan Stanley Facility from $500 million to $1 billion, as well as certain changes to the concentration limits.

 

As of September 30, 2025 and December 31, 2024, the Company was in compliance with all covenants associated with the Morgan Stanley Facility.

 

91

 

 

Foreign Currency Transactions and Translations

 

The Company’s outstanding foreign-denominated debt obligations were as follows:

 

   September 30, 2025 
   Original Principal
Amount (Local)
   Original Principal
Amount (USD)
   Outstanding Principal   Unrealized Gain
(Loss)
 
Canadian Dollar   26,756   $18,647   $19,221   $(574)
European Euro   4,688    4,998    5,501    (503)
Great British Pound   4,020    5,156    5,405    (249)
Total       $28,801   $30,127   $(1,326)

 

   December 31, 2024 
   Original Principal
Amount (Local)
   Original Principal
Amount (USD)
   Outstanding Principal   Unrealized Gain
(Loss)
 
Canadian Dollar   18,000   $12,541   $12,514   $27 
European Euro   5,000    5,222    5,177    45 
Great British Pound   2,000    2,520    2,503    17 
Total       $20,283   $20,194   $89 

 

Interest and Debt Expenses

 

The components of interest and debt expenses were as follows:

 

   Three Months Ended September 30, 2025   Nine Months Ended September 30, 2025 
Stated interest expense  $10,244   $22,379 
Facility unused fees   224    541 
Amortization of deferred financing costs   311    821 
Total interest and debt expenses  $10,779   $23,741 
Cash paid for interest expense  $10,260   $21,136 
Weighted average interest rate   6.10%   6.11%
Average debt outstanding  $657,315   $483,686 

 

Weighted average interest rates do not include impact of unused commitment fees or deferred financing costs. For both the three and nine months ended September 30, 2024, no interest expense was accrued.

 

As of September 30, 2025 and December 31, 2024, $2,105 and $174 of interest expense and $40 and $187, respectively, of unused commitment fees were included in interest payable on the Consolidated Statement of Assets and Liabilities.

 

92

 

 

Note 7. Commitments and Contingencies

 

In the normal course of business, the Company may enter into contracts that provide a variety of general indemnifications. Any exposure to the Company under these arrangements could involve future claims that may be made against the Company. Currently, no such claims exist or are expected to arise and, accordingly, the Company has not accrued any liability in connection with such indemnifications.

 

Unfunded commitments

 

The Company’s investment portfolio contains revolving line of credit or delayed draw commitments, which require the Company to fund when requested by the portfolio companies. As of September 30, 2025 and December 31, 2024, the Company had unfunded investment commitments in the aggregate par amount of $368,519 and $290,998, respectively. Such commitments are subject to the satisfaction of certain conditions set forth in the documents governing these loans and letters of credit and there can be no assurance that such conditions will be satisfied.

 

Off balance sheet risk

 

Off-balance sheet risk refers to an unrecorded potential liability that may result in a future obligation or loss, even though it does not appear on the Consolidated Statements of Assets and Liabilities. The Company may enter into derivative instruments that contain elements of off-balance sheet market and credit risk. As of September 30, 2025 and December 31, 2024, there were no commitments outstanding for derivative contracts.

 

Legal proceedings

 

From time to time, the Company may become a party to certain legal proceedings incidental to the normal course of its business. As of September 30, 2025 and December 31, 2024, management is not aware of any material pending legal proceedings individually or in the aggregate.

 

93

 

 

Note 8. Net Assets

 

The Company is currently offering on a continuous basis up to $2 billion of Common Shares at $0.01 per share par value, and has the authority to issue an unlimited number of Common Shares at $0.01 per share par value, in connection with its formation. The Company expects to offer to sell a combination of three separate classes of Common Shares: Class S shares, Class D shares and Class I shares, with a dollar value up to the maximum offering amount. The share classes have different ongoing shareholder servicing and/or distribution fees. The per share purchase price for Common Shares in the Company’s Offering will be equal to the Company’s NAV per share, as of the effective date of the monthly share purchase date.

 

The following table summarizes transactions in Common Shares during the three and nine months ended September 30, 2025:

 

   Three Months Ended September 30, 2025   Nine Months Ended September 30, 2025 
   Shares   Amount   Shares   Amount 
CLASS I                    
Subscriptions   1,263,848   $31,882    2,470,603   $62,198 
Share transfers between classes                
Distributions reinvested   15,136    382    17,862    450 
Net increase (decrease)   1,278,984   $32,264    2,488,465   $62,648 
CLASS S                    
Subscriptions      $       $ 
Share transfers between classes                
Distributions reinvested                
Net increase (decrease)      $       $ 
CLASS D                    
Subscriptions      $       $ 
Share transfers between classes                
Distributions reinvested                
Net increase (decrease)      $       $ 
Total net increase (decrease)   1,278,984   $32,264    2,488,465   $62,648 

 

On August 29, 2023, an affiliate of the Adviser subscribed for 1,000 shares of the Company’s Class I Shares of beneficial interest at $25.00 per share. On November 5, 2024, an affiliate of the Adviser sold 1,000 Class I Shares for an aggregate consideration at a price of $25.00 per Class I Share. As of September 30, 2025 and December 31, 2024, no entity with an advisory relationship with Antares or its affiliates, including the Company, as appropriate given the context of the disclosure (including the Adviser) ("Antares Parties") own Common Shares of the Company.

 

94

 

 

Share Repurchase Program

 

The Company has commenced a share repurchase program in which the Company intends to repurchase, in each quarter, up to 5% of the Common Shares outstanding (either by number of Common Shares or aggregate net asset value) as of the close of the previous calendar quarter. The Company’s Board may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Company and the best interest of the Company’s shareholders. As a result, share repurchases may not be available each quarter. The Company intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the 1940 Act. All shares purchased pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued shares.

 

Under the Company’s share repurchase program, to the extent the Company offers to repurchase shares in any particular quarter, the Company expects to repurchase shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived, at the Company’s discretion, in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Company for the benefit of remaining shareholders across all shares.

 

Distributions

 

The Company authorizes and declares distribution amounts per share of Common Shares payable monthly in arrears. The following table presents distributions that were declared during the nine months ended September 30, 2025:

 

Declaration Date  Payment Date  Base Distribution
Per Share (1)
   Special Distribution
Per Share (1)
   Total Distribution
Per Share (1)
   Total
Distribution
Amount
 
January 31, 2025  February 28, 2025  $0.1912   $0.0159   $0.2071   $5,261 
February 28, 2025  March 31, 2025   0.1734    0.0193    0.1927    4,896 
March 31, 2025  April 30, 2025   0.1920    0.0213    0.2133    5,426 
April 30, 2025  May 30, 2025   0.1858    0.0258    0.2116    5,443 
May 30, 2025  June 30, 2025   0.1916    0.0266    0.2182    5,647 
June 25, 2025  July 31, 2025   0.1859    0.0258    0.2117    5,634 
July 31, 2025  August 29, 2025   0.1927    0.0268    0.2195    5,908 
August 28, 2025  September 29, 2025   0.1930    0.0268    0.2198    6,037 
September 30, 2025  October 30, 2025   0.1866    0.0207    0.2073    5,782 
Total     $1.6922   $0.2090   $1.9012   $50,034 

 

(1)Rounded to four decimal places.

 

Distribution Reinvestment Plan

 

The Company has adopted a distribution reinvestment plan, pursuant to which the Company reinvests all cash distributions declared on behalf of the Company’s shareholders who do not elect to receive their distributions in cash. As a result, if the Board authorizes and declares a cash distribution, then the shareholders who have enrolled in the distribution reinvestment plan will have their cash distributions automatically reinvested in additional shares of the Company's Common Shares, rather than receiving the cash distribution. The Company expects to use newly issued shares to implement the distribution reinvestment plan. Distributions on fractional shares are credited to each participating shareholder’s account to three decimal places.

 

95

 

 

Note 9. Financial Highlights

 

The following are the financial highlights for the nine months ended September 30, 2025:

 

    Nine Months Ended September 30, 2025  
Per Share Data: (1) (2)        
Net assets, beginning of period   $ 25.09  
Net investment income (loss)     2.09  
Net realized and change in unrealized appreciation (depreciation)     (0.07 )
Net increase (decrease) in net assets resulting from operations     2.02  
Distributions declared     (1.90 )
Total increase (decrease) in net assets     0.12  
Net assets, end of period   $ 25.21  
Common Shares outstanding, end of period     27,894,139  
Total return based on net asset value (3)     8.33 %
Ratios: (4)        
Expenses to average net assets gross of fee waivers     8.30 %
Net expenses to average net assets net of fee waivers     6.57 %
Net investment income to average net assets     10.60 %
Portfolio turnover rate (5)     13.79 %
Supplemental Data:        
Net assets, end of period   $ 703,219  
Asset coverage ratio (6)     197.65 %

 

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data was derived using the actual shares outstanding at the date of the relevant transaction (See Note 8).

(3)Total return (not annualized) is calculated as the change in net assets per share during the period, plus distributions per share (assuming distributions are reinvested in accordance with the Company’s distribution reinvestment plan), divided by the net assets per share at the beginning of the period.

(4)Amounts are annualized except for non-recurring income and expenses (organization and offering expenses, management fee waiver, incentive fee waiver and reimbursable expenses paid to adviser).

(5)Portfolio turnover rate is calculated using the lesser of the year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the period reported. Ratio does not include impact of short-term investments.

(6)In accordance with the 1940 Act, with certain limitations, the Company is allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is at least 150% after such borrowing.

 

96

 

 

Note 10. Segment Reporting

 

The Company operates through a single operating and reporting segment with the investment objective to provide risk-adjusted returns and current income to shareholders by investing primarily in loans to U.S. borrowers. The Chief Operating Decision Maker ("CODM") function is comprised of the Company’s chief executive officer, chief financial officer and chief compliance officer, which evaluates the performance of the Company on a consolidated basis, and which operates under the specific regulatory requirements of the Investment Company Act of 1940. The CODM function utilizes key metrics including, but not limited to, net increase (decrease) in net assets resulting from operations (as reported on the Consolidated Statements of Operations) for determining the Company’s investment strategy, capital allocation, expense structure, and potential significant transactions. As the Company’s operations comprise of a single reporting segment, the segment assets are reflected on the accompanying Consolidated Statements of Assets and Liabilities as “total assets” and the significant segment expenses are listed on the accompanying Consolidated Statements of Operations. The Company’s adoption of this guidance did not have a material impact on the Company’s financial position, results of operations or cash flows.

 

Note 11. Subsequent Events

 

The Company has evaluated events and transactions for potential recognition or disclosure through November 13, 2025. There are no subsequent events to disclose except for the following:

 

Subscriptions

 

On October 1, 2025, the Company sold and issued 503,194 Class I shares for an aggregate consideration of approximately $12.7 million at a price of $25.21 per share.

 

On October 31, 2025, the Company declared a regular distribution in the amount of $0.1928 per share and a special distribution in the amount of $0.0161 per share for its Common Shares, which are payable to shareholders of record as of October 31, 2025, and will be paid on or about November 25, 2025. These distributions will be paid in cash or reinvested in additional Common Shares for shareholders participating in the Company’s distribution reinvestment plan.

 

The Company received $9.4 million of net proceeds relating to the issuance of Class I shares for subscriptions effective November 1, 2025.

 

97

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Overview

 

We are a newly organized, non-diversified closed-end management investment company that has elected to be treated as a business development company (“BDC”) under the 1940 Act as of November 5, 2024. We also have elected to be treated, and intend to comply with the requirements to qualify annually, as a regulated investment company (“RIC”) under the Internal Revenue Code of 1986, as amended (the “Code”). We are a non-traded, perpetual-life BDC, which is a BDC whose common shares of beneficial interest (“Common Shares”) are not listed for trading on a stock exchange or other securities market. The Company uses the term “perpetual-life BDC” to describe an investment vehicle of indefinite duration whose Common Shares are intended to be sold by the Company monthly on a continuous basis at a price generally equal to the Company’s net asset value (“NAV”) per Common Share. Formed as a Delaware statutory trust on May 1, 2023, we are externally managed by Antares Capital Credit Advisers LLC (the "Adviser"), which is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring our portfolio on an ongoing basis. Our Adviser is registered as an investment adviser with the SEC.

 

Our investment objective is to provide risk-adjusted returns and current income to shareholders by investing primarily in loans to U.S. borrowers.

 

Our investment strategy focuses primarily on private credit investments structured as Portfolio Loans to U.S. borrowers. A “Portfolio Loan” is a senior secured loan, which may be first lien, second lien or unitranche loan, consisting of term loans and/or related delayed draw term loans and/or revolving loans, and each tranche of a senior secured loan acquired by the Company is referred to as a Portfolio Loan. The Company acquires Portfolio Loans that have been sourced and underwritten (i.e., evaluated for associated potential risks) by Antares Capital LP, its consolidated subsidiaries or joint ventures whose equity securities or whose subordinated notes or other interests that constitute the economic equity therein, as applicable, are directly or indirectly majority-owned by Antares Holdings LLC, and any entity with an advisory relationship with Antares or its affiliates, including the Company, as appropriate given the context of the disclosure (including the Adviser) (the “Antares Parties”) or by other loan originators that can include, among others, joint ventures in which one or more Antares Parties have interests. A Portfolio Loan is one that the Company may generally hold on its own or in a group with other Antares Parties advised funds and accounts and/or third-party investors. Portfolio Loans are generally expected to have an average contractual term of five to seven years, with an expected life typically between three to four years. Unitranche loans represent a hybrid loan structure that combines senior debt and subordinated debt into one loan.

 

While our investment strategy primarily focuses on companies in the U.S., we also intend to leverage the Antares platform’s global presence to invest in companies in Canada, Europe and other locations outside the U.S., subject to compliance with BDC requirements to invest at least 70% of assets in “eligible portfolio companies”. The Company’s subsidiaries’ (including entities that engage in investment activities in securities or other assets that are primarily controlled by the Company) principal investment strategies and associated principal risks will be consistent with the Company’s principal investment strategies and associated principal risks. We may also invest in preferred equity, or our debt investments may be accompanied by equity-related securities (such as options or warrants) and/or select common equity investments.

 

Our investment strategy also includes a smaller allocation to more liquid credit investments such as broadly syndicated loans and corporate bonds. We may use these investments to maintain liquidity for our share repurchase program and manage cash before investing subscription proceeds into originated loans, while also seeking attractive investment returns. We may also invest in publicly traded securities of larger corporate issuers on an opportunistic basis when market conditions create compelling potential return opportunities, subject to compliance with BDC requirements.

 

To seek to enhance our returns, we intend to employ leverage as market conditions permit and at the discretion of the Adviser, but in no event will leverage employed exceed the limitations set forth in the 1940 Act, which currently allows us to borrow up to a 2:1 debt to equity ratio. We intend to use leverage in the form of borrowings, including loans from certain financial institutions and the issuance of debt securities. We may also use leverage in the form of the issuance of preferred shares, but do not currently intend to do so. In determining whether to borrow money, we will analyze the maturity, covenant package and rate structure of the proposed borrowings as well as the risks of such borrowings compared to our investment outlook. Any such leverage, if incurred, would be expected to increase the total capital available for investment by the Company.

 

Revenues

 

We generate revenue in the form of interest and fee income on debt investments, capital gains, and dividend income from our equity investments in our portfolio companies. Our senior and subordinated debt investments bear interest at a fixed or floating rate. Interest on debt securities is generally payable quarterly or semiannually. In some cases, some of our investments may provide for deferred interest payments or payment-in-kind (“PIK”) interest. The principal amount of the debt securities and any accrued but unpaid PIK interest generally become due at the maturity date. In addition, we may generate revenue from various fees in the ordinary course of business such as in the form of structuring, consent, waiver, amendment, syndication and other miscellaneous fees. Original issue discounts and market discounts or premiums are capitalized, and we accrete or amortize such amounts as interest income. We record prepayment premiums on loans and debt securities as interest income. Dividend income, if any, is recognized on an accrual basis to the extent that we expect to collect such amounts.

 

98

 

 

Expenses

 

Except as specifically provided below, all investment professionals and staff of the Adviser, when and to the extent engaged in providing investment advisory services to us, and the base compensation, bonus and benefits, and the routine overhead expenses, of such personnel allocable to such services, will be provided and paid for by the Adviser. We bear all other costs and expenses of our operations, administration and transactions, including, but not limited to:

 

·investment advisory fees, including management fees and incentive fees, paid to the Adviser pursuant to the Investment Advisory Agreement;

 

·the Company’s allocable portion of compensation, overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement, including but not limited to: (i) the Company’s chief compliance officer, chief financial officer and their respective staffs; (ii) investor relations, legal, operations and other non-investment professionals at the Administrator that perform duties for the Company; and (iii) any internal audit group personnel of the Adviser or any of its affiliates; and

 

·all other expenses of the Company’s operations, administration and transactions (which may be directly incurred by the Company or allocated among the Company and the Adviser’s other clients).

 

From time to time, the Adviser or its affiliates may pay third-party providers of goods or services. We reimburse the Adviser such affiliates thereof for any such amounts paid on our behalf. From time to time, the Adviser may defer or waive fees and/or rights to be reimbursed for expenses. All of the foregoing expenses are ultimately borne by our shareholders, unless waived.

 

Portfolio and Investment Activity

 

As of September 30, 2025, we had investments in 432 portfolio companies across 45 industries. Based on fair value as of September 30, 2025, approximately 99.94% of our debt portfolio was invested in debt bearing a floating interest rate (e.g. Secured Overnight Financing Rate (“SOFR”)), which primarily is subject to interest rate floors. As of September 30, 2025, our weighted average total yield of debt securities at amortized cost was 8.70%. Weighted average yields excludes the effect of accretion of discounts and amortization of premiums and are based on interest rates as of September 30, 2025.

 

As of December 31, 2024, we had investments in 368 portfolio companies across 43 industries. Based on fair value as of December 31, 2024, approximately 99.92% of our debt portfolio was invested in debt bearing a floating interest rate, which primarily is subject to interest rate floors. As of December 31, 2024, our weighted average total yield of debt securities at amortized cost was 9.22%. Weighted average yields excludes the effect of accretion of discounts and amortization of premiums and are based on interest rates as of December 31, 2024.

 

Investment disclosures in this section are related to non-controlled/non-affiliated investments unless otherwise indicated.

 

Our investment activity is presented below (information presented herein is at amortized cost unless otherwise indicated, table below in thousands):

 

   Three Months Ended
September 30, 2025
   Nine Months Ended
September 30, 2025
 
Total investments, beginning of period  $1,243,529   $849,742 
Purchases of investments (including received in-kind)   217,407    702,935 
Net accretion of discount and amortization of premium   464    1,372 
Net realized (gains) losses on investments   1    (13)
Proceeds from sale of investments and principal repayments   (65,571)   (158,206)
Total investments, end of period  $1,395,830   $1,395,830 

 

99

 

 

The following table presents certain selected information regarding our investment portfolio:

 

   September 30, 2025   December 31, 2024 
Weighted average yield on debt and income producing investments, at amortized cost (1)   8.70%   9.22%
Weighted average yield on debt and income producing investments, at fair value (1)   8.70%   9.22%
Number of portfolio companies   432    368 
Median LTM EBITDA (2)(3)  $84.6M   $85.1M 
Weighted average net senior leverage (2)(4)   5.1x    5.0x 
Weighted average loan-to-value (“LTV”) (2)(5)   34%   33%
Percentage of debt investments bearing a floating rate, at fair value   99.94%   99.92%
Percentage of debt investments bearing a fixed rate, at fair value   0.06%   0.08%

 

(1)Computed based on the stated interest rate or yield as of September 30, 2025 and December 31, 2024, and weighted based on the total debt and income producing investments (at fair value or amortized cost, as applicable). Actual yields earned over the life of each investment could differ materially from the yields presented above. Weighted average yield excludes the effect of accretion of discounts and amortization of premiums.

(2)Includes all private loan investments for which fair value is determined by the Adviser at least quarterly (with assistance, as applicable, from a third-party valuation firm, and subject to oversight by the Board). Figures are derived from the financial statements most recently obtained by the Adviser.

(3)LTM EBITDA refers to adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) in accordance with the underlying governing documents, over the last twelve months as reported by respective borrowers. Excludes investments with no reported EBITDA or where EBITDA, in the Adviser’s judgment, was not a material component of the investment thesis, such as annual recurring revenue loans, or investments with negative EBITDA.

(4)Net senior leverage is the ratio of total debt minus unrestricted cash divided by LTM EBITDA and taking into account leverage through the tranche in which the Company holds an investment, excluding recurring revenue loans. Weighted average net senior leverage is weighted based on the funded commitment of total applicable private loans.

(5)LTV is calculated as net debt through each respective investment tranche in which the Company holds an investment divided by estimated enterprise value or value of the underlying collateral of the portfolio company, excluding recurring revenue loans. Weighted average LTV is weighted based on the funded commitment of the total applicable private loans.

 

100

 

 

As part of the monitoring process, our Adviser has developed risk policies pursuant to which it regularly assesses the risk profile of each of our debt investments. Our Adviser has developed a classification system to group investments into five categories. The investments are evaluated regularly and assigned a category based on certain credit metrics. Our Adviser’s ratings do not constitute any rating of investments by a nationally recognized statistical rating organization or represent or reflect any third-party assessment of any of our investments. Please see below for a description of the five categories of the Adviser’s Internal Risk Rating system:

 

·Internal Performance Rating A: Portfolio Companies performing generally as expected or above expectations and the trends and risk factors are generally neutral to favorable since origination. No concern about repayment of both interest and principal. All investments or acquired investments in new portfolio companies are initially assessed this level.

 

·Internal Performance Rating B: Portfolio Companies performing generally as expected but the trends require increased monitoring. Portfolio companies are current on both interest and principal payments.

 

·Internal Performance Rating C: Portfolio Companies performing below expectations and level of risk has increased since the time of origination. Portfolio companies are generally current on both interest and principal payments.

 

·Internal Performance Rating D: Portfolio Companies performing materially below expectations and the level of risk has increased materially since origination. In addition to the borrower being generally out of compliance with original debt covenants, loan payments may be past due, but generally not by more than 120 days. There is a higher risk of both payment default and repayment of interest and principal in full.

 

·Internal Performance Rating E: Portfolio Companies are non-earning and performing substantially below expectations. The level of risk has increased substantially since origination. Most or all of the original debt covenants are out of compliance and payments are substantially delinquent. There is a high risk that all principal and interest will not be recovered in full.

 

The following tables show the distribution of our investments on the A to E internal performance rating scale at fair value:

 

   September 30, 2025 
Internal Performance Rating  Investments at Fair Value
(in thousands)
   % of Total Investments
at Fair Value
   Number of Portfolio
Companies
 
A  $1,363,580    97.84%   396 
B   12,438    0.89    20 
C   17,467    1.25    14 
D   273    0.02    2 
E            
   $1,393,758    100.00%   432 

 

   December 31, 2024 
Internal Performance Rating  Investments at Fair Value
(in thousands)
   % of Total Investments
at Fair Value
   Number of Portfolio
Companies
 
A  $844,820    99.59%   340 
B   3,345    0.39    27 
C   195    0.02    1 
D            
E            
   $848,360    100.00%   368 

 

As of both September 30, 2025 and December 31, 2024 there were no portfolio companies with loans on non-accrual status.

 

The composition of our investment portfolio at amortized cost and fair value is as follows (dollar amounts in thousands):

 

   September 30, 2025   December 31, 2024 
   Amortized
Cost
   Fair Value   % of Total
Investments
at Fair Value
   Amortized
Cost
   Fair Value   % of Total
Investments
at Fair Value
 
Secured Debt  $1,377,503   $1,374,990    96.64%  $845,082   $843,710    99.45%
Unsecured Debt   793    783    0.06    713    703    0.08 
Equity Investments   17,534    17,985    1.26    3,947    3,947    0.47 
Short-Term Investments (1)   29,010    29,010    2.04             
Total Investments at fair value  $1,424,840   $1,422,768    100.00%  $849,742   $848,360    100.00%

 

(1)As of June 30, 2025, the Company has made a prospective presentation change to reclassify money market fund investments as short-term investments. As of December 31, 2024, the amortized cost and fair value of money market investments held by the Company was $39.5 million.

 

101

 

 

The industry composition of the Company's non-controlled, non-affiliated investments (at fair value) was as follows:

 

   September 30, 2025   December 31, 2024 
Aerospace and Defense   0.61%   0.43%
Air Freight and Logistics   0.79    0.66 
Automobile Components   1.37    2.26 
Beverages   0.07     
Building Products   0.24    0.31 
Capital Markets   1.94    2.99 
Chemicals   3.91    2.23 
Commercial Services and Supplies   8.01    9.76 
Construction & Engineering   1.20    0.84 
Construction Materials   0.83    0.84 
Containers and Packaging   4.62    3.17 
Distributors   1.99    2.44 
Diversified Consumer Services   6.55    8.78 
Diversified Telecommunication Services   0.57    0.50 
Electrical Equipment   1.16    1.53 
Electronic Equipment, Instruments and Components   0.81    1.33 
Energy Equipment and Services   0.99    1.35 
Financial Services   6.66    4.39 
Food Products   1.39    0.91 
Gas Utilities   0.83     
Ground Transportation   0.01    0.02 
Health Care Technology   5.98    4.44 
Healthcare Equipment and Supplies   0.54    0.56 
Healthcare Providers and Services   7.41    5.54 
Hotels, Restaurants and Leisure   0.64    1.04 
Household Durables   0.01    0.02 
Household Products   0.75    0.33 
Industrial Conglomerates   1.10    0.96 
Insurance   6.21    7.32 
IT Services   3.25    4.23 
Life Sciences Tools & Services   0.67    0.94 
Machinery   1.32    0.99 
Media   0.50    2.18 
Oil, Gas and Consumable Fuels   0.63    1.30 
Personal Care Products   0.03    0.05 
Pharmaceuticals   2.14    1.77 
Professional Services   7.23    9.40 
Real Estate Management and Development   0.72    0.77 
Software   12.53    11.14 
Specialty Retail   0.49    0.02 
Technology Hardware, Storage and Peripherals   0.72    1.15 
Textiles, Apparel and Luxury Goods   0.65    0.25 
Trading Companies and Distributors   0.35    0.30 
Transportation Infrastructure   0.84    0.25 
Wireless Telecommunication Services   0.74    0.31 
    100.00%   100.00%

 

102

 

 

The tables below describe investments by geographic composition based on amortized cost and fair value (dollar amounts in thousands):

 

   September 30, 2025 
   Amortized
Cost
   Fair Value   % of Total
Investments at
Fair Value
   Fair Value
as % of
Net Assets
 
United States  $1,363,804   $1,361,612    97.69%   193.63%
Canada   32,026    32,146    2.31    4.57 
Total  $1,395,830   $1,393,758    100.00%   198.20%

 

   December 31, 2024 
   Amortized
Cost
   Fair Value   % of Total
Investments at
Fair Value
   Fair Value
as % of
Net Assets
 
United States  $824,707   $823,915    97.12%   129.25%
Canada   17,851    17,375    2.05    2.73 
United Kingdom   7,184    7,070    0.83    1.11 
Total  $849,742   $848,360    100.00%   133.09%

 

Results of Operations

 

Operating results for the three and nine months ended September 30, 2025 were as follows (table below in thousands):

 

   Three Months Ended
September 30, 2025
   Nine Months Ended
September 30, 2025
 
Total investment income  $32,216   $85,055 
Total expenses   16,815    41,537 
Management fees waiver   (1,005)   (5,009)
Incentive fees waiver   (1,143)   (5,811)
Reimbursable expenses paid by adviser   (35)   (683)
Net expenses, net of fee waivers   14,632    30,034 
Net investment income (loss)   17,584    55,021 
Net realized gain (loss)   154    947 
Net change in unrealized appreciation (depreciation)   101    (2,822)
Net increase (decrease) in net assets resulting from operations  $17,839   $53,146 

 

Net increase (decrease) in net assets resulting from operations can vary from period to period as a result of various factors, including deployment, the level of new investment commitments, the recognition of realized gains and losses and changes in unrealized appreciation and depreciation on the investment portfolio. As a result, comparisons may not be meaningful.

 

As we commenced investment operations on November 5, 2024, there were no significant operations or results for both the three and nine months ended September 30, 2024.

 

Investment Income

 

Investment income, was as follows for the three and nine months ended September 30, 2025 (table below in thousands):

 

   Three Months Ended
September 30, 2025
   Nine Months Ended
September 30, 2025
 
Interest income  $31,035   $80,732 
Payment-in-kind interest income   170    423 
Dividend income   220    539 
Other income   791    3,361 
Total investment income  $32,216   $85,055 

 

For the three and nine months ended September 30, 2025, our total investment income was driven by our deployment of capital and increase in invested balance of investments quarter-over-quarter. The size of our investment portfolio at fair value increased from $1.2 billion as of June 30, 2025 to $1.4 billion as of September 30, 2025, which has increased the balance of interest-bearing securities quarter-over-quarter. The weighted average yield on debt and income producing investments, at fair value, decreased from 9.0% as of June 30, 2025 to 8.7% as of September 30, 2025, which is attributable to decreases in index rates and incremental increases to allocations of broadly syndicated loans.

 

103

 

 

Interest income on our debt investments is dependent on interest rates and volume of loans outstanding, as well as the composition and credit quality of the portfolio. Generally, we expect the portfolio to generate predictable quarterly interest income based on the terms stated in each loan’s respective credit agreement.

 

Expenses

 

Expenses were as follows:

 

   Three Months Ended
September 30, 2025
   Nine Months Ended
September 30, 2025
 
Interest and debt expenses  $10,779   $23,741 
Management fees   2,180    6,184 
Income based incentive fee   2,366    7,034 
Administrative service fee   190    522 
Board of Trustees’ fee   45    115 
Other general and administrative expenses   743    2,366 
Organization and offering costs   512    1,575 
Total expenses   16,815    41,537 
Management fees waiver   (1,005)   (5,009)
Incentive fees waiver   (1,143)   (5,811)
Reimbursable expenses paid by adviser   (35)   (683)
Net expenses, net of fee waivers  $14,632   $30,034 

 

Other general and administrative expenses include professional fees related to legal, audit, tax, valuation services, insurance, filing, research, subscriptions and other costs. Administrative service expenses represent fees paid to the Administrator for our allocable portion of the cost of certain of our executive officers that perform duties for us. Organization costs and offering costs include expenses incurred in our initial formation and our offering of Common Shares. See "Item 1. Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 3. Agreements and Related Party Transactions". The increase in gross management fees was driven by growth in the NAV of the fund. The decrease in gross incentive fees quarter-over-quarter is attributable to lower pre-incentive fee net investment income earned during the three months ended September 30, 2025 compared to the three months ended June 30, 2025, which itself is attributable to the end of the management fee waiver period and decreasing index rates.

 

Interest and Debt Expenses

 

The components of interest and debt expenses, cash paid for interest, annualized average interest rates and average outstanding balances were as follows:

 

   Three Months Ended
September 30, 2025
   Nine Months Ended
September 30, 2025
 
Stated interest expense  $10,244   $22,379 
Facility unused fees   224    541 
Amortization of deferred financing costs   311    821 
Total interest and debt expenses  $10,779   $23,741 
Cash paid for interest expense  $10,260   $21,136 
Weighted average interest rate   6.10%   6.11%
Average debt outstanding  $657,315   $483,686 

 

Interest expense for the three and nine months ended September 30, 2025 was driven by approximately $657.3 million and $483.7 million, respectively, of average borrowings outstanding (at an average effective interest rate, of 6.10% and 6.11%, respectively) related to borrowings for investments and expenses.

 

104

 

 

Net Realized and Change in Unrealized Gains and Losses

 

The following table summarizes our net realized and unrealized gains (losses) (table below in thousands):

 

   Three Months Ended
September 30, 2025
   Nine Months Ended
September 30, 2025
 
Net realized gain (loss) on investments  $1   $(13)
Unrealized appreciation on investments   3,550    4,725 
Unrealized (depreciation) on investments   (3,799)   (5,414)
Net change in unrealized appreciation (depreciation) on investments  $(249)  $(689)

 

We determine the fair value of our investments quarterly and any changes in fair value are recorded as unrealized appreciation or depreciation. For the three and nine months ended September 30, 2025, net change in unrealized gains (losses) on our investments was ($0.2) million and ($0.7) million, respectively.

 

The valuations of our debt investments generally increase or decrease as a result of various factors, including tightening and widening credit spreads of public and private markets, changes in the credit quality of borrowers, as well as changes in transaction prices during the period.

 

Management fee

 

The base management fee is payable monthly in arrears at an annual rate of 1.25% of the Company’s NAV as of the beginning of the first business day of the month. For the three and nine months ended September 30, 2025, the Company incurred management fees of $2.2 million and $6.2 million, respectively, before impact of waived fees. For the three and nine months ended September 30, 2025, the Adviser elected to waive $1.0 million and $5.0 million, respectively, resulting in $1.2 million and $1.2 million in management fees net of waiver, respectively. For both the three and nine months ended September 30, 2024, the Company had not commenced operations and did not accrue any management fees.

 

Incentive fee

 

The incentive fee consists of two components that are independent of each other, with the result that one component may be payable even if the other is not. A portion of the incentive fee is based on a percentage of income and a portion is based on a percentage of capital gains, each described below.

 

Income based incentive fee

 

The income based incentive fee is based on “Pre-Incentive Fee Net Investment Income Returns” meaning dividends, cash interest or other distributions or other cash income and any third-party fees received from portfolio companies (such as upfront fees, commitment fees, origination fees, amendment fees, ticking fees and break-up fees, as well as prepayments premiums, but excluding fees for providing managerial assistance and fees earned by the Adviser or an affiliate in its capacity as an administrative agent, syndication agent, collateral agent, loan servicer or other similar capacity) accrued during the month, minus operating expenses for the month (including the management fee, taxes, any expenses payable under the Investment Advisory Agreement and Administration Agreement (as defined below), any expense of securitizations, and interest expense or other financing fees and any dividends paid on preferred shares, but excluding the incentive fee and shareholder servicing and /or distribution fees). Pre-Incentive Fee Net Investment Income Returns includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero-coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments are also excluded from Pre-Incentive Fee Net Investment Income Returns.

 

Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of net assets at the end of the preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6.0% annualized). The Company pays an incentive fee quarterly as follows:

 

·No investment income incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which the Pre-Incentive Fee Net Investment Income Returns does not exceed the hurdle rate of 1.50% per quarter (6.0% annualized).

 

·100% of the dollar amount of the Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.71% (6.86% annualized).

 

·12.5% of the dollar amount of the Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.71% (6.86% annualized).

 

Capital gains incentive fee

 

The second component of the incentive fee, the capital gains incentive fee, is payable at the end of each calendar year in arrears. The amount payable is equal to 12.5% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fee as calculated in accordance with U.S. GAAP. U.S. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee actually payable under the investment advisory agreement. This U.S. GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation, net of any expense associated with cumulative unrealized capital depreciation or appreciation. If such amount is positive at the end of a period, then U.S. GAAP requires the Company to record a capital gains incentive fee equal to 12.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees paid or capital gains incentive fees accrued under U.S. GAAP in all prior periods. Gross capital gains incentive fee is net of reversal on accrued capital gains incentive fees.

 

105

 

 

For purposes of computing the Company’s investment income incentive fee and capital gains incentive fee, the calculation methodology looks through derivative financial instruments or swaps as if the Company owned the reference assets directly. The fees that are payable under the Investment Advisory Agreement for any partial period are appropriately prorated.

 

On October 31, 2024, the Company and the Adviser entered into a waiver letter agreement (the “Waiver Letter Agreement”), pursuant to which the Adviser agreed to irrevocably waive, which may be effected by a rebate or otherwise, (i) any base management fee due from the Company to the Adviser under Section 5(a) of the Investment Advisory Agreement and (ii) any incentive fee from the Company to the Adviser under Section 5(b) of the Investment Advisory Agreement for a six-month period following the effective date of the Company’s registration statement on Form N-2, which was declared effective on February 12, 2025.

 

For the three and nine months ended September 30, 2025, the Company incurred income based incentive fees of $2.4 million and $7.0 million, and did not incur any incentive fees on capital gains. For the three and nine months ended September 30, 2025, the Adviser agreed to waive $1.2 million and $5.8 million in total incentive fees, respectively, resulting in $1.2 million and $1.2 million incentive fees payable, respectively.

 

Expense Support Agreement

 

The Company has entered into an Expense Support and Conditional Reimbursement Agreement (the “Expense Support Agreement”) with the Adviser. Pursuant to the Expense Support Agreement, the Adviser is obligated to advance all of the Company’s Other Operating Expenses (defined below) (each, a “Required Expense Payment”) to the extent that such expenses do not exceed 1.00% (on an annualized basis) of the Company’s NAV. Any Required Expense Payment must be paid by the Adviser to the Company in any combination of cash or other immediately available funds and/or offset against amounts due from us to the Adviser or its affiliates. The Adviser may elect to pay certain additional expenses on the Company’s behalf (each, a “Voluntary Expense Payment” and together with a Required Expense Payment, the “Expense Payments”), provided that no portion of the payment will be used to pay any interest expense of the Company. Any Voluntary Expense Payment that the Adviser has committed to pay must be paid by the Adviser to the Company in any combination of cash or other immediately available funds no later than forty-five (45) days after such commitment was made in writing, and/or offset against amounts due from the Company to the Adviser or its affiliates. “Other Operating Expenses” means the Company’s total organization and offering expenses, professional fees, trustee fees, administration fees, and other general and administrative expenses (including the Company’s allocable portion of compensation (including salaries, bonuses and benefits), overhead (including rent, office equipment and utilities) and other expenses incurred by the Administrator in performing its administrative obligations under the Administration Agreement), excluding the Management Fee and Incentive Fee owed to the Adviser, financing fees and costs, brokerage commissions, placement agent fees, costs and expenses of distributing and placing the Common Shares, extraordinary expenses and any interest expenses owed by the Company, all as determined in accordance with U.S. GAAP.

 

Following any calendar month in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Company’s shareholders based on distributions declared with respect to record dates occurring in such calendar month (the amount of such excess being hereinafter referred to as “Excess Operating Funds”), we shall pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Expense Payments made by the Adviser to the Company within three years prior to the last business day of such calendar month have been reimbursed. Any payments required to be made by the Company shall be referred to herein as a “Reimbursement Payment.” “Available Operating Funds” means the sum of (i) our net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) our net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to us on account of investments in Portfolio Companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above).

 

No Reimbursement Payment for any month shall be made if: (1) the Effective Rate of Distributions Per Share declared by the Company at the time of such Reimbursement Payment is less than the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, (2) the Company’s Operating Expense Ratio at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relate, or (3) the Company’s Other Operating Expenses at the time of such Reimbursement Payment exceeds 1.00% of the Company’s NAV. “Effective Rate of Distributions Per Share” means the annualized rate (based on a 365 day year) of regular cash distributions per share exclusive of returns of capital, distribution rate reductions due to distribution and shareholder servicing fees, and declared special dividends or special distributions, if any. The “Operating Expense Ratio” is calculated by dividing Operating Expenses, less organizational and offering expenses, base management and incentive fees owed to the Adviser, shareholder servicing and/or distribution fees, and interest expense, by the Company’s net assets. “Operating Expenses” means all of the Company’s operating costs and expenses incurred, as determined in accordance with generally accepted accounting principles for investment companies.

 

106

 

 

The Company’s obligation to make a Reimbursement Payment shall automatically become a liability of the Company on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month.

 

In addition, effective October 31, 2024, the Company and the Adviser entered into a waiver letter agreement (the “Waiver Letter Agreement”), pursuant to which the Adviser agreed to waive any reimbursement by the Company for any of the Company’s organization expenses, operating expenses and offering expenses the Adviser incurs or has incurred on the Company’s behalf in an aggregate amount not to exceed $2 million. The Waiver Letter Agreement includes reimbursement provisions substantially similar to the reimbursement provisions included in the Expense Support Agreement.

 

For the nine months ended September 30, 2025 and 2024, the Company waived $0.7 million and $0.2 million, respectively, pursuant to the Expense Support Agreement which is included in the Consolidated Statements of Operations.

 

Financial Condition, Liquidity and Capital Resources

 

We expect to generate cash primarily from (i) the net proceeds of the Offering, (ii) cash flows from our operations, (iii) any financing arrangements we may enter into in the future and (iv) any future offerings of our equity or debt securities. We intend to sell our Common Shares on a continuous monthly basis at a per share price equal to the then-current NAV per share. Our primary uses of cash will be for (i) investments in Portfolio Companies and other investments, (ii) the cost of operations (including paying the Adviser (in its capacity as the Adviser and/or the Administrator)), (iii) cost of any borrowings or other financing arrangements and (iv) cash distributions to the holders of our shares.

 

As of September 30, 2025 we had one credit facility outstanding. From time to time, we may enter into additional credit facilities, increase the size of our existing credit facilities, enter additional short-term lending arrangements, and/or issue debt securities, including additional unsecured notes. In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. As of September 30, 2025 we had an aggregate amount of $720.1 million of debt outstanding and our asset coverage ratio was 197.65%. We seek to carefully consider our unfunded commitments for the purpose of planning our ongoing financial leverage. We believe that our current cash and cash equivalents on hand, our short-term investments, our available borrowing capacity under our Revolving Credit Facility and our anticipated cash flows from operations will be adequate to meet our cash needs for our daily operations in the near term.

 

Equity

 

The following table summarizes transactions in Common Shares during the three and nine months ended September 30, 2025 (table below in thousands):

 

   Three Months Ended September 30, 2025   Nine Months Ended September 30, 2025 
   Shares   Amount   Shares   Amount 
Issuance of shares   1,263,848   $31,882    2,470,603   $62,198 
Reinvestment of distributions   15,136    382    17,862    450 
Net increase (decrease)   1,278,984   $32,264    2,488,465   $62,648 

 

Share Repurchase Program

 

The Company has commenced a share repurchase program in which the Company intends to repurchase, in each quarter, up to 5% of the Common Shares outstanding (either by number of Common Shares or aggregate NAV) as of the close of the previous calendar quarter. The Company’s Board of Trustees may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Company and the best interest of the Company’s shareholders. As a result, share repurchases may not be available each quarter. The Company intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Exchange Act and the 1940 Act. All shares purchased pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued shares.

 

Under the Company’s share repurchase program, to the extent the Company offers to repurchase shares in any particular quarter, the Company expects to repurchase shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived, at the Company’s discretion, in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Company for the benefit of remaining shareholders across all shares.

 

107

 

 

Distributions

 

We authorize and declare distribution amounts per share of Common Share payable monthly in arrears.

 

The following table presents distributions that were declared during the nine months ended September 30, 2025:

 

Declaration Date  Payment Date  Base Distribution
Per Share (1)
   Special Distribution
Per Share (1)
   Total Distribution Per Share (1)   Total
Distribution
Amount
 
January 31, 2025  February 28, 2025  $0.1912   $0.0159   $0.2071   $5,261 
February 28, 2025  March 31, 2025   0.1734    0.0193    0.1927    4,896 
March 31, 2025  April 30, 2025   0.1920    0.0213    0.2133    5,426 
April 30, 2025  May 30, 2025   0.1858    0.0258    0.2116    5,443 
May 30, 2025  June 30, 2025   0.1916    0.0266    0.2182    5,647 
June 25, 2025  July 31, 2025   0.1859    0.0258    0.2117    5,634 
July 31, 2025  August 29, 2025   0.1927    0.0268    0.2195    5,908 
August 28, 2025  September 29, 2025   0.1930    0.0268    0.2198    6,037 
September 30, 2025  October 30, 2025   0.1866    0.0207    0.2073    5,782 
Total     $1.6922   $0.2090   $1.9012   $50,034 

 

(1)Rounded to four decimal places.

 

Sources of distributions, other than net investment income and realized gains on a U.S. GAAP basis, include required adjustments to U.S. GAAP net investment income in the current period to determine taxable income available for distributions. The following table reflects the sources of cash distributions on a U.S. GAAP basis that we declared on our Common Shares during the nine months ended September 30, 2025:

 

Source of Distribution  Per Share   Amount 
Net investment income (loss)  $2.09   $55,021 
Total net realized gain (loss)       (13)
Total  $2.09   $55,008 

 

Distribution Reinvestment Plan

 

We have adopted a distribution reinvestment plan, pursuant to which we will reinvest all cash distributions declared on behalf of our shareholders who do not elect to receive their distributions in cash. As a result, if we declare a cash distribution, then shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional shares, rather than receiving the cash distribution. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places.

 

Related-Party Transactions

 

We have entered into a number of business relationships with affiliated or related parties, including the following:

 

·the Investment Advisory Agreement;

 

·the Administration Agreement; and

 

·Expense Support and Conditional Reimbursement Agreement;

 

In addition to the aforementioned agreements, we, our Adviser and certain of our Adviser’s affiliates have been granted exemptive relief by the SEC to co-invest with other funds and accounts sponsored or managed by our Adviser or its affiliates in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors. For additional information, see “Note 3. Agreements and Related Party Transactions” to the consolidated financial statements.

 

Recent Developments

 

Subscriptions

 

On October 1, 2025, the Company sold and issued 503,194 Class I shares for an aggregate consideration of approximately $12.7 million at a price of $25.21 per share. The Company received $9.4 million of net proceeds relating to the issuance of Class I shares for subscriptions effective November 1, 2025.

 

Critical Accounting Estimates

 

The preparation of the consolidated financial statements will require our management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ. In addition, our critical accounting estimates related to investments, fair value measurement, interest and dividends income recognition and income taxes are included in the notes to our consolidated financial statements.

 

108

 

 

Contractual Obligations

 

The Company is required to report its investments for which current market values are not readily available at fair value. The Company values its investments in accordance with ASC 820, Fair Value Measurement, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the applicable measurement date. ASC 820 prioritizes the use of observable market prices derived from such prices over entity-specific inputs. Due to the inherent uncertainties of valuation, certain estimated fair values may differ significantly from the values that would have been realized had a ready market for these investments existed, and these differences could be material.

 

We entered into the Investment Advisory Agreement with the Adviser to provide us with investment advisory services and the Administration Agreement with Antares Capital Credit Advisers LLC (in its capacity as the Administrator) to provide us with administrative services. Payments for investment advisory services under the Investment Advisory Agreements and reimbursements under the Administration Agreement are described in “Item 1. Business.

 

We have established one or more credit facilities and may in the future establish additional credit facilities or enter into other financing arrangements to facilitate investments and the timely payment of our expenses. It is anticipated that any such credit facilities will bear interest at floating rates at to-be-determined spreads over SOFR (or other applicable reference rate). We cannot assure shareholders that we will be able to enter into a credit facility on favorable terms or at all. In connection with a credit facility or other borrowings, lenders may require us to pledge assets, commitments and/or drawdowns (and the ability to enforce the payment thereof and may ask to comply with positive or negative covenants that could have an effect on our operations).

 

Off-Balance Sheet Arrangements

 

Other than contractual commitments and other legal contingencies incurred in the normal course of our business, we do not have any off-balance sheet financings or liabilities.

 

Unfunded Commitments

 

The Company’s investment portfolio may contain revolving line of credit or delayed draw commitments, which require the Company to fund when requested by portfolio companies. As of September 30, 2025 and December 31, 2024, the Company had unfunded investment commitment in the aggregate par amount of $368.5 million and $291.0 million, respectively. Such commitments are subject to the satisfaction of certain conditions set forth in the documents governing these loans and letters of credit and there can be no assurance that such conditions will be satisfied.

 

109

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are subject to financial market risks, including changes in interest rates and foreign exchange rates. A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to the variable rate investments we may hold and to declines in the value of any fixed rate investments we may hold. A rise in interest rates would also be expected to lead to higher cost on our floating rate borrowings. If deemed prudent, we may use interest rate risk management techniques in an effort to minimize our exposure to interest rate fluctuations. The Company seeks to mitigate interest rate risk and foreign currency risk by generally employing a funding strategy of matching the duration and interest rate indices of our floating rate assets with floating rate liabilities, as well as matching currencies between our borrowing and lending, to the extent possible.

 

Valuation Risk

 

We plan to invest primarily in illiquid debt securities of private companies. Most of our investments do not have a readily available market price, and we value these investments at fair value as determined in good faith pursuant to procedures adopted by, and under the oversight of, the Board in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make.

 

Interest Rate Risk

 

Interest rate sensitivity refers to the change in earnings that may result from changes in the level of interest rates. We intend to fund portions of our investments with borrowings, and at such time, our net investment income will be affected by the difference between the rate at which we invest and the rate at which we borrow. Accordingly, we cannot assure shareholders that a significant change in market interest rates will not have a material adverse effect on our net investment income.

 

As of September 30, 2025, 99.94% of our performing debt investments at fair value were at floating rates, which are generally SOFR based and typically have durations of one to three months after which they reset to current interest rates, and many of which are subject to certain floors. Our credit facility (i.e. the Morgan Stanley Facility) bears interest at a floating rate with a zero percent interest rate floor. Based on our Consolidated Statements of Assets and Liabilities as of September 30, 2025, the following table shows the annualized impact on net interest income of hypothetical base rate changes in interest rates (considering base rate floors and ceilings for floating rate instruments) and assuming no changes in our investment and borrowing structure (table below in thousands):

 

Change in Interest Rates  Interest Income   Interest Expense   Net Interest Income 
Up 300 basis points  $41,778   $(21,604)  $20,174 
Up 200 basis points   27,852    (14,403)   13,449 
Up 100 basis points   13,926    (7,201)   6,725 
Down 100 basis points   (13,926)   7,201    (6,725)
Down 200 basis points   (27,710)   14,403    (13,307)
Down 300 basis points   (41,124)   21,604    (19,520)

 

We may in the future hedge against interest rate fluctuations by using hedging instruments such as additional interest rate swaps, futures, options and forward contracts. While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of changes in interest rates with respect to our portfolio investments.

 

110

 

 

Item 4. Controls and Procedures

 

(a)         Evaluation of Disclosure Controls and Procedures

 

In accordance with Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by the Quarterly Report on Form 10-Q.

 

(b)         Changes in Internal Controls Over Financial Reporting

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

111

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of any such future legal or regulatory proceedings cannot be predicted with certainty, we do not expect that any such future proceedings will have a material effect upon our financial condition or results of operations.

 

Item 1A. Risk Factors.

 

For information regarding factors that could affect our results of operations, financial condition and liquidity, see risk factors disclosed in “Item 1A Risk Factors” of our Annual Report on Form 10-K, filed with the SEC on March 18, 2025 and in “Item 1A. Risk Factors” of our Quarterly Reports on Form 10-Q, filed with the SEC on May 14, 2025 and August 13, 2025. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results. Except as set forth below, there have been no material changes during the three months ended September 30, 2025 to the risk factors set forth in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2024 and in “Item 1A. Risk Factors” of our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Except as described and as previously reported on our current reports on Form 8-K, we did not sell any securities during the period covered by this Quarterly Report on Form 10-Q that were not registered under the Securities Act.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

None.

 

Item 5. Other Information.

 

None.

 

112

 

 

Item 6. Exhibits

 

Exhibit
Number
  Description of Exhibits
31.1   Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2   Certification of Principal Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101.INS   Inline XBRL Instance Document
101.PRE   Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
104   Cover Page formatted as Inline XBRL and contained in Exhibit 101

 

 

* Filed herewith.

 

113

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Antares Private Credit Fund

 

Date: November 13, 2025   /s/ Vivek Mathew
      Vivek Mathew
      Chief Executive Officer
       
Date: November 13, 2025   /s/ Monica Kelsey
      Monica Kelsey
      Chief Financial Officer

 

114